Вы находитесь на странице: 1из 44

EUROPEAN PHARMACOPOEIA 5.

INDEX
To aid users the index includes a reference to the supplement where the latest version of a text can be found.
For example: Acetone...............................................5.1-2875
means the monograph Acetone can be found on page 2875 of Supplement 5.1.
Note that where no reference for a supplement is made, the text can be found in the principal volume.

General Notices (1) apply to all monographs and other texts 3649
EUROPEAN PHARMACOPOEIA 5.3

3650 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Numerics 2.2.56. Amino acid analysis ....................................................... 86


1.1. General statements.................................................................5 2.2.5. Relative density................................................................. 27
1.2. Other provisions applying to general chapters and 2.2.6. Refractive index ................................................................ 28
monographs ...................................................................................5 2.2.7. Optical rotation ................................................................. 28
1.3. General chapters .....................................................................6 2.2.8. Viscosity.............................................................................. 29
1.4. Monographs .............................................................................7 2.2.9. Capillary viscometer method ......................................... 29
1.5. Abbreviations and symbols...................................................9 2.2. Physical and physicochemical methods.......................... 23
1.6. Units of the International System (SI) used in the 2.3.1. Identification reactions of ions and functional
Pharmacopoeia and equivalence with other units..............10 groups .......................................................................................... 95
1,8-Cineole in essential oils, assay of (2.8.11.) ......................216 2.3.2. Identification of fatty oils by thin-layer
1. General notices ...........................................................................5 chromatography......................................................................... 98
2.1.1. Droppers..............................................................................17 2.3.3. Identification of phenothiazines by thin-layer
2.1.2. Comparative table of porosity of sintered-glass chromatography......................................................................... 99
filters..............................................................................................17 2.3.4. Odour .................................................................................. 99
2.1.3. Ultraviolet ray lamps for analytical purposes..............17 2.3. Identification......................................................................... 95
2.1.4. Sieves ...................................................................................18 2.4.10. Lead in sugars............................................................... 107
2.1.5. Tubes for comparative tests ............................................19 2.4.11. Phosphates..................................................................... 108
2.1.6. Gas detector tubes.............................................................19 2.4.12. Potassium....................................................................... 108
2.1. Apparatus ...............................................................................17 2.4.13. Sulphates ....................................................................... 108
2.2.10. Viscosity - Rotating viscometer method .........5.3-3337 2.4.14. Sulphated ash ......................................................5.3-3341
2.2.11. Distillation range ............................................................ 30 2.4.15. Nickel in polyols ........................................................... 108
2.2.12. Boiling point ....................................................................31 2.4.16. Total ash......................................................................... 108
2.2.13. Determination of water by distillation....................... 32 2.4.17. Aluminium...................................................................... 108
2.2.14. Melting point - capillary method................................. 32 2.4.18. Free formaldehyde ....................................................... 109
2.2.15. Melting point - open capillary method ...................... 33 2.4.19. Alkaline impurities in fatty oils ................................. 109
2.2.16. Melting point - instantaneous method ...................... 33 2.4.1. Ammonium....................................................................... 103
2.2.17. Drop point ........................................................................ 33 2.4.21. Foreign oils in fatty oils by thin-layer
2.2.18. Freezing point................................................................. 34 chromatography....................................................................... 109
2.2.19. Amperometric titration ................................................. 34 2.4.22. Composition of fatty acids by gas
2.2.1. Clarity and degree of opalescence of liquids.............. 23 chromatography........................................................................110
2.2.20. Potentiometric titration ................................................ 35 2.4.23. Sterols in fatty oils ..............................................5.1-2787
2.2.21. Fluorimetry...................................................................... 35 2.4.24. Identification and control of residual solvents...... 113
2.2.22. Atomic emission spectrometry.................................... 35 2.4.25. Ethylene oxide and dioxan..........................................118
2.2.23. Atomic absorption spectrometry ................................ 36 2.4.26. N,N-Dimethylaniline .....................................................119
2.2.24. Absorption spectrophotometry, infrared .................. 37 2.4.27. Heavy metals in herbal drugs and fatty oils............119
2.2.25. Absorption spectrophotometry, ultraviolet and 2.4.28. 2-Ethylhexanoic acid ................................................... 120
visible.................................................................................5.2-3089 2.4.29. Composition of fatty acids in oils rich in
2.2.26. Paper chromatography ................................................. 40 omega-3-acids............................................................................ 121
2.2.27. Thin-layer chromatography ...............................5.2-3090 2.4.2. Arsenic .............................................................................. 103
2.2.28. Gas chromatography ..................................................... 42 2.4.30. Ethylene glycol and diethylene glycol in ethoxylated
2.2.29. Liquid chromatography ................................................ 43 substances ........................................................................5.2-3095
2.2.2. Degree of coloration of liquids...................................... 24 2.4.3. Calcium............................................................................. 103
2.2.30. Size-exclusion chromatography .................................. 45 2.4.4. Chlorides .......................................................................... 104
2.2.31. Electrophoresis ............................................................... 45 2.4.5. Fluorides .......................................................................... 104
2.2.32. Loss on drying ................................................................ 50 2.4.6. Magnesium....................................................................... 104
2.2.33. Nuclear magnetic resonance spectrometry ...............51 2.4.7. Magnesium and alkaline-earth metals ....................... 104
2.2.34. Thermal analysis............................................................. 52 2.4.8. Heavy metals ................................................................... 104
2.2.35. Osmolality ........................................................................ 54 2.4.9. Iron .................................................................................... 107
2.2.36. Potentiometric determination of ionic 2.4. Limit tests............................................................................ 103
concentration using ion-selective electrodes....................... 55 2.5.10. Oxygen-flask method................................................... 130
2.2.37. X-ray fluorescence spectrometry................................. 56 2.5.11. Complexometric titrations.......................................... 130
2.2.38. Conductivity .........................................................5.1-2783 2.5.12. Water: semi-micro determination ............................. 130
2.2.39. Molecular mass distribution in dextrans .................. 57 2.5.13. Aluminium in adsorbed vaccines...............................131
2.2.3. Potentiometric determination of pH ............................ 26 2.5.14. Calcium in adsorbed vaccines ....................................131
2.2.40. Near-infrared spectrophotometry ............................... 59 2.5.15. Phenol in immunosera and vaccines ........................131
2.2.41. Circular dichroism.......................................................... 63 2.5.16. Protein in polysaccharide vaccines ...........................131
2.2.42. Density of solids ............................................................. 64 2.5.17. Nucleic acids in polysaccharide vaccines ................ 132
2.2.43. Mass spectrometry ......................................................... 65 2.5.18. Phosphorus in polysaccharide vaccines.................. 132
2.2.44. Total organic carbon in water for pharmaceutical 2.5.19. O-Acetyl in polysaccharide vaccines......................... 132
use................................................................................................. 68 2.5.1. Acid value................................................................5.2-3099
2.2.45. Supercritical fluid chromatography........................... 68 2.5.20. Hexosamines in polysaccharide vaccines................ 132
2.2.46. Chromatographic separation techniques.................. 69 2.5.21. Methylpentoses in polysaccharide vaccines ........... 133
2.2.47. Capillary electrophoresis ...............................................74 2.5.22. Uronic acids in polysaccharide vaccines ................. 133
2.2.48. Raman spectrometry ..................................................... 79 2.5.23. Sialic acid in polysaccharide vaccines ..................... 133
2.2.49. Falling ball viscometer method................................... 80 2.5.24. Carbon dioxide in gases.............................................. 134
2.2.4. Relationship between reaction of solution, 2.5.25. Carbon monoxide in gases......................................... 134
approximate pH and colour of certain indicators .............. 27 2.5.26. Nitrogen monoxide and nitrogen dioxide in
2.2.54. Isoelectric focusing.........................................................81 gases ........................................................................................... 135
2.2.55. Peptide mapping............................................................. 82 2.5.27. Oxygen in gases ............................................................ 136

General Notices (1) apply to all monographs and other texts 3651
Index EUROPEAN PHARMACOPOEIA 5.3

2.5.28. Water in gases............................................................... 136 2.7.6. Assay of diphtheria vaccine (adsorbed) ..................... 196
2.5.29. Sulphur dioxide ............................................................ 136 2.7.7. Assay of pertussis vaccine............................................. 197
2.5.2. Ester value ....................................................................... 127 2.7.8. Assay of tetanus vaccine (adsorbed)..................5.1-2791
2.5.30. Oxidising substances................................................... 137 2.7.9. Test for Fc function of immunoglobulin ................... 202
2.5.31. Ribose in polysaccharide vaccines............................ 137 2.7. Biological assays ................................................................ 187
2.5.32. Water: micro determination ...................................... 137 2.8.10. Solubility in alcohol of essential oils ........................216
2.5.33. Total protein.................................................................. 138 2.8.11. Assay of 1,8-cineole in essential oils .........................216
2.5.34. Acetic acid in synthetic peptides ...............................141 2.8.12. Determination of essential oils in vegetable
2.5.35. Nitrous oxide in gases..................................................141 drugs............................................................................................217
2.5.36. Anisidine value ............................................................. 142 2.8.13. Pesticide residues..........................................................218
2.5.3. Hydroxyl value ................................................................ 127 2.8.14. Determination of tannins in herbal drugs .............. 221
2.5.4. Iodine value ..................................................................... 127 2.8.15. Bitterness value ............................................................ 221
2.5.5. Peroxide value................................................................. 128 2.8.16. Dry residue of extracts................................................ 222
2.5.6. Saponification value ...................................................... 129 2.8.17. Loss on drying of extracts .......................................... 222
2.5.7. Unsaponifiable matter ................................................... 129 2.8.1. Ash insoluble in hydrochloric acid ............................. 215
2.5.8. Determination of primary aromatic 2.8.2. Foreign matter ................................................................ 215
amino-nitrogen ......................................................................... 129 2.8.3. Stomata and stomatal index ........................................ 215
2.5.9. Determination of nitrogen by sulphuric acid 2.8.4. Swelling index ................................................................. 215
digestion .................................................................................... 129 2.8.5. Water in essential oils.....................................................216
2.5. Assays ................................................................................... 127 2.8.6. Foreign esters in essential oils .....................................216
2.6.10. Histamine ....................................................................... 153 2.8.7. Fatty oils and resinified essential oils in essential
2.6.11. Depressor substances.................................................. 153 oils................................................................................................216
2.6.12. Microbiological examination of non-sterile products 2.8.8. Odour and taste of essential oils..................................216
(total viable aerobic count).................................................... 154 2.8.9. Residue on evaporation of essential oils....................216
2.6.13. Microbiological examination of non-sterile products 2.8. Methods in pharmacognosy ............................................ 215
(test for specified micro-organisms)..................................... 156 2.9.10. Ethanol content and alcoholimetric tables ............ 237
2.6.14. Bacterial endotoxins .....................................................161 2.9.11. Test for methanol and 2-propanol ...................5.3-3362
2.6.15. Prekallikrein activator................................................. 168 2.9.12. Sieve test ........................................................................ 239
2.6.16. Tests for extraneous agents in viral vaccines for 2.9.13. Limit test of particle size by microscopy................. 239
human use................................................................................. 169 2.9.14. Specific surface area by air permeability ................ 239
2.6.17. Test for anticomplementary activity of 2.9.15. Apparent volume .......................................................... 241
immunoglobulin....................................................................... 170 2.9.16. Flowability...................................................................... 242
2.6.18. Test for neurovirulence of live virus vaccines........ 172 2.9.17. Test for extractable volume of parenteral
2.6.19. Test for neurovirulence of poliomyelitis vaccine preparations.....................................................................5.3-3363
(oral) ........................................................................................... 172 2.9.18. Preparations for inhalation : aerodynamic assessment
2.6.1. Sterility ............................................................................. 145 of fine particles ............................................................... 5.2-3103
2.6.20. Anti-A and anti-B haemagglutinins 2.9.19. Particulate contamination : sub-visible particles... 253
(indirect method) ......................................................................174 2.9.1. Disintegration of tablets and capsules..............5.3-3351
2.6.21. Nucleic acid amplification techniques ......................174 2.9.20. Particulate contamination : visible particles.......... 255
2.6.22. Activated coagulation factors .................................... 177 2.9.22. Softening time determination of lipophilic
2.6.24. Avian viral vaccines : tests for extraneous agents in suppositories............................................................................. 256
seed lots ..................................................................................... 177 2.9.23. Pycnometric density of solids.................................... 257
2.6.25. Avian live virus vaccines : tests for extraneous agents 2.9.24. Resistance to rupture of suppositories and
in batches of finished product .....................................5.3-3345 pessaries .................................................................................... 258
2.6.26. Test for anti-D antibodies in human immunoglobulin 2.9.25. Dissolution test for medicated chewing
for intravenous administration ....................................5.3-3348 gums .................................................................................. 5.2-3116
2.6.2. Mycobacteria ................................................................... 149 2.9.26. Specific surface area by gas adsorption......... 5.1-2811
2.6.7. Mycoplasmas.................................................................... 149 2.9.27. Uniformity of mass of delivered doses from multidose
2.6.8. Pyrogens........................................................................... 152 containers.................................................................................. 263
2.6.9. Abnormal toxicity ........................................................... 153 2.9.28. Test for deliverable mass or volume of liquid and
2.6. Biological tests ................................................................... 145 semi-solid preparations........................................................... 263
2.7.10. Assay of human coagulation factor VII ................... 203 2.9.2. Disintegration of suppositories and pessaries ......... 227
2.7.11. Assay of human coagulation factor IX ..................... 204 2.9.36. Powder flow..........................................................5.3-3363
2.7.12. Assay of heparin in coagulation factors .................. 204 2.9.37. Optical microscopy..............................................5.3-3366
2.7.13. Assay of human anti-D immunoglobulin................. 205 2.9.38. Particle-size distribution estimation by analytical
2.7.14. Assay of hepatitis A vaccine ..............................5.1-2795 sieving ...............................................................................5.3-3368
2.7.15. Assay of hepatitis B vaccine (rDNA)......................... 207 2.9.3. Dissolution test for solid dosage forms ............5.3-3353
2.7.16. Assay of pertussis vaccine (acellular)....................... 208 2.9.40. Uniformity of dosage units................................5.3-3370
2.7.17. Assay of human antithrombin III .............................. 209 2.9.42. Dissolution test for lipophilic solid dosage
2.7.18. Assay of human coagulation factor II ...................... 209 forms..................................................................................5.3-3373
2.7.19. Assay of human coagulation factor X .......................210 2.9.4. Dissolution test for transdermal patches .................. 231
2.7.1. Immunochemical methods ........................................... 187 2.9.5. Uniformity of mass of single-dose preparations....... 233
2.7.20. In vivo assay of poliomyelitis vaccine 2.9.6. Uniformity of content of single-dose preparations.. 234
(inactivated) ...............................................................................210 2.9.7. Friability of uncoated tablets .............................. 5.2-3103
2.7.21. Assay of human von Willebrand factor.....................211 2.9.8. Resistance to crushing of tablets................................ 235
2.7.22. Assay of human coagulation factor XI..................... 212 2.9.9. Measurement of consistency by penetrometry ........ 235
2.7.2. Microbiological assay of antibiotics............................ 188 2.9. Pharmaceutical technical procedures ........................... 225
2.7.4. Assay of human coagulation factor VIII .................... 194 2-Ethylhexanoic acid (2.4.28.) ................................................. 120
2.7.5. Assay of heparin.............................................................. 195 2-Propanol and methanol, test for (2.9.11.).................5.3-3362

3652 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

3.1.10. Materials based on non-plasticised poly(vinyl chloride) 5.1.2. Biological indicators of sterilisation........................... 447
for containers for non-injectable, aqueous solutions ...... 289 5.1.3. Efficacy of antimicrobial preservation ....................... 447
3.1.11. Materials based on non-plasticised poly(vinyl 5.1.4. Microbiological quality of pharmaceutical
chloride) for containers for dry dosage forms for oral preparations.............................................................................. 449
administration .......................................................................... 291 5.1.5. Application of the F0 concept to steam sterilisation of
3.1.1.1. Materials based on plasticised poly(vinyl chloride) for aqueous preparations ....................................................5.1-2821
containers for human blood and blood components....... 269 5.1. General texts on sterility .................................................. 445
3.1.1.2. Materials based on plasticised poly(vinyl chloride) 5.2.1. Terminology used in monographs on vaccines ....... 453
for tubing used in sets for the transfusion of blood and 5.2.2. Chicken flocks free from specified pathogens for the
blood components ................................................................... 272 production and quality control of vaccines...............5.1-2825
3.1.13. Plastic additives ............................................................ 293 5.2.3. Cell substrates for the production of vaccines for
3.1.14. Materials based on plasticised poly(vinyl chloride) human use................................................................................. 455
for containers for aqueous solutions for intravenous 5.2.4. Cell cultures for the production of veterinary
infusion ...................................................................................... 296 vaccines...................................................................................... 458
3.1.15. Polyethylene terephthalate for containers for 5.2.5. Substances of animal origin for the production of
preparations not for parenteral use..................................... 298 veterinary vaccines.................................................................. 460
3.1.1. Materials for containers for human blood and blood 5.2.6. Evaluation of safety of veterinary vaccines and
components............................................................................... 269 immunosera ....................................................................5.1-2827
3.1.3. Polyolefines...................................................................... 274 5.2.7. Evaluation of efficacy of veterinary vaccines and
3.1.4. Polyethylene without additives for containers immunosera .....................................................................5.1-2829
for parenteral preparations and for ophthalmic 5.2.8. Minimising the risk of transmitting animal spongiform
preparations.............................................................................. 278 encephalopathy agents via human and veterinary medicinal
3.1.5. Polyethylene with additives for containers products ..................................................................................... 463
for parenteral preparations and for ophthalmic 5.2.9. Evaluation of safety of each batch of veterinary
preparations.............................................................................. 279 vaccines and immunosera.............................................5.1-2830
3.1.6. Polypropylene for containers and closures for 5.2. General texts on vaccines................................................. 453
parenteral preparations and ophthalmic preparations ... 282 5.3. Statistical analysis of results of biological assays and
3.1.7. Poly(ethylene - vinyl acetate) for containers and tubing tests............................................................................................. 475
for total parenteral nutrition preparations ........................ 285 5.4. Residual solvents ............................................................... 507
3.1.8. Silicone oil used as a lubricant ................................... 287 5.5. Alcoholimetric tables .........................................................519
3.1.9. Silicone elastomer for closures and tubing .............. 288 5.6. Assay of interferons..................................................5.3-3381
3.1. Materials used for the manufacture of containers ..... 269 5.7. Table of physical characteristics of radionuclides
3.2.1. Glass containers for pharmaceutical use .................. 303 mentioned in the European Pharmacopoeia..................... 539
3.2.2.1. Plastic containers for aqueous solutions for 5.8. Pharmacopoeial harmonisation ..................................... 551
parenteral infusion .................................................................. 309 5.9. Polymorphism..................................................................... 555
3.2.2. Plastic containers and closures for pharmaceutical
use............................................................................................... 308 A
3.2.3. Sterile plastic containers for human blood and blood Abbreviations and symbols (1.5.).................................................9
components............................................................................... 309 Abnormal toxicity (2.6.9.)......................................................... 153
3.2.4. Empty sterile containers of plasticised poly(vinyl Absinthii herba ........................................................................ 2710
chloride) for human blood and blood components...........311 Absorption spectrophotometry, infrared (2.2.24.)................ 37
3.2.5. Sterile containers of plasticised poly (vinyl chloride) Absorption spectrophotometry, ultraviolet and visible
for human blood containing anticoagulant solution....... 312 (2.2.25.) .............................................................................5.2-3089
3.2.6. Sets for the transfusion of blood and blood Acacia............................................................................................ 905
components................................................................................313 Acaciae gummi .......................................................................... 905
3.2.8. Sterile single-use plastic syringes ................................314 Acaciae gummi dispersione desiccatum............................. 905
3.2.9. Rubber closures for containers for aqueous parenteral Acacia, spray-dried ..................................................................... 905
preparations, for powders and for freeze-dried powders ..316 Acamprosate calcium ................................................................ 906
3.2. Containers ........................................................................... 303 Acamprosatum calcicum......................................................... 906
4.1.1. Reagents ........................................................................... 321 Acarbose..............................................................................5.1-2873
4.1.1. Reagents .................................................................. 5.1-2817 Acarbosum .........................................................................5.1-2873
4.1.1. Reagents ..................................................................5.2-3123 Acebutolol hydrochloride......................................................... 907
4.1.1. Reagents ..................................................................5.3-3377 Acebutololi hydrochloridum .................................................. 907
4.1.2. Standard solutions for limit tests................................ 426 Aceclofenac.................................................................................. 909
4.1.2. Standard solutions for limit tests....................... 5.1-2818 Aceclofenacum........................................................................... 909
4.1.3. Buffer solutions .............................................................. 430 Acesulfame potassium .....................................................5.3-3435
4.1.3. Buffer solutions .....................................................5.3-3378 Acesulfamum kalicum ....................................................5.3-3435
4.1. Reagents, standard solutions, buffer solutions ........... 321 Acetazolamide............................................................................. 912
4.2.1. Primary standards for volumetric solutions............. 435 Acetazolamidum........................................................................ 912
4.2.1. Primary standards for volumetric solutions....5.3-3378 Acetic acid, glacial ......................................................................913
4.2.2. Volumetric solutions...................................................... 435 Acetic acid in synthetic peptides (2.5.34.) .............................141
4.2.2. Volumetric solutions.............................................5.3-3378 Acetone................................................................................5.1-2875
4.2. Volumetric analysis............................................................ 435 Acetonum ...........................................................................5.1-2875
4-Aminobenzoic acid ................................................................. 973 Acetylcholine chloride ...............................................................914
4. Reagents.................................................................................. 321 Acetylcholini chloridum...........................................................914
5.10. Control of impurities in substances for pharmaceutical Acetylcysteine ..............................................................................915
use............................................................................................... 559 Acetylcysteinum .........................................................................915
5.11. Characters section in monographs .............................. 565 Acetylsalicylic acid ......................................................................917
5.1.1. Methods of preparation of sterile products .............. 445 Acetyltryptophan, N- ..................................................................918

General Notices (1) apply to all monographs and other texts 3653
Index EUROPEAN PHARMACOPOEIA 5.3

Acetyltyrosine, N- ....................................................................... 920 Activated charcoal....................................................................1246


Aciclovir ..............................................................................5.3-3436 Activated coagulation factors (2.6.22.).................................. 177
Aciclovirum .......................................................................5.3-3436 Additives, plastic (3.1.13.)......................................................... 293
Acidum 4-aminobenzoicum ................................................... 973 Adenine ........................................................................................ 924
Acidum aceticum glaciale........................................................913 Adeninum.................................................................................... 924
Acidum acetylsalicylicum ........................................................917 Adenosine .................................................................................... 925
Acidum adipicum...................................................................... 926 Adenosinum ............................................................................... 925
Acidum alginicum..................................................................... 942 Adeps lanae .......................................................................5.2-3285
Acidum amidotrizoicum dihydricum .................................. 967 Adeps lanae cum aqua...........................................................2709
Acidum aminocaproicum ....................................................... 974 Adeps lanae hydrogenatus ...................................................2708
Acidum ascorbicum................................................................ 1025 Adeps solidus............................................................................ 1711
Acidum asparticum ................................................................ 1029 Adipic acid ................................................................................... 926
Acidum benzoicum................................................................. 1072 Adrenaline tartrate .................................................................... 927
Acidum boricum .......................................................................1117 Adrenalini tartras...................................................................... 927
Acidum caprylicum ................................................................ 1172 Aer medicinalis.......................................................................... 929
Acidum chenodeoxycholicum..............................................1247 Aer medicinalis artificiosus ................................................... 932
Acidum citricum anhydricum .............................................1306 Aerodynamic assessment of fine particles in preparations for
Acidum citricum monohydricum .......................................1307 inhalation (2.9.18.) ......................................................... 5.2-3103
Acidum edeticum .................................................................... 1494 Aether .........................................................................................1548
Acidum etacrynicum..............................................................1542 Aether anaestheticus ..............................................................1549
Acidum folicum ....................................................................... 1630 Agar............................................................................................... 928
Acidum fusidicum ................................................................... 1645 Agrimoniae herba ..................................................................... 929
Acidum glutamicum ............................................................... 1670 Agrimony ..................................................................................... 929
Acidum hydrochloridum concentratum............................ 1755 Air, medicinal .............................................................................. 929
Acidum hydrochloridum dilutum ....................................... 1756 Air, synthetic medicinal ............................................................ 932
Acidum iopanoicum............................................................... 1824 Alanine ......................................................................................... 933
Acidum iotalamicum.............................................................. 1825 Alaninum..................................................................................... 933
Acidum ioxaglicum................................................................. 1826 Albendazole................................................................................. 934
Acidum lacticum ..............................................................5.2-3227 Albendazolum ............................................................................ 934
Acidum lactobionicum........................................................... 1885 Albumini humani solutio............................................... 5.3-3511
Acidum maleicum ................................................................... 1966 Albumin solution, human................................................ 5.3-3511
Acidum malicum ..................................................................... 1966 Alchemilla .................................................................................... 935
Acidum mefenamicum........................................................... 1984 Alchemillae herba ..................................................................... 935
Acidum methacrylicum et ethylis acrylas polymerisatum Alcohol benzylicus ...........................................................5.1-2886
1:1 .............................................................................................2005 Alcohol cetylicus...............................................................5.3-3475
Acidum methacrylicum et ethylis acrylas polymerisatum Alcohol cetylicus et stearylicus ....................................5.3-3474
1:1 dispersio 30 per centum ..............................................2005 Alcohol cetylicus et stearylicus emulsificans A ..............1239
Acidum methacrylicum et methylis methacrylas Alcohol cetylicus et stearylicus emulsificans B .............. 1241
polymerisatum 1:1................................................................2006 Alcoholes adipis lanae ...........................................................2703
Acidum methacrylicum et methylis methacrylas Alcoholimetric tables (2.9.10.) ................................................ 237
polymerisatum 1:2................................................................2007 Alcoholimetric tables (5.5.) .......................................................519
Acidum nalidixicum...............................................................2080 Alcohol isopropylicus............................................................. 1841
Acidum nicotinicum...............................................................2097 Alcohol oleicus......................................................................... 2134
Acidum nitricum ..................................................................... 2105 Alcohol stearylicus...........................................................5.3-3621
Acidum oleicum....................................................................... 2132 Alcuronii chloridum................................................................. 935
Acidum oxolinicum ................................................................ 2165 Alcuronium chloride.................................................................. 935
Acidum palmiticum ................................................................ 2179 Alexandrian senna pods .........................................................2404
Acidum phosphoricum concentratum...............................2237 Alfacalcidol .................................................................................. 937
Acidum phosphoricum dilutum ..........................................2238 Alfacalcidolum ........................................................................... 937
Acidum pipemidicum trihydricum.....................................2249 Alfadex.......................................................................................... 938
Acidum salicylicum .........................................................5.1-3007 Alfadexum ................................................................................... 938
Acidum (S)-lacticum ........................................................5.2-3227 Alfentanil hydrochloride........................................................... 939
Acidum sorbicum ....................................................................2467 Alfentanili hydrochloridum.................................................... 939
Acidum stearicum ...................................................................2490 Alfuzosin hydrochloride ........................................................... 941
Acidum sulfuricum .................................................................2520 Alfuzosini hydrochloridum .................................................... 941
Acidum tartaricum .................................................................2534 Alginic acid .................................................................................. 942
Acidum tiaprofenicum...........................................................2578 Alkaline-earth metals and magnesium (2.4.7.) .................... 104
Acidum tolfenamicum............................................................ 2601 Alkaline impurities in fatty oils (2.4.19.)............................... 109
Acidum tranexamicum ..........................................................2609 Allantoin....................................................................................... 942
Acidum trichloraceticum ......................................................2620 Allantoinum................................................................................ 942
Acidum undecylenicum ........................................................2658 Allergen products....................................................................... 569
Acidum ursodeoxycholicum.................................................2662 Allii sativi bulbi pulvis ........................................................... 1651
Acidum valproicum ................................................................2669 Allium sativum ad praeparationes homoeopathicas ....... 897
Acid value (2.5.1.)..............................................................5.2-3099 Allopurinol................................................................................... 943
Acitretin........................................................................................ 922 Allopurinolum............................................................................ 943
Acitretinum ................................................................................. 922 all-rac-α-Tocopherol..........................................................5.3-3631
Acriflavinii monochloridum .................................................. 924 all-rac-α-Tocopheryl acetate ...........................................5.3-3632
Acriflavinium monochloride.................................................... 924 Almagate ............................................................................. 5.2-3169
Actinobacillosis vaccine (inactivated), porcine .................... 784 Almagatum......................................................................... 5.2-3169

3654 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Almond oil, refined .................................................................... 946 Ammonii hydrogenocarbonas ............................................... 988


Almond oil, virgin .............................................................5.3-3437 Ammonio methacrylate copolymer (type A) ........................ 983
Aloe barbadensis ....................................................................... 947 Ammonio methacrylate copolymer (type B) ........................ 984
Aloe capensis.............................................................................. 948 Ammonio methacrylatis copolymerum A........................... 983
Aloes, barbados .......................................................................... 947 Ammonio methacrylatis copolymerum B .......................... 984
Aloes, Cape .................................................................................. 948 Ammonium (2.4.1.) .................................................................... 103
Aloes dry extract, standardised............................................... 949 Ammonium bromide.................................................................. 985
Aloes extractum siccum normatum...................................... 949 Ammonium chloride.................................................................. 986
Alphacyclodextrin ...................................................................... 938 Ammonium glycyrrhizate................................................5.1-2876
Alprazolam .................................................................................. 950 Ammonium hydrogen carbonate ............................................ 988
Alprazolamum ........................................................................... 950 Amobarbital................................................................................. 988
Alprenolol hydrochloride ......................................................... 952 Amobarbital sodium .................................................................. 989
Alprenololi hydrochloridum................................................... 952 Amobarbitalum .......................................................................... 988
Alprostadil ................................................................................... 953 Amobarbitalum natricum ....................................................... 989
Alprostadilum............................................................................. 953 Amoxicillin sodium .................................................................... 990
Alteplase for injection ............................................................... 956 Amoxicillin trihydrate ......................................................5.3-3440
Alteplasum ad iniectabile........................................................ 956 Amoxicillinum natricum......................................................... 990
Althaeae folium........................................................................ 1974 Amoxicillinum trihydricum...........................................5.3-3440
Althaeae radix ...................................................................5.2-3232 Amperometric titration (2.2.19.) ............................................... 34
Alum.............................................................................................. 959 Amphotericin B .......................................................................... 995
Alumen......................................................................................... 959 Amphotericinum B ................................................................... 995
Aluminii chloridum hexahydricum ..................................... 960 Ampicillin, anhydrous .............................................................. 996
Aluminii hydroxidum hydricum ad adsorptionem.......... 960 Ampicillin sodium ...................................................................... 998
Aluminii magnesii silicas ....................................................... 961 Ampicillin trihydrate ............................................................... 1001
Aluminii oxidum hydricum.................................................... 962 Ampicillinum anhydricum ..................................................... 996
Aluminii phosphas hydricus .................................................. 963 Ampicillinum natricum........................................................... 998
Aluminii phosphatis liquamen.....................................5.3-3438 Ampicillinum trihydricum.................................................... 1001
Aluminii sulfas........................................................................... 964 Amygdalae oleum raffinatum ................................................ 946
Aluminium (2.4.17.) ................................................................... 108 Amygdalae oleum virginale ..........................................5.3-3437
Aluminium chloride hexahydrate........................................... 960 Amylum pregelificatum .........................................................2490
Aluminium hydroxide, hydrated, for adsorption................. 960 Anaesthetic ether .....................................................................1549
Aluminium in adsorbed vaccines (2.5.13.).............................131 Analysis, thermal (2.2.34.).......................................................... 52
Aluminium magnesium silicate............................................... 961 Analytical sieving, particle-size distribution estimation by
Aluminium oxide, hydrated...................................................... 962 (2.9.38.) .............................................................................5.3-3368
Aluminium phosphate gel ...............................................5.3-3438 Angelicae radix........................................................................ 1003
Aluminium phosphate, hydrated ............................................ 963 Angelica root............................................................................. 1003
Aluminium sulphate .................................................................. 964 Animal anti-T lymphocyte immunoglobulin for human
Amantadine hydrochloride ...................................................... 964 use............................................................................................. 1010
Amantadini hydrochloridum ................................................. 964 Animal spongiform encephalopathies, products with risk of
Ambroxol hydrochloride........................................................... 965 transmitting agents of............................................................. 577
Ambroxoli hydrochloridum .................................................... 965 Animal spongiform encephalopathy agents, minimising the
Amfetamine sulphate ................................................................ 966 risk of transmitting via human and veterinary medicinal
Amfetamini sulfas ..................................................................... 966 products (5.2.8.) ....................................................................... 463
Amidotrizoic acid dihydrate..................................................... 967 Aniseed ....................................................................................... 1006
Amikacin ...................................................................................... 968 Anise oil...................................................................................... 1004
Amikacini sulfas ........................................................................ 970 Anisi aetheroleum................................................................... 1004
Amikacin sulphate ..................................................................... 970 Anisidine value (2.5.36.) ........................................................... 142
Amikacinum ............................................................................... 968 Anisi fructus ............................................................................. 1006
Amiloride hydrochloride..................................................5.3-3439 Anisi stellati aetheroleum .....................................................2488
Amiloridi hydrochloridum.............................................5.3-3439 Anisi stellati fructus................................................................2487
Amino acid analysis (2.2.56.)..................................................... 86 Antazoline hydrochloride....................................................... 1006
Aminocaproic acid ..................................................................... 974 Antazolini hydrochloridum.................................................. 1006
Aminoglutethimide.................................................................... 975 Anthrax spore vaccine (live) for veterinary use................... 715
Aminoglutethimidum............................................................... 975 Anti-A and anti-B haemagglutinins (indirect method)
Amiodarone hydrochloride ...................................................... 977 (2.6.20.) .......................................................................................174
Amiodaroni hydrochloridum ................................................. 977 Antibiotics, microbiological assay of (2.7.2.) ........................ 188
Amisulpride ................................................................................. 978 Anticoagulant and preservative solutions for human blood
Amisulpridum ............................................................................ 978 ................................................................................................... 1007
Amitriptyline hydrochloride .................................................... 980 Anticomplementary activity of immunoglobulin (2.6.17.).. 170
Amitriptylini hydrochloridum ............................................... 980 Anticorpora monoclonalia ad usum humanum ......5.2-3127
Amlodipine besilate ................................................................... 981 Anti-D antibodies in human immunoglobulins for intravenous
Amlodipini besilas .................................................................... 981 administration, test for (2.6.26.)..................................5.3-3348
Ammonia (13N) injection ............................................................817 Anti-D immunoglobulin, human ........................................... 1732
Ammoniae (13N) solutio iniectabilis ......................................817 Anti-D immunoglobulin, human, assay of (2.7.13.)............. 205
Ammoniae solutio concentrata ............................................. 983 Anti-D immunoglobulin, human, for intravenous
Ammonia solution, concentrated ........................................... 983 administration ........................................................................ 1733
Ammonii bromidum ................................................................. 985 Antimicrobial preservation, efficacy of (5.1.3.) .................... 447
Ammonii chloridum ................................................................. 986 Antiserum, European viper venom ........................................ 806
Ammonii glycyrrhizas ....................................................5.1-2876 Antithrombin III concentrate, human ................................. 1733

General Notices (1) apply to all monographs and other texts 3655
Index EUROPEAN PHARMACOPOEIA 5.3

Antithrombin III, human, assay of (2.7.17.) .......................... 209 Assay of pertussis vaccine (2.7.7.)........................................... 197
Antithrombinum III humanum densatum ....................... 1733 Assay of pertussis vaccine (acellular) (2.7.16.) .................... 208
Anti-T lymphocyte immunoglobulin for human use, Assay of tetanus vaccine (adsorbed) (2.7.8.) ...............5.1-2791
animal....................................................................................... 1010 Assays (2.5.)................................................................................. 127
Apis mellifera ad praeparationes homoeopathicas.......... 898 Astemizole ................................................................................. 1030
Apomorphine hydrochloride ..................................................1014 Astemizolum............................................................................. 1030
Apomorphini hydrochloridum .............................................1014 Atenolol...................................................................................... 1032
Apparatus (2.1.) .............................................................................17 Atenololum................................................................................ 1032
Apparent volume (2.9.15.)........................................................ 241 Atomic absorption spectrometry (2.2.23.) .............................. 36
Application of the F0 concept to steam sterilisation of Atomic emission spectrometry (2.2.22.).................................. 35
aqueous preparations (5.1.5.).......................................5.1-2821 Atracurii besilas................................................................ 5.2-3170
Aprotinin .................................................................................... 1015 Atracurium besilate .......................................................... 5.2-3170
Aprotinin concentrated solution........................................... 1016 Atropine ..................................................................................... 1033
Aprotinini solutio concentrata ............................................ 1016 Atropine sulphate..................................................................... 1035
Aprotininum ............................................................................. 1015 Atropini sulfas.......................................................................... 1035
Aqua ad dilutionem solutionium concentratarum ad Atropinum ................................................................................. 1033
haemodialysim ...................................................................... 1699 Aujeszky’s disease vaccine (inactivated) for pigs................ 715
Aqua ad iniectabilia ...............................................................2692 Aujeszky’s disease vaccine (live) for pigs for parenteral
Aquae (15O) solutio iniectabilis.............................................. 868 administration, freeze-dried....................................................717
Aquae tritiatae (3H) solutio iniectabilis............................... 867 Aurantii amari epicarpii et mesocarpii tinctura ............ 1110
Aqua purificata........................................................................2697 Aurantii amari epicarpium et mesocarpium................... 1110
Aqua valde purificata.............................................................2695 Aurantii amari flos ..................................................................1111
Arachidis oleum hydrogenatum.......................................... 1018 Aurantii dulcis aetheroleum.................................................2526
Arachidis oleum raffinatum ................................................. 1018 Auricularia.........................................................................5.2-3137
Arachis oil, hydrogenated ...................................................... 1018 Avian infectious bronchitis vaccine (inactivated)................ 718
Arachis oil, refined................................................................... 1018 Avian infectious bronchitis vaccine (live) ............................. 720
Argenti nitras ........................................................................... 2412 Avian infectious bursal disease vaccine (inactivated) ....... 722
Argentum colloidale ad usum externum ...................5.3-3613 Avian infectious bursal disease vaccine (live) ...................... 723
Arginine...................................................................................... 1019 Avian infectious encephalomyelitis vaccine (live) ............... 725
Arginine aspartate ................................................................... 1020 Avian infectious laryngotracheitis vaccine (live)................. 727
Arginine hydrochloride........................................................... 1021 Avian live virus vaccines : tests for extraneous agents in
Arginini aspartas .................................................................... 1020 batches of finished product (2.6.25.)..........................5.3-3345
Arginini hydrochloridum...................................................... 1021 Avian paramyxovirus 3 vaccine (inactivated)....................... 728
Argininum................................................................................. 1019 Avian viral tenosynovitis vaccine (live).................................. 729
Arnicae flos............................................................................... 1022 Avian viral vaccines : tests for extraneous agents in seed lots
Arnicae tinctura ...............................................................5.1-2877 (2.6.24.) ...................................................................................... 177
Arnica flower............................................................................. 1022 Azaperone for veterinary use ................................................ 1036
Arnica tincture...................................................................5.1-2877 Azaperonum ad usum veterinarium.................................. 1036
Arsenic (2.4.2.)............................................................................ 103 Azathioprine.............................................................................. 1037
Arsenii trioxidum ad praeparationes homoeopathicas .. 895 Azathioprinum......................................................................... 1037
Arsenious trioxide for homoeopathic preparations............ 895 Azelastine hydrochloride........................................................ 1037
Articaine hydrochloride.......................................................... 1023 Azelastini hydrochloridum................................................... 1037
Articaini hydrochloridum..................................................... 1023 Azithromycin......................................................................5.3-3442
Ascorbic acid ............................................................................. 1025 Azithromycinum...............................................................5.3-3442
Ascorbylis palmitas................................................................. 1026
Ascorbyl palmitate ................................................................... 1026 B
Ash insoluble in hydrochloric acid (2.8.1.)........................... 215 Bacampicillin hydrochloride.................................................. 1043
Ash leaf....................................................................................... 1026 Bacampicillini hydrochloridum.......................................... 1043
Asparagine monohydrate ....................................................... 1027 Bacitracin................................................................................... 1045
Asparaginum monohydricum.............................................. 1027 Bacitracinum............................................................................ 1045
Aspartame.................................................................................. 1028 Bacitracinum zincum ............................................................ 1047
Aspartamum ............................................................................. 1028 Bacitracin zinc .......................................................................... 1047
Aspartic acid.............................................................................. 1029 Baclofen ..................................................................................... 1050
Assay of 1,8-cineole in essential oils (2.8.11.) .......................216 Baclofenum............................................................................... 1050
Assay of diphtheria vaccine (adsorbed) (2.7.6.) ................... 196 Bacterial endotoxins (2.6.14.)...................................................161
Assay of heparin (2.7.5.) ........................................................... 195 Ballotae nigrae herba ............................................................ 1113
Assay of heparin in coagulation factors (2.7.12.)................ 204 Balsamum peruvianum......................................................... 2215
Assay of hepatitis A vaccine (2.7.14.) ............................5.1-2795 Balsamum tolutanum ............................................................2603
Assay of hepatitis B vaccine (rDNA) (2.7.15.) ...................... 207 Bambuterol hydrochloride..................................................... 1051
Assay of human anti-D immunoglobulin (2.7.13.)............... 205 Bambuteroli hydrochloridum .............................................. 1051
Assay of human antithrombin III (2.7.17.) ............................ 209 Barbados aloes ........................................................................... 947
Assay of human coagulation factor II (2.7.18.).................... 209 Barbital....................................................................................... 1052
Assay of human coagulation factor IX (2.7.11.)................... 204 Barbitalum ................................................................................ 1052
Assay of human coagulation factor VII (2.7.10.) ................. 203 Barii chloridum dihydricum ad praeparationes
Assay of human coagulation factor VIII (2.7.4.).................. 194 homoeopathicas ............................................................. 5.2-3161
Assay of human coagulation factor X (2.7.19.) .....................210 Barii sulfas.........................................................................5.3-3447
Assay of human coagulation factor XI (2.7.22.) .................. 212 Barium chloride dihydrate for homoeopathic
Assay of human von Willebrand factor (2.7.21.) ..................211 preparations..................................................................... 5.2-3161
Assay of interferons (5.6.)................................................5.3-3381 Barium sulphate................................................................5.3-3447

3656 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Basic butylated methacrylate copolymer............................ 1053 Betamethasone sodium phosphate...................................... 1092


BCG ad immunocurationem.................................................. 635 Betamethasone valerate ..................................................5.3-3449
BCG for immunotherapy .......................................................... 635 Betamethasoni acetas ............................................................ 1089
BCG vaccine, freeze-dried ........................................................ 636 Betamethasoni dipropionas ..........................................5.3-3447
Bearberry leaf ........................................................................... 1054 Betamethasoni natrii phosphas .......................................... 1092
Beclometasone dipropionate, anhydrous ....................5.1-2881 Betamethasoni valeras....................................................5.3-3449
Beclometasone dipropionate monohydrate ................5.1-2883 Betamethasonum .................................................................... 1087
Beclometasoni dipropionas anhydricus ....................5.1-2881 Betaxolol hydrochloride ......................................................... 1095
Beclometasoni dipropionas monohydricus ..............5.1-2883 Betaxololi hydrochloridum................................................... 1095
Bee for homoeopathic preparations, honey......................... 898 Betulae folium.......................................................................... 1103
Beeswax, white ......................................................................... 1057 Bezafibrate ................................................................................ 1096
Beeswax, yellow........................................................................ 1058 Bezafibratum............................................................................ 1096
Belladonnae folii extractum siccum normatum ............. 1060 Bifonazole.................................................................................. 1098
Belladonnae folii tinctura normata ................................... 1061 Bifonazolum............................................................................. 1098
Belladonnae folium ................................................................ 1058 Bilberry fruit, dried ................................................................. 1099
Belladonnae pulvis normatus.............................................. 1062 Bilberry fruit, fresh.................................................................. 1099
Belladonna leaf......................................................................... 1058 Biological assays (2.7.) .............................................................. 187
Belladonna leaf dry extract, standardised .......................... 1060 Biological assays and tests, statistical analysis of (5.3.) .... 475
Belladonna leaf tincture, standardised................................ 1061 Biological indicators of sterilisation (5.1.2.) ........................ 447
Belladonna, prepared .............................................................. 1062 Biological tests (2.6.)................................................................. 145
Bendroflumethiazide .......................................................5.1-2885 Biotin .......................................................................................... 1100
Bendroflumethiazidum ..................................................5.1-2885 Biotinum ................................................................................... 1100
Benfluorex hydrochloride ...................................................... 1064 Biperiden hydrochloride..........................................................1101
Benfluorexi hydrochloridum ............................................... 1064 Biperideni hydrochloridum ..................................................1101
Benperidol ................................................................................. 1065 Biphasic insulin injection....................................................... 1802
Benperidolum .......................................................................... 1065 Biphasic isophane insulin injection ..................................... 1803
Benserazide hydrochloride .................................................... 1067 Birch leaf.................................................................................... 1103
Benserazidi hydrochloridum ............................................... 1067 Bisacodyl.................................................................................... 1104
Bentonite ................................................................................... 1068 Bisacodylum............................................................................. 1104
Bentonitum............................................................................... 1068 Bismuthi subcarbonas ........................................................... 1105
Benzalkonii chloridi solutio ................................................ 1069 Bismuthi subgallas ................................................................. 1106
Benzalkonii chloridum.......................................................... 1068 Bismuthi subnitras ponderosum......................................... 1107
Benzalkonium chloride........................................................... 1068 Bismuthi subsalicylas ............................................................ 1107
Benzalkonium chloride solution .......................................... 1069 Bismuth subcarbonate............................................................ 1105
Benzathine benzylpenicillin .................................................. 1077 Bismuth subgallate.................................................................. 1106
Benzbromarone........................................................................ 1070 Bismuth subnitrate, heavy ..................................................... 1107
Benzbromaronum................................................................... 1070 Bismuth subsalicylate ............................................................. 1107
Benzethonii chloridum ......................................................... 1071 Bitter fennel ..............................................................................1580
Benzethonium chloride .......................................................... 1071 Bitter-fennel fruit oil................................................................ 1108
Benzocaine ................................................................................ 1072 Bitterness value (2.8.15.).......................................................... 221
Benzocainum ........................................................................... 1072 Bitter-orange epicarp and mesocarp.................................... 1110
Benzoe tonkinensis ......................................................... 5.2-3175 Bitter-orange-epicarp and mesocarp tincture .................... 1110
Benzoic acid .............................................................................. 1072 Bitter-orange flower .................................................................1111
Benzoin, Siam.................................................................... 5.2-3175 Bitter-orange-flower oil....................................................5.3-3562
Benzoylis peroxidum cum aqua ......................................... 1073 Black horehound ..................................................................... 1113
Benzoyl peroxide, hydrous .................................................... 1073 Bleomycini sulfas............................................................. 5.2-3179
Benzyl alcohol ...................................................................5.1-2886 Bleomycin sulphate .......................................................... 5.2-3179
Benzyl benzoate ....................................................................... 1076 Blood and blood components, empty sterile containers of
Benzylis benzoas..................................................................... 1076 plasticised poly(vinyl chloride) for (3.2.4.) ..........................311
Benzylpenicillin, benzathine ................................................. 1077 Blood and blood components, materials for containers for
Benzylpenicillin potassium............................................. 5.2-3175 (3.1.1.)......................................................................................... 269
Benzylpenicillin, procaine...................................................... 1080 Blood and blood components, sets for the transfusion of
Benzylpenicillin sodium .................................................. 5.2-3177 (3.2.6.) .........................................................................................313
Benzylpenicillinum benzathinum...................................... 1077 Blood and blood components, sterile plastic containers for
Benzylpenicillinum kalicum......................................... 5.2-3175 (3.2.3.) ........................................................................................ 309
Benzylpenicillinum natricum ...................................... 5.2-3177 Blood, anticoagulant and preservative solutions for ....... 1007
Benzylpenicillinum procainum.......................................... 1080 Blood, sterile containers of plasticised poly (vinyl chloride)
Betacarotene ............................................................................. 1083 containing anticoagulant solution (3.2.5.) ......................... 312
Betacarotenum ........................................................................ 1083 Bogbean leaf ............................................................................. 1115
Betacyclodextrin ...................................................................... 1084 Boiling point (2.2.12.) ..................................................................31
Betadex ...................................................................................... 1084 Boldi folium.......................................................................5.3-3450
Betadexum ................................................................................ 1084 Boldo leaf............................................................................5.3-3450
Betahistine dihydrochloride ...........................................5.1-2887 Borage (starflower) oil, refined......................................5.1-2889
Betahistine mesilate ................................................................ 1086 Borago officinalis oleum raffinatum ..........................5.1-2889
Betahistini dihydrochloridum ......................................5.1-2887 Borax .......................................................................................... 1116
Betahistini mesilas ................................................................. 1086 Boric acid....................................................................................1117
Betamethasone......................................................................... 1087 Botulinum antitoxin .................................................................. 801
Betamethasone acetate .......................................................... 1089 Botulinum toxin type A for injection....................................1117
Betamethasone dipropionate .........................................5.3-3447

General Notices (1) apply to all monographs and other texts 3657
Index EUROPEAN PHARMACOPOEIA 5.3

Bovine infectious rhinotracheitis vaccine (live), Calcii chloridum dihydricum .............................................. 1152
freeze-dried................................................................................ 768 Calcii chloridum hexahydricum ......................................... 1153
Bovine insulin........................................................................... 1797 Calcii dobesilas monohydricum.......................................... 1153
Bovine leptospirosis vaccine (inactivated)............................ 730 Calcii folinas ............................................................................ 1154
Bovine parainfluenza virus vaccine (live), freeze-dried ..... 732 Calcii glucoheptonas.............................................................. 1156
Bovine respiratory syncytial virus vaccine (live), Calcii gluconas ........................................................................ 1157
freeze-dried................................................................................ 733 Calcii gluconas ad iniectabile ............................................. 1158
Bovine viral diarrhoea vaccine (inactivated)........................ 734 Calcii glycerophosphas.......................................................... 1159
Bromazepam ............................................................................. 1119 Calcii hydrogenophosphas anhydricus............................. 1160
Bromazepamum...................................................................... 1119 Calcii hydrogenophosphas dihydricus.............................. 1160
Bromhexine hydrochloride .................................................... 1120 Calcii hydroxidum .................................................................. 1161
Bromhexini hydrochloridum ............................................... 1120 Calcii iodidum tetrahydricum ad praeparationes
Bromocriptine mesilate .......................................................... 1121 homoeopathicas ............................................................. 5.2-3162
Bromocriptini mesilas ........................................................... 1121 Calcii lactas anhydricus.................................................5.1-2894
Bromperidol .............................................................................. 1124 Calcii lactas monohydricus...........................................5.1-2895
Bromperidol decanoate .......................................................... 1125 Calcii lactas pentahydricus ...........................................5.1-2896
Bromperidoli decanoas ......................................................... 1125 Calcii lactas trihydricus .................................................5.1-2897
Bromperidolum ....................................................................... 1124 Calcii laevulinas dihydricum............................................... 1165
Brompheniramine maleate..................................................... 1127 Calcii levofolinas pentahydricus ........................................ 1163
Brompheniramini maleas .................................................... 1127 Calcii pantothenas.................................................................. 1166
Brucellosis vaccine (live) (Brucella melitensis Rev. 1 strain), Calcii stearas ............................................................................ 1167
freeze-dried, for veterinary use ...................................5.1-2859 Calcii sulfas dihydricus ......................................................... 1169
Buccal tablets and sublingual tablets.................................... 613 Calcipotriol, anhydrous ...................................................5.3-3460
Buckwheat herb ................................................................ 5.2-3180 Calcipotriol monohydrate ...............................................5.3-3462
Budesonide................................................................................ 1128 Calcipotriolum anhydricum..........................................5.3-3460
Budesonidum ........................................................................... 1128 Calcipotriolum monohydricum....................................5.3-3462
Bufexamac ................................................................................. 1130 Calcitonin (salmon)...........................................................5.3-3465
Bufexamacum .......................................................................... 1130 Calcitoninum salmonis ..................................................5.3-3465
Buffer solutions (4.1.3.) ............................................................ 430 Calcitriol..................................................................................... 1149
Buffer solutions (4.1.3.) ...................................................5.3-3378 Calcitriolum.............................................................................. 1149
Buflomedil hydrochloride ...................................................... 1131 Calcium (2.4.3.)........................................................................... 103
Buflomedili hydrochloridum ............................................... 1131 Calcium acetate .................................................................5.1-2893
Bumetanide ............................................................................... 1132 Calcium ascorbate.................................................................... 1150
Bumetanidum .......................................................................... 1132 Calcium carbonate ............................................................5.1-2894
Bupivacaine hydrochloride .................................................... 1133 Calcium carboxymethylcellulose .......................................... 1188
Bupivacaini hydrochloridum............................................... 1133 Calcium chloride dihydrate.................................................... 1152
Buprenorphine ......................................................................... 1135 Calcium chloride hexahydrate .............................................. 1153
Buprenorphine hydrochloride .............................................. 1136 Calcium dobesilate monohydrate ......................................... 1153
Buprenorphini hydrochloridum ......................................... 1136 Calcium folinate ....................................................................... 1154
Buprenorphinum ................................................................... 1135 Calcium glucoheptonate......................................................... 1156
Buserelin.................................................................................... 1137 Calcium gluconate ................................................................... 1157
Buserelinum ............................................................................. 1137 Calcium gluconate for injection............................................ 1158
Buspirone hydrochloride.................................................5.3-3452 Calcium glycerophosphate..................................................... 1159
Buspironi hydrochloridum............................................5.3-3452 Calcium hydrogen phosphate, anhydrous .......................... 1160
Busulfan..................................................................................... 1138 Calcium hydrogen phosphate dihydrate ............................. 1160
Busulfanum .............................................................................. 1138 Calcium hydroxide ................................................................... 1161
Butcher’s broom................................................................5.3-3454 Calcium in adsorbed vaccines (2.5.14.) ..................................131
Butylhydroxyanisole.................................................................1141 Calcium iodide tetrahydrate for homoeopathic
Butylhydroxyanisolum ...........................................................1141 preparations..................................................................... 5.2-3162
Butylhydroxytoluene................................................................1141 Calcium lactate, anhydrous ............................................5.1-2894
Butylhydroxytoluenum...........................................................1141 Calcium lactate monohydrate ........................................5.1-2895
Butylis parahydroxybenzoas................................................ 1140 Calcium lactate pentahydrate ........................................5.1-2896
Butyl parahydroxybenzoate................................................... 1140 Calcium lactate trihydrate...............................................5.1-2897
Calcium levofolinate pentahydrate ...................................... 1163
C Calcium levulinate dihydrate................................................. 1165
Cabergoline ........................................................................5.3-3459 Calcium pantothenate............................................................. 1166
Cabergolinum ...................................................................5.3-3459 Calcium phosphate .................................................................. 1167
Cachets ................................................................................5.2-3136 Calcium stearate....................................................................... 1167
Cadmii sulfas hydricus Calcium sulphate dihydrate................................................... 1169
ad praeparationes homoeopathicas..........................5.3-3429 Calendulae flos ........................................................................ 1169
Cadmium sulphate hydrate for homoeopathic prepara- Calendula flower ...................................................................... 1169
tions ...................................................................................5.3-3429 Calf coronavirus diarrhoea vaccine (inactivated)................ 736
Caffeine ...................................................................................... 1145 Calf rotavirus diarrhoea vaccine (inactivated)..................... 737
Caffeine monohydrate............................................................. 1146 Calicivirosis vaccine (inactivated), feline............................... 757
Calcifediol .................................................................................. 1147 Calicivirosis vaccine (live), feline, freeze-dried..................... 758
Calcifediolum ........................................................................... 1147 Camphora racemica ............................................................... 1172
Calcii acetas ......................................................................5.1-2893 Camphor, D- ............................................................................... 1170
Calcii ascorbas......................................................................... 1150 Camphor, racemic .................................................................... 1172
Calcii carbonas .................................................................5.1-2894 Canine adenovirus vaccine (inactivated) .............................. 738

3658 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Canine adenovirus vaccine (live) ............................................ 738 Carmustine ................................................................................ 1191


Canine distemper vaccine (live), freeze-dried....................... 740 Carmustinum ........................................................................... 1191
Canine leptospirosis vaccine (inactivated)............................ 740 Carnauba wax ........................................................................... 1191
Canine parainfluenza virus vaccine (live)............................. 742 Carteolol hydrochloride.......................................................... 1192
Canine parvovirosis vaccine (inactivated)............................. 743 Carteololi hydrochloridum ................................................... 1192
Canine parvovirosis vaccine (live) .......................................... 744 Carthami oleum raffinatum .................................................2389
Cape aloes.................................................................................... 948 Carvedilol................................................................................... 1193
Capillary electrophoresis (2.2.47.).............................................74 Carvedilolum............................................................................ 1193
Capillary viscometer method (2.2.9.)....................................... 29 Carvi aetheroleum ...........................................................5.3-3467
Caprylic acid.............................................................................. 1172 Carvi fructus............................................................................. 1177
Caprylocaproyl macrogolglycerides..................................... 1173 Caryophylli floris aetheroleum ...........................................1335
Capsici fructus ..........................................................................1174 Caryophylli flos .......................................................................1334
Capsicum.....................................................................................1174 Cascara ....................................................................................... 1194
Capsulae .............................................................................5.2-3135 Cassia oil .................................................................................... 1196
Capsules ..............................................................................5.2-3135 Castor oil, hydrogenated ........................................................ 1197
Capsules and tablets, disintegration of (2.9.1.) ..........5.3-3351 Castor oil, polyoxyl ...........................................................5.3-3547
Capsules, gastro-resistant................................................5.2-3136 Castor oil, polyoxyl hydrogenated.................................5.2-3231
Capsules, hard ...................................................................5.2-3135 Castor oil, virgin....................................................................... 1197
Capsules, intrauterine......................................................5.3-3397 Catgut, sterile.............................................................................. 873
Capsules, modified-release ..............................................5.2-3136 Catgut, sterile, in distributor for veterinary use ................. 885
Capsules, oromucosal ............................................................... 613 Cefaclor ...............................................................................5.3-3470
Capsules, rectal.................................................................. 5.2-3149 Cefaclorum ........................................................................5.3-3470
Capsules, soft .....................................................................5.2-3135 Cefadroxil monohydrate ..................................................5.3-3471
Capsules, vaginal...............................................................5.2-3153 Cefadroxilum monohydricum ......................................5.3-3471
Captopril ............................................................................. 5.2-3185 Cefalexin monohydrate...........................................................1202
Captoprilum ...................................................................... 5.2-3185 Cefalexinum monohydricum ...............................................1202
Caraway fruit............................................................................. 1177 Cefalotin sodium ......................................................................1203
Caraway oil .........................................................................5.3-3467 Cefalotinum natricum ...........................................................1203
Carbachol................................................................................... 1177 Cefamandole nafate.................................................................1204
Carbacholum ............................................................................ 1177 Cefamandoli nafas..................................................................1204
Carbamazepine ......................................................................... 1178 Cefapirin sodium......................................................................1206
Carbamazepinum ................................................................... 1178 Cefapirinum natricum...........................................................1206
Carbasalate calcium................................................................. 1179 Cefatrizine propylene glycol..................................................1207
Carbasalatum calcicum......................................................... 1179 Cefatrizinum propylen glycolum........................................1207
Carbidopa .................................................................................. 1180 Cefazolin sodium......................................................................1209
Carbidopum.............................................................................. 1180 Cefazolinum natricum...........................................................1209
Carbimazole .............................................................................. 1182 Cefixime ..................................................................................... 1211
Carbimazolum ......................................................................... 1182 Cefiximum................................................................................. 1211
Carbo activatus ........................................................................1246 Cefoperazone sodium ............................................................. 1212
Carbocisteine ............................................................................ 1182 Cefoperazonum natricum..................................................... 1212
Carbocisteinum ....................................................................... 1182 Cefotaxime sodium .................................................................. 1214
Carbomera ................................................................................ 1183 Cefotaximum natricum ......................................................... 1214
Carbomers ................................................................................. 1183 Cefoxitin sodium ...................................................................... 1216
Carbon dioxide ......................................................................... 1185 Cefoxitinum natricum ........................................................... 1216
Carbon dioxide in gases (2.5.24.) ........................................... 134 Cefradine.................................................................................... 1217
Carbonei dioxidum................................................................. 1185 Cefradinum............................................................................... 1217
Carbonei monoxidum (15O) .....................................................818 Ceftazidime................................................................................ 1218
Carbon monoxide (15O) ..............................................................818 Ceftazidimum........................................................................... 1218
Carbon monoxide in gases (2.5.25.)....................................... 134 Ceftriaxone sodium..................................................................1220
Carboplatin................................................................................ 1186 Ceftriaxonum natricum.........................................................1220
Carboplatinum......................................................................... 1186 Cefuroxime axetil .....................................................................1222
Carboprost trometamol ...................................................5.3-3468 Cefuroxime sodium..................................................................1223
Carboprostum trometamolum ......................................5.3-3468 Cefuroximum axetili...............................................................1222
Carboxymethylamylum natricum A............................5.2-3272 Cefuroximum natricum.........................................................1223
Carboxymethylamylum natricum B............................5.2-3273 Celiprolol hydrochloride..................................................5.3-3473
Carboxymethylamylum natricum C................................... 2451 Celiprololi hydrochloridum...........................................5.3-3473
Carboxymethylcellulose calcium .......................................... 1188 Cell cultures for the production of veterinary vaccines
Carboxymethylcellulose sodium........................................... 1189 (5.2.4.) ........................................................................................ 458
Carboxymethylcellulose sodium, cross-linked ................... 1371 Cell substrates for the production of vaccines for human use
Carboxymethylcellulose sodium, low-substituted............. 1190 (5.2.3.) ........................................................................................ 455
Carisoprodol.............................................................................. 1187 Cellulose acetate ......................................................................1226
Carisoprodolum....................................................................... 1187 Cellulose acetate butyrate......................................................1227
Carmellose calcium.................................................................. 1188 Cellulose acetate phthalate....................................................1227
Carmellose sodium .................................................................. 1189 Cellulose, microcrystalline.....................................................1228
Carmellose sodium, low-substituted .................................... 1190 Cellulose, powdered ................................................................1232
Carmellosum calcicum .......................................................... 1188 Cellulosi acetas ........................................................................1226
Carmellosum natricum ......................................................... 1189 Cellulosi acetas butyras.........................................................1227
Carmellosum natricum conexum ....................................... 1371 Cellulosi acetas phthalas.......................................................1227
Carmellosum natricum, substitutum humile................... 1190 Cellulosi pulvis ........................................................................1232

General Notices (1) apply to all monographs and other texts 3659
Index EUROPEAN PHARMACOPOEIA 5.3

Cellulosum microcristallinum.............................................1228 Chlorobutanolum anhydricum............................................ 1261


Centaurii herba .......................................................................1235 Chlorobutanolum hemihydricum ....................................... 1261
Centaury ....................................................................................1235 Chlorocresol ..............................................................................1262
Centella ......................................................................................1236 Chlorocresolum .......................................................................1262
Centellae asiaticae herba......................................................1236 Chloroquine phosphate ..........................................................1262
Cera alba ................................................................................... 1057 Chloroquine sulphate..............................................................1263
Cera carnauba ......................................................................... 1191 Chloroquini phosphas ...........................................................1262
Cera flava .................................................................................. 1058 Chloroquini sulfas...................................................................1263
Cetirizine dihydrochloride .....................................................1237 Chlorothiazide ..........................................................................1264
Cetirizini dihydrochloridum................................................1237 Chlorothiazidum .....................................................................1264
Cetobemidoni hydrochloridum ........................................... 1871 Chlorphenamine maleate ................................................5.3-3476
Cetostearyl alcohol ...........................................................5.3-3474 Chlorphenamini maleas.................................................5.3-3476
Cetostearyl alcohol (type A), emulsifying ...........................1239 Chlorpromazine hydrochloride......................................5.3-3477
Cetostearyl alcohol (type B), emulsifying........................... 1241 Chlorpromazini hydrochloridum ................................5.3-3477
Cetostearylis isononanoas....................................................1242 Chlorpropamide........................................................................1266
Cetostearyl isononanoate.......................................................1242 Chlorpropamidum ..................................................................1266
Cetrimide ...................................................................................1243 Chlorprothixene hydrochloride ............................................1267
Cetrimidum...............................................................................1243 Chlorprothixeni hydrochloridum .......................................1267
Cetyl alcohol ......................................................................5.3-3475 Chlortalidone .....................................................................5.3-3478
Cetylis palmitas .......................................................................1244 Chlortalidonum ................................................................5.3-3478
Cetyl palmitate..........................................................................1244 Chlortetracycline hydrochloride...........................................1270
Cetylpyridinii chloridum ......................................................1244 Chlortetracyclini hydrochloridum......................................1270
Cetylpyridinium chloride........................................................1244 Cholecalciferol ..........................................................................1272
Ceylon cinnamon bark oil ......................................................1295 Cholecalciferol concentrate (oily form)...............................1273
Ceylon cinnamon leaf oil........................................................1296 Cholecalciferol concentrate (powder form)........................1275
Chamomile flower, Roman.....................................................1245 Cholecalciferol concentrate (water-dispersible form).......1277
Chamomillae romanae flos ..................................................1245 Cholecalciferoli pulvis ...........................................................1275
Characters section in monographs (5.11.)............................ 565 Cholecalciferolum ...................................................................1272
Charcoal, activated ..................................................................1246 Cholecalciferolum densatum oleosum ..............................1273
Chelidonii herba...................................................................... 1690 Cholecalciferolum in aqua dispergibile ............................1277
Chenodeoxycholic acid ..........................................................1247 Cholera vaccine .......................................................................... 637
Chewing gum, medicated, dissolution test for Cholera vaccine, freeze-dried .................................................. 638
(2.9.25.) ............................................................................. 5.2-3116 Cholesterol ................................................................................1279
Chewing gums, medicated ..............................................5.2-3136 Cholesterolum ..........................................................................1279
Chicken flocks free from specified pathogens for Chorda resorbilis sterilis ......................................................... 873
the production and quality control of vaccines Chorda resorbilis sterilis in fuso ad usum veterinarium.. 885
(5.2.2.) ...............................................................................5.1-2825 Chromatographic separation techniques (2.2.46.) ............... 69
Chicken infectious anaemia vaccine (live)............................ 769 Chromatography, gas (2.2.28.).................................................. 42
Chinidini sulfas .......................................................................2347 Chromatography, liquid (2.2.29.) ............................................. 43
Chinini hydrochloridum .......................................................2348 Chromatography, paper (2.2.26.).............................................. 40
Chinini sulfas...........................................................................2350 Chromatography, size-exclusion (2.2.30.)............................... 45
Chitosan hydrochloride ..........................................................1248 Chromatography, supercritical fluid (2.2.45.) ....................... 68
Chitosani hydrochloridum ...................................................1248 Chromatography, thin-layer (2.2.27.) ............................5.2-3090
Chloral hydrate.........................................................................1249 Chromii (51Cr) edetatis solutio iniectabilis..........................819
Chlorali hydras ........................................................................1249 Chromium (51Cr) edetate injection ..........................................819
Chlorambucil.............................................................................1250 Chymotrypsin............................................................................1280
Chlorambucilum......................................................................1250 Chymotrypsinum ....................................................................1280
Chloramine ................................................................................2605 Ciclopirox...................................................................................1282
Chloramphenicol......................................................................1250 Ciclopirox olamine ...................................................................1283
Chloramphenicoli natrii succinas ......................................1252 Ciclopirox olaminum .............................................................1283
Chloramphenicoli palmitas .................................................. 1251 Ciclopiroxum............................................................................1282
Chloramphenicol palmitate ................................................... 1251 Ciclosporin ................................................................................1285
Chloramphenicol sodium succinate.....................................1252 Ciclosporinum .........................................................................1285
Chloramphenicolum...............................................................1250 Cilastatin sodium .....................................................................1286
Chlorcyclizine hydrochloride ................................................1253 Cilastatinum natricum ..........................................................1286
Chlorcyclizini hydrochloridum...........................................1253 Cilazapril....................................................................................1288
Chlordiazepoxide ..............................................................5.2-3186 Cilazaprilum ............................................................................1288
Chlordiazepoxide hydrochloride ................................... 5.2-3188 Cimetidine..................................................................................1289
Chlordiazepoxidi hydrochloridum .............................. 5.2-3188 Cimetidine hydrochloride.......................................................1290
Chlordiazepoxidum ......................................................... 5.2-3186 Cimetidini hydrochloridum .................................................1290
Chlorhexidine diacetate..........................................................1256 Cimetidinum ............................................................................1289
Chlorhexidine digluconate solution ....................................1258 Cinchocaine hydrochloride.................................................... 1291
Chlorhexidine dihydrochloride .............................................1259 Cinchocaini hydrochloridum .............................................. 1291
Chlorhexidini diacetas...........................................................1256 Cinchona bark ..........................................................................1292
Chlorhexidini digluconatis solutio.....................................1258 Cinchonae cortex ....................................................................1292
Chlorhexidini dihydrochloridum........................................1259 Cineole........................................................................................1294
Chlorides (2.4.4.) ........................................................................ 104 Cineole in essential oils, assay of, 1,8- (2.8.11.)....................216
Chlorobutanol, anhydrous ..................................................... 1261 Cineolum...................................................................................1294
Chlorobutanol hemihydrate .................................................. 1261 Cinnamomi cassiae aetheroleum ....................................... 1196

3660 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Cinnamomi cortex ..................................................................1295 Clostridium perfringens beta antitoxin for veterinary use
Cinnamomi corticis tinctura................................................1297 ............................................................................................5.1-2866
Cinnamomi zeylanici folii aetheroleum...........................1296 Clostridium perfringens epsilon antitoxin for veterinary use
Cinnamomi zeylanicii corticis aetheroleum ...................1295 ............................................................................................5.1-2867
Cinnamon ..................................................................................1295 Clostridium perfringens vaccine for veterinary use ........... 747
Cinnamon bark oil, Ceylon ....................................................1295 Clostridium septicum vaccine for veterinary use................ 749
Cinnamon leaf oil, Ceylon ......................................................1296 Closures and containers for parenteral preparations and
Cinnamon tincture...................................................................1297 ophthalmic preparations, polypropylene for (3.1.6.)........ 282
Cinnarizine ................................................................................1297 Closures and containers for pharmaceutical use, plastic
Cinnarizinum ..........................................................................1297 (3.2.2.) ........................................................................................ 308
Ciprofibrate ...............................................................................1299 Closures and tubing, silicone elastomer for (3.1.9.)........... 288
Ciprofibratum...........................................................................1299 Closures for containers for aqueous parenteral preparations,
Ciprofloxacin.............................................................................1300 for powders and for freeze-dried powders, rubber
Ciprofloxacin hydrochloride..................................................1302 (3.2.9.) .........................................................................................316
Ciprofloxacini hydrochloridum ..........................................1302 Clotrimazole..............................................................................1333
Ciprofloxacinum .....................................................................1300 Clotrimazolum .........................................................................1333
Circular dichroism (2.2.41.) ....................................................... 63 Clove ...........................................................................................1334
Cisapride monohydrate...........................................................1303 Clove oil .....................................................................................1335
Cisapride tartrate .....................................................................1304 Cloxacillin sodium....................................................................1335
Cisapridi tartras ......................................................................1304 Cloxacillinum natricum ........................................................1335
Cisapridum monohydricum.................................................1303 Clozapine ...................................................................................1337
Cisplatin .....................................................................................1306 Clozapinum ..............................................................................1337
Cisplatinum ..............................................................................1306 Coagulation factor II, assay of (2.7.18.)................................. 209
Citric acid, anhydrous .............................................................1306 Coagulation factor IX, assay of (2.7.11.)................................ 204
Citric acid monohydrate .........................................................1307 Coagulation factor IX, human............................................... 1738
Citronellae aetheroleum........................................................1308 Coagulation factors, activated (2.6.22.)................................. 177
Citronella oil..............................................................................1308 Coagulation factors, assay of heparin (2.7.12.) ................... 204
Clarithromycin...................................................................5.1-2900 Coagulation factor VII, assay of (2.7.10.).............................. 203
Clarithromycinum ...........................................................5.1-2900 Coagulation factor VII, human ............................................. 1734
Clarity and degree of opalescence of liquids (2.2.1.)............ 23 Coagulation factor VIII, assay of (2.7.4.)............................... 194
Clary sage oil............................................................................. 1311 Coagulation factor VIII, human.....................................5.3-3513
Clazuril for veterinary use ..................................................... 1312 Coagulation factor VIII (rDNA), human ............................. 1737
Clazurilum ad usum veterinarium..................................... 1312 Coagulation factor X, assay of (2.7.19.)..................................210
Clebopride malate.................................................................... 1314 Coagulation factor XI, assay of (2.7.22.) ............................... 212
Clebopridi malas ..................................................................... 1314 Coagulation factor XI, human............................................... 1739
Clemastine fumarate ............................................................... 1315 Coated granules ................................................................ 5.2-3141
Clemastini fumaras ................................................................ 1315 Coated tablets .................................................................... 5.2-3151
Clenbuterol hydrochloride..............................................5.1-2902 Cocaine hydrochloride............................................................1338
Clenbuteroli hydrochloridum .......................................5.1-2902 Cocaini hydrochloridum.......................................................1338
Clindamycin hydrochloride.................................................... 1318 Cocois oleum raffinatum.......................................................1339
Clindamycini hydrochloridum............................................ 1318 Coconut oil, refined.................................................................1339
Clindamycini phosphas......................................................... 1319 Cocoyl caprylocaprate...................................................... 5.2-3189
Clindamycin phosphate .......................................................... 1319 Cocoylis caprylocapras................................................... 5.2-3189
Clioquinol .................................................................................. 1321 Codeine ...............................................................................5.1-2905
Clioquinolum ........................................................................... 1321 Codeine hydrochloride dihydrate..................................5.1-2906
Clobazam ...................................................................................1322 Codeine phosphate hemihydrate...................................5.1-2908
Clobazamum ............................................................................1322 Codeine phosphate sesquihydrate ................................5.1-2909
Clobetasone butyrate ..............................................................1323 Codeini hydrochloridum dihydricum.........................5.1-2906
Clobetasoni butyras ................................................................1323 Codeini phosphas hemihydricus .................................5.1-2908
Clofazimine................................................................................1324 Codeini phosphas sesquihydricus ...............................5.1-2909
Clofaziminum ..........................................................................1324 Codeinum...........................................................................5.1-2905
Clofibrate ...................................................................................1325 Codergocrine mesilate ............................................................1347
Clofibratum...............................................................................1325 Codergocrini mesilas .............................................................1347
Clomifene citrate ......................................................................1326 Cod-liver oil (type A)................................................................1348
Clomifeni citras .......................................................................1326 Cod-liver oil (type B)................................................................1352
Clomipramine hydrochloride.................................................1328 Coffeinum.................................................................................. 1145
Clomipramini hydrochloridum ...........................................1328 Coffeinum monohydricum ................................................... 1146
Clonazepam...............................................................................1330 Cola .............................................................................................1356
Clonazepamum .......................................................................1330 Colae semen .............................................................................1356
Clonidine hydrochloride......................................................... 1331 Colchicine ..................................................................................1357
Clonidini hydrochloridum.................................................... 1331 Colchicinum .............................................................................1357
Closantel sodium dihydrate for veterinary use ..........5.1-2903 Colestyramine ...........................................................................1359
Closantelum natricum dihydricum Colestyraminum ......................................................................1359
ad usum veterinarium..................................................5.1-2903 Colibacillosis vaccine (inactivated), neonatal piglet........... 776
Clostridium botulinum vaccine for veterinary use ............. 745 Colibacillosis vaccine (inactivated), neonatal ruminant .... 778
Clostridium chauvoei vaccine for veterinary use................ 745 Colistimethate sodium ............................................................1360
Clostridium novyi alpha antitoxin for veterinary use ........5.1- Colistimethatum natricum ...................................................1360
2865 Colistini sulfas ..................................................................5.3-3480
Clostridium novyi (type B) vaccine for veterinary use....... 746 Colistin sulphate ...............................................................5.3-3480

General Notices (1) apply to all monographs and other texts 3661
Index EUROPEAN PHARMACOPOEIA 5.3

Colloidal anhydrous silica ...................................................... 2410 Copovidone................................................................................1363


Colloidal hydrated silica ......................................................... 2411 Copovidonum...........................................................................1363
Colloidal silver, for external use ....................................5.3-3613 Copper acetate monohydrate for homoeopathic
Colophonium ...........................................................................1362 preparations..................................................................... 5.2-3162
Colophony .................................................................................1362 Copper for homoeopathic preparations................................ 896
Coloration of liquids (2.2.2.)...................................................... 24 Copper sulphate, anhydrous..................................................1364
Common stinging nettle for homoeopathic Copper sulphate pentahydrate..............................................1365
preparations.....................................................................5.3-3429 Coriander ...................................................................................1365
Comparative table of porosity of sintered-glass filters Coriander oil .............................................................................1366
(2.1.2.)............................................................................................17 Coriandri aetheroleum ..........................................................1366
Complexometric titrations (2.5.11.)........................................ 130 Coriandri fructus ....................................................................1365
Composition of fatty acids by gas chromatography Corpora ad usum pharmaceuticum ..................................... 586
(2.4.22.) .......................................................................................110 Cortisone acetate .....................................................................1367
Composition of fatty acids in oils rich in omega-3-acids Cortisoni acetas.......................................................................1367
(2.4.29.) ...................................................................................... 121 Cotton, absorbent ....................................................................1369
Compressed lozenges................................................................ 613 Cottonseed oil, hydrogenated ..............................................1370
Compressi...........................................................................5.2-3150 Couch grass rhizome .............................................................. 1371
Concentrated solutions for haemodialysis ......................... 1700 Crataegi folii cum flore
Concentrates for injections or infusions...................... 5.2-3145 extractum fluidum quantificatum ............................. 5.3-3511
Concentrates for intrauterine solutions.......................5.3-3397 Crataegi folii cum flore extractum siccum....................... 1714
Conductivity (2.2.38.).......................................................5.1-2783 Crataegi folium cum flore..................................................... 1713
Coneflower root, narrow-leaved.....................................5.2-3246 Crataegi fructus ....................................................................... 1712
Coneflower root, pale.......................................................5.2-3257 Creams.......................................................................................... 625
Conjugated estrogens .............................................................1539 Cresol, crude ............................................................................. 1371
Containers (3.2.)......................................................................... 303 Cresolum crudum ................................................................... 1371
Containers and closures for parenteral preparations and Croci stigma ad praeparationes homoeopathicas............ 900
ophthalmic preparations, polypropylene for (3.1.6.)........ 282 Croscarmellose sodium........................................................... 1371
Containers and closures for pharmaceutical use, plastic Crospovidone ............................................................................1373
(3.2.2.) ........................................................................................ 308 Crospovidonum .......................................................................1373
Containers and tubing for total parenteral nutrition Crotamiton ................................................................................ 1374
preparations, poly(ethylene - vinyl acetate) for (3.1.7.) ... 285 Crotamitonum.......................................................................... 1374
Containers for aqueous solutions for intravenous infusion, Cupri acetas monohydricus ad praeparationes
materials based on plasticised poly(vinyl chloride) for homoeopathicas ............................................................. 5.2-3162
(3.1.14.) ...................................................................................... 296 Cupri sulfas anhydricus ........................................................1364
Containers for aqueous solutions for parenteral infusion, Cupri sulfas pentahydricus ..................................................1365
plastic (3.2.2.1.) ........................................................................ 309 Cuprum ad praeparationes homoeopathicas .................... 896
Containers for dry dosage forms for oral administration, Curcumae xanthorrhizae rhizoma.....................................2645
materials based on non-plasticised poly(vinyl chloride) for Cutaneous application, liquid preparations for................... 607
(3.1.11.)....................................................................................... 291 Cutaneous application, powders for ............................. 5.2-3147
Containers for human blood and blood components, Cutaneous application, semi-solid preparations for ........... 624
materials based on plasticised poly(vinyl chloride) for Cutaneous application, veterinary liquid preparations
(3.1.1.1.) ..................................................................................... 269 for ................................................................................................ 630
Containers for human blood and blood components, Cutaneous foams........................................................................ 608
materials for (3.1.1.) ................................................................ 269 Cyamopsidis seminis pulvis................................................. 1694
Containers for human blood and blood components, plastic, Cyanocobalamin .......................................................................1375
sterile (3.2.3.) ............................................................................ 309 Cyanocobalamin (57Co) capsules .............................................819
Containers for non-injectable aqueous solutions, materials Cyanocobalamin (57Co) solution ............................................. 820
based on non-plasticised poly(vinyl chloride) for Cyanocobalamin (58Co) capsules ............................................ 821
(3.1.10.) ...................................................................................... 289 Cyanocobalamin (58Co) solution ............................................. 822
Containers for parenteral preparations and for ophthalmic Cyanocobalamini (57Co) capsulae .........................................819
preparations, polyethylene with additives for (3.1.5.) ..... 279 Cyanocobalamini (57Co) solutio ............................................ 820
Containers for parenteral preparations and for ophthalmic Cyanocobalamini (58Co) capsulae ........................................ 821
preparations, polyethylene without additives for Cyanocobalamini (58Co) solutio ............................................ 822
(3.1.4.)......................................................................................... 278 Cyanocobalaminum ...............................................................1375
Containers for pharmaceutical use, glass (3.2.1.)............... 303 Cyclizine hydrochloride.......................................................... 1376
Containers for preparations not for parenteral use, Cyclizini hydrochloridum..................................................... 1376
polyethylene terephthalate for (3.1.15) .............................. 298 Cyclopentolate hydrochloride ...............................................1377
Containers of plasticised poly(vinyl chloride) for human Cyclopentolati hydrochloridum ..........................................1377
blood and blood components, empty sterile (3.2.4.).........311 Cyclophosphamide...................................................................1378
Containers of plasticised poly (vinyl chloride) for human Cyclophosphamidum .............................................................1378
blood containing anticoagulant solution, sterile (3.2.5.).. 312 Cyproheptadine hydrochloride .............................................1379
Contamination, microbial, test for specified micro-organisms Cyproheptadini hydrochloridum ........................................1379
(2.6.13.) ...................................................................................... 156 Cyproterone acetate ................................................................1380
Contamination, microbial, total viable aerobic count Cyproteroni acetas..................................................................1380
(2.6.12.) ...................................................................................... 154 Cysteine hydrochloride monohydrate ................................. 1381
Content uniformity of single-dose preparations (2.9.6.).... 234 Cysteini hydrochloridum monohydricum........................ 1381
Control of impurities in substances for pharmaceutical use Cystine........................................................................................1382
(5.10.).......................................................................................... 559 Cystinum ...................................................................................1382
Copolymerum methacrylatis butylati basicum ............... 1053 Cytarabine .................................................................................1383

3662 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Cytarabinum.............................................................................1383 Dextrin........................................................................................ 1412


Dextrinum ................................................................................. 1412
D Dextromethorphan hydrobromide ....................................... 1412
Dalteparin sodium ...................................................................1387 Dextromethorphani hydrobromidum ................................ 1412
Dalteparinum natricum ........................................................1387 Dextromoramide tartrate ........................................................1414
Dapsone .....................................................................................1388 Dextromoramidi tartras..........................................................1414
Dapsonum.................................................................................1388 Dextropropoxyphene hydrochloride.....................................1414
Daunorubicin hydrochloride .................................................1389 Dextropropoxypheni hydrochloridum................................1414
Daunorubicini hydrochloridum..........................................1389 Diazepam ................................................................................... 1415
D-Camphor ................................................................................. 1170 Diazepamum ............................................................................ 1415
D-Camphora .............................................................................. 1170 Diazoxide ................................................................................... 1416
Decylis oleas.............................................................................1390 Diazoxidum .............................................................................. 1416
Decyl oleate ...............................................................................1390 Dibrompropamidine diisetionate ...................................5.3-3486
Deferoxamine mesilate............................................................1390 Dibrompropamidini diisetionas...................................5.3-3486
Deferoxamini mesilas ............................................................1390 Dibutylis phthalas ....................................................................1417
Degree of coloration of liquids (2.2.2.).................................... 24 Dibutyl phthalate ......................................................................1417
Deliverable mass or volume of liquid and semi-solid Dichloromethane...................................................................... 2017
preparations, test for (2.9.28.)............................................... 263 Diclazuril for veterinary use.................................................. 1418
Demeclocycline hydrochloride..............................................1392 Diclazurilum ad usum veterinarium................................. 1418
Demeclocyclini hydrochloridum ........................................1392 Diclofenac potassium .............................................................. 1419
Density of solids (2.2.42.)........................................................... 64 Diclofenac sodium ................................................................... 1420
Density, relative (2.2.5.) .............................................................. 27 Diclofenacum kalicum........................................................... 1419
Dental type silica...................................................................... 2411 Diclofenacum natricum ........................................................ 1420
Depressor substances (2.6.11.)................................................ 153 Dicloxacillin sodium ................................................................ 1422
Deptropine citrate....................................................................1393 Dicloxacillinum natricum..................................................... 1422
Deptropini citras .....................................................................1393 Dicycloverine hydrochloride.................................................. 1423
Dequalinii chloridum.............................................................1394 Dicycloverini hydrochloridum ............................................ 1423
Dequalinium chloride..............................................................1394 Didanosine.......................................................................... 5.2-3193
Desipramine hydrochloride ...................................................1395 Didanosinum..................................................................... 5.2-3193
Desipramini hydrochloridum ..............................................1395 Dienestrol .................................................................................. 1424
Deslanoside ...............................................................................1396 Dienestrolum............................................................................ 1424
Deslanosidum ..........................................................................1396 Diethylcarbamazine citrate.................................................... 1426
Desmopressin............................................................................1397 Diethylcarbamazini citras .................................................... 1426
Desmopressinum.....................................................................1397 Diethylene glycol and ethylene glycol in ethoxylated
Desoxycortone acetate............................................................1399 substances (2.4.30.)........................................................5.2-3095
Desoxycortoni acetas .............................................................1399 Diethylene glycol monoethyl ether...................................... 1426
Detector tubes, gas (2.1.6.) .........................................................19 Diethylene glycol palmitostearate................................. 5.2-3194
Determination of essential oils in vegetable drugs Diethylenglycoli monoethylicum aetherum .................... 1426
(2.8.12.) .......................................................................................217 Diethylenglycoli palmitostearas................................... 5.2-3194
Determination of nitrogen by sulphuric acid digestion Diethylis phthalas ................................................................... 1425
(2.5.9.) ........................................................................................ 129 Diethyl phthalate ..................................................................... 1425
Determination of primary aromatic amino-nitrogen Diethylstilbestrol ...................................................................... 1429
(2.5.8.) ........................................................................................ 129 Diethylstilbestrolum ............................................................... 1429
Determination of tannins in herbal drugs (2.8.14.)............ 221 Diflunisal.................................................................................... 1429
Determination of water by distillation (2.2.13.) .................... 32 Diflunisalum ............................................................................ 1429
Detomidine hydrochloride for veterinary use ................... 1400 Digitalis leaf .............................................................................. 1431
Detomidini hydrochloridum ad usum veterinarium..... 1400 Digitalis purpureae folium ................................................... 1431
Devil’s claw root ....................................................................... 1401 Digitoxin..................................................................................... 1432
Dexamethasone ........................................................................ 1402 Digitoxinum.............................................................................. 1432
Dexamethasone acetate.......................................................... 1403 Digoxin ....................................................................................... 1433
Dexamethasone isonicotinate ........................................5.3-3485 Digoxinum ................................................................................ 1433
Dexamethasone sodium phosphate ..................................... 1404 Dihydralazine sulphate, hydrated ........................................ 1434
Dexamethasoni acetas ........................................................... 1403 Dihydralazini sulfas hydricus.............................................. 1434
Dexamethasoni isonicotinas.........................................5.3-3485 Dihydrocodeine hydrogen tartrate....................................... 1435
Dexamethasoni natrii phosphas ......................................... 1404 Dihydrocodeini hydrogenotartras ...................................... 1435
Dexamethasonum ................................................................... 1402 Dihydroergocristine mesilate ................................................ 1437
Dexchlorpheniramine maleate .............................................. 1406 Dihydroergocristini mesilas................................................. 1437
Dexchlorpheniramini maleas .............................................. 1406 Dihydroergotamine mesilate ................................................. 1439
Dexpanthenol............................................................................ 1407 Dihydroergotamine tartrate .................................................. 1440
Dexpanthenolum..................................................................... 1407 Dihydroergotamini mesilas.................................................. 1439
Dextran 1 for injection............................................................ 1408 Dihydroergotamini tartras.................................................... 1440
Dextran 40 for injection ......................................................... 1409 Dihydrostreptomycini sulfas ad usum veterinarium..... 1441
Dextran 60 for injection ......................................................... 1410 Dihydrostreptomycin sulphate for veterinary use ............ 1441
Dextran 70 for injection ..........................................................1411 Dihydrotachysterol ...........................................................5.3-3487
Dextrans, molecular mass distribution in (2.2.39.) .............. 57 Dihydrotachysterolum ....................................................5.3-3487
Dextranum 1 ad iniectabile ................................................. 1408 Dikalii clorazepas ................................................................... 1457
Dextranum 40 ad iniectabile ............................................... 1409 Dikalii phosphas...................................................................... 1458
Dextranum 60 ad iniectabile ............................................... 1410 Diltiazem hydrochloride ......................................................... 1443
Dextranum 70 ad iniectabile ................................................1411 Diltiazemi hydrochloridum.................................................. 1443

General Notices (1) apply to all monographs and other texts 3663
Index EUROPEAN PHARMACOPOEIA 5.3

Dimenhydrinate........................................................................ 1444 Disintegration of suppositories and pessaries (2.9.2.)....... 227


Dimenhydrinatum .................................................................. 1444 Disintegration of tablets and capsules (2.9.1.) ...........5.3-3351
Dimercaprol............................................................................... 1445 Disodium edetate ..................................................................... 1462
Dimercaprolum........................................................................ 1445 Disodium phosphate, anhydrous.......................................... 1463
Dimethylacetamide ...........................................................5.1-2915 Disodium phosphate dihydrate............................................. 1464
Dimethylacetamidum......................................................5.1-2915 Disodium phosphate dodecahydrate ............................ 5.1-2916
Dimethylaniline, N,N- (2.4.26.).................................................119 Disopyramide ............................................................................ 1465
Dimethylis sulfoxidum........................................................... 1445 Disopyramide phosphate........................................................ 1466
Dimethyl sulfoxide ................................................................... 1445 Disopyramidi phosphas......................................................... 1466
Dimeticone ................................................................................ 1447 Disopyramidum....................................................................... 1465
Dimeticonum............................................................................ 1447 Dispersible tablets ............................................................ 5.2-3151
Dimetindene maleate .............................................................. 1448 Dissolution test for lipophilic solid dosage forms
Dimetindeni maleas ............................................................... 1448 (2.9.42.) .............................................................................5.3-3373
Dinatrii edetas ......................................................................... 1462 Dissolution test for medicated chewing gums (2.9.25.)
Dinatrii phosphas anhydricus............................................. 1463 ............................................................................................ 5.2-3116
Dinatrii phosphas dihydricus .............................................. 1464 Dissolution test for solid dosage forms (2.9.3.)..........5.3-3353
Dinatrii phosphas dodecahydricus ............................. 5.1-2916 Dissolution test for transdermal patches (2.9.4.)................ 231
Dinitrogenii oxidum........................................................5.1-2981 Distemper vaccine (live), canine, freeze-dried...................... 740
Dinoprostone ............................................................................ 1450 Distemper vaccine (live) for mustelids, freeze-dried........... 751
Dinoprostonum........................................................................ 1450 Distillation range (2.2.11.).......................................................... 30
Dinoprost trometamol............................................................. 1449 Distribution estimation by analytical sieving, particle-size
Dinoprostum trometamolum ............................................... 1449 (2.9.38.) .............................................................................5.3-3368
Diosmin ...................................................................................... 1452 Disulfiram .................................................................................. 1467
Diosminum ............................................................................... 1452 Disulfiramum ........................................................................... 1467
Dioxan and ethylene oxide (2.4.25.) .......................................118 Dithranol.................................................................................... 1468
Dip concentrates ........................................................................ 630 Dithranolum ............................................................................. 1468
Diphenhydramine hydrochloride.......................................... 1454 DL-Methionine ........................................................................... 2010
Diphenhydramini hydrochloridum.................................... 1454 DL-Methioninum ...................................................................... 2010
Diphenoxylate hydrochloride ................................................ 1455 DL-α-Tocopheryl hydrogen succinate...................................2597
Diphenoxylati hydrochloridum........................................... 1455 DL-α-Tocopherylis hydrogenosuccinas..............................2597
Diphtheria and tetanus vaccine (adsorbed) ......................... 639 Dobutamine hydrochloride.................................................... 1469
Diphtheria and tetanus vaccine (adsorbed) for adults and Dobutamini hydrochloridum ............................................... 1469
adolescents................................................................................ 639 Docusate sodium...................................................................... 1471
Diphtheria antitoxin .................................................................. 801 Dodecyl gallate ......................................................................... 1472
Diphtheria, tetanus and hepatitis B (rDNA) vaccine Dodecylis gallas....................................................................... 1472
(adsorbed).................................................................................. 641 Dog rose..................................................................................... 1472
Diphtheria, tetanus and pertussis (acellular, component) Domperidone ............................................................................ 1473
vaccine (adsorbed)................................................................... 642 Domperidone maleate............................................................. 1475
Diphtheria, tetanus and pertussis vaccine (adsorbed) ..... 643 Domperidoni maleas.............................................................. 1475
Diphtheria, tetanus, pertussis (acellular, component) and Domperidonum ....................................................................... 1473
haemophilus type b conjugate vaccine (adsorbed) .......... 645 Dopamine hydrochloride........................................................ 1476
Diphtheria, tetanus, pertussis (acellular, component) and Dopamini hydrochloridum................................................... 1476
hepatitis B (rDNA) vaccine (adsorbed) ............................... 647 Dosage units, uniformity of (2.9.40.) ............................5.3-3370
Diphtheria, tetanus, pertussis (acellular, component) and Dosulepin hydrochloride........................................................ 1477
poliomyelitis (inactivated) vaccine (adsorbed) .................. 648 Dosulepini hydrochloridum ................................................. 1477
Diphtheria, tetanus, pertussis (acellular, component), Doxapram hydrochloride........................................................ 1479
hepatitis B (rDNA), poliomyelitis (inactivated) and Doxaprami hydrochloridum ................................................ 1479
haemophilus type b conjugate vaccine (adsorbed) .......... 650 Doxepin hydrochloride ........................................................... 1480
Diphtheria, tetanus, pertussis (acellular, component), Doxepini hydrochloridum .................................................... 1480
poliomyelitis (inactivated) and haemophilus type b Doxorubicin hydrochloride.................................................... 1481
conjugate vaccine (adsorbed)................................................ 653 Doxorubicini hydrochloridum............................................. 1481
Diphtheria, tetanus, pertussis and poliomyelitis (inactivated) Doxycycline hyclate ................................................................. 1482
vaccine (adsorbed)................................................................... 656 Doxycycline monohydrate...................................................... 1484
Diphtheria, tetanus, pertussis, poliomyelitis (inactivated) and Doxycyclini hyclas.................................................................. 1482
haemophilus type b conjugate vaccine (adsorbed) .......... 657 Doxycyclinum monohydricum............................................ 1484
Diphtheria vaccine (adsorbed) ................................................ 660 Doxylamine hydrogen succinate........................................... 1486
Diphtheria vaccine (adsorbed), assay of (2.7.6.).................. 196 Doxylamini hydrogenosuccinas ......................................... 1486
Diphtheria vaccine (adsorbed) for adults and Droperidol.................................................................................. 1487
adolescents................................................................................ 661 Droperidolum........................................................................... 1487
Dipivefrine hydrochloride ...................................................... 1456 Droppers (2.1.1.)............................................................................17
Dipivefrini hydrochloridum ................................................. 1456 Drop point (2.2.17.)...................................................................... 33
Dipotassium clorazepate ........................................................ 1457 Dry extracts ................................................................................. 572
Dipotassium phosphate .......................................................... 1458 Dry residue of extracts (2.8.16.).............................................. 222
Diprophylline ............................................................................ 1459 Duck plague vaccine (live) ..............................................5.3-3419
Diprophyllinum ....................................................................... 1459 Duck viral hepatitis type I vaccine (live)............................... 751
Dipyridamole............................................................................. 1460
Dipyridamolum ....................................................................... 1460 E
Dirithromycin............................................................................ 1461 Ear-drops and sprays ........................................................5.2-3137
Dirithromycinum .................................................................... 1461 Ear powders .......................................................................5.2-3138

3664 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Ear preparations................................................................5.2-3137 Erythromycin ethylsuccinate................................................. 1521


Ear preparations, semi-solid ...........................................5.2-3138 Erythromycini estolas............................................................1520
Ear tampons.......................................................................5.2-3138 Erythromycini ethylsuccinas............................................... 1521
Ear washes..........................................................................5.2-3138 Erythromycini lactobionas...................................................1523
Ebastine ..................................................................................... 1491 Erythromycini stearas ...........................................................1526
Ebastinum ................................................................................. 1491 Erythromycin lactobionate ....................................................1523
Echinaceae angustifoliae radix....................................5.2-3246 Erythromycin stearate ............................................................1526
Echinaceae pallidae radix .............................................5.2-3257 Erythromycinum..................................................................... 1518
Econazole .................................................................................. 1492 Erythropoietin concentrated solution..........................5.3-3494
Econazole nitrate..................................................................... 1493 Erythropoietini solutio concentrata............................5.3-3494
Econazoli nitras ...................................................................... 1493 Eserine salicylate .....................................................................2239
Econazolum.............................................................................. 1492 Eserine sulphate.......................................................................2240
Edetic acid ................................................................................. 1494 Eserini salicylas ......................................................................2239
Edrophonii chloridum ........................................................... 1495 Eserini sulfas............................................................................2240
Edrophonium chloride............................................................ 1495 Esketamine hydrochloride .....................................................1533
Effervescent granules....................................................... 5.2-3141 Esketamini hydrochloridum ................................................1533
Effervescent powders ....................................................... 5.2-3148 Essential oils, assay of 1,8-cineole (2.8.11.)...........................216
Effervescent tablets .......................................................... 5.2-3151 Essential oils, fatty oils and resinified essential oils in
Efficacy of antimicrobial preservation (5.1.3.)..................... 447 (2.8.7.)..........................................................................................216
Egg drop syndrome ’76 vaccine (inactivated)...................... 753 Essential oils, foreign esters in (2.8.6.) ..................................216
Elder flower............................................................................... 1496 Essential oils in vegetable drugs, determination of
Electrophoresis (2.2.31.)............................................................. 45 (2.8.12.) .......................................................................................217
Electrophoresis, capillary (2.2.47.)............................................74 Essential oils, odour and taste (2.8.8.) ...................................216
Eleutherococci radix .......................................................5.3-3491 Essential oils, residue on evaporation (2.8.9.)......................216
Eleutherococcus................................................................5.3-3491 Essential oils, solubility in alcohol (2.8.10.)..........................216
Emetine hydrochloride heptahydrate.................................. 1499 Essential oils, water in (2.8.5.) .................................................216
Emetine hydrochloride pentahydrate..................................1500 Ester value (2.5.2.) ..................................................................... 127
Emetini hydrochloridum heptahydricum......................... 1499 Estradiol benzoate...................................................................1534
Emetini hydrochloridum pentahydricum ........................1500 Estradiol hemihydrate.............................................................1535
Emplastra transcutanea ................................................. 5.2-3146 Estradioli benzoas...................................................................1534
Empty sterile containers of plasticised poly(vinyl chloride) Estradioli valeras.....................................................................1536
for human blood and blood components (3.2.4.) ..............311 Estradiolum hemihydricum .................................................1535
Emulsifying cetostearyl alcohol (type A) ............................1239 Estradiol valerate .....................................................................1536
Emulsifying cetostearyl alcohol (type B)............................ 1241 Estriol .........................................................................................1537
Enalaprili maleas............................................................. 5.1-2919 Estriolum...................................................................................1537
Enalapril maleate .............................................................. 5.1-2919 Estrogeni coniuncti ................................................................1539
Encephalitis vaccine (inactivated), tick-borne ............ 5.3-3414 Estrogens, conjugated ............................................................1539
Endotoxins, bacterial (2.6.14.)..................................................161 Etacrynic acid ...........................................................................1542
Enilconazole for veterinary use............................................1503 Etamsylate .................................................................................1542
Enilconazolum ad usum veterinarium .............................1503 Etamsylatum ............................................................................1542
Enoxaparin sodium...........................................................5.3-3493 Ethacridine lactate monohydrate.........................................1543
Enoxaparinum natricum ...............................................5.3-3493 Ethacridini lactas monohydricus .......................................1543
Enoxolone..................................................................................1505 Ethambutol hydrochloride.....................................................1544
Enoxolonum .............................................................................1505 Ethambutoli hydrochloridum ..............................................1544
Ephedrine, anhydrous.............................................................1506 Ethanol (96 per cent) ..............................................................1545
Ephedrine hemihydrate ..........................................................1507 Ethanol, anhydrous .................................................................1547
Ephedrine hydrochloride .......................................................1508 Ethanol content and alcoholimetric tables (2.9.10.) .......... 237
Ephedrine hydrochloride, racemic.......................................1509 Ethanolum (96 per centum).................................................1545
Ephedrini hydrochloridum ..................................................1508 Ethanolum anhydricum ........................................................1547
Ephedrini racemici hydrochloridum.................................1509 Ether ...........................................................................................1548
Ephedrinum anhydricum .....................................................1506 Ether, anaesthetic....................................................................1549
Ephedrinum hemihydricum ................................................1507 Ethinylestradiol ........................................................................1550
Epirubicin hydrochloride .......................................................1509 Ethinylestradiolum .................................................................1550
Epirubicini hydrochloridum................................................1509 Ethionamide.............................................................................. 1551
Equine herpesvirus vaccine (inactivated) ............................. 754 Ethionamidum......................................................................... 1551
Equine influenza vaccine (inactivated) ................................. 755 Ethosuximide .....................................................................5.3-3498
Equiseti herba .......................................................................... 1511 Ethosuximidum ................................................................5.3-3498
Equisetum stem........................................................................ 1511 Ethoxylated substances, ethylene glycol and diethylene
Ergocalciferol............................................................................ 1512 glycol in (2.4.30.) ............................................................5.2-3095
Ergocalciferolum..................................................................... 1512 Ethyl acetate .............................................................................1553
Ergometrine maleate............................................................... 1514 Ethylcellulose ...........................................................................1555
Ergometrini maleas................................................................ 1514 Ethylcellulosum .......................................................................1555
Ergotamine tartrate................................................................. 1515 Ethylendiaminum ...................................................................1556
Ergotamini tartras .................................................................. 1515 Ethylenediamine ......................................................................1556
Erysipelas vaccine (inactivated), swine ................................. 793 Ethylene glycol and diethylene glycol in ethoxylated
Erythritol ................................................................................... 1516 substances (2.4.30.)........................................................5.2-3095
Erythritolum............................................................................. 1516 Ethylene glycol monopalmitostearate.................................1556
Erythromycin ............................................................................ 1518 Ethylene glycol monostearate...............................................1556
Erythromycin estolate.............................................................1520 Ethylene oxide and dioxan (2.4.25.) .......................................118

General Notices (1) apply to all monographs and other texts 3665
Index EUROPEAN PHARMACOPOEIA 5.3

Ethylenglycoli monopalmitostearas...................................1556 Factor VII, human coagulation............................................. 1734


Ethylhexanoic acid, 2- (2.4.28.)............................................... 120 Factor VII, human coagulation, assay of (2.7.10.) .............. 203
Ethylis acetas ...........................................................................1553 Factor VIII coagulationis humanus............................5.3-3513
Ethylis oleas..............................................................................1553 Factor VIII coagulationis humanus (ADNr) .................... 1737
Ethylis parahydroxybenzoas................................................1554 Factor VIII, human coagulation ....................................5.3-3513
Ethylis parahydroxybenzoas natricum ......................5.1-2920 Factor VIII, human coagulation, assay of (2.7.4.) ............... 194
Ethylmorphine hydrochloride...............................................1557 Factor VIII (rDNA), human coagulation ............................. 1737
Ethylmorphini hydrochloridum..........................................1557 Factor X, human coagulation, assay of (2.7.19.) ..................210
Ethyl oleate ...............................................................................1553 Factor XI coagulationis humanus ...................................... 1739
Ethyl parahydroxybenzoate...................................................1554 Factor XI, human coagulation .............................................. 1739
Ethyl parahydroxybenzoate sodium .............................5.1-2920 Factor XI, human coagulation, assay of (2.7.22.)................ 212
Etilefrine hydrochloride .........................................................1558 Fagopyri herba ................................................................. 5.2-3180
Etilefrini hydrochloridum.....................................................1558 Falling ball viscometer method (2.2.49.) ................................ 80
Etodolac .....................................................................................1560 Famotidine.................................................................................1575
Etodolacum...............................................................................1560 Famotidinum............................................................................1575
Etofenamate .............................................................................. 1561 Fatty acids, composition by gas chromatography
Etofenamatum ......................................................................... 1561 (2.4.22.) .......................................................................................110
Etofylline....................................................................................1563 Fatty oils, alkaline impurities in (2.4.19.) ............................. 109
Etofyllinum ...............................................................................1563 Fatty oils and herbal drugs, heavy metals in (2.4.27.) ........119
Etomidate ..................................................................................1564 Fatty oils and resinified essential oils in essential oils
Etomidatum ..............................................................................1564 (2.8.7.)..........................................................................................216
Etoposide ...................................................................................1565 Fatty oils, foreign oils in, by thin-layer chromatography
Etoposidum...............................................................................1565 (2.4.21.) ...................................................................................... 109
Eucalypti aetheroleum ...................................................5.2-3203 Fatty oils, identification by thin-layer chromatography
Eucalypti folium......................................................................1569 (2.3.2.) .......................................................................................... 98
Eucalyptus leaf .........................................................................1569 Fatty oils, sterols in (2.4.23.) ..........................................5.1-2787
Eucalyptus oil ....................................................................5.2-3203 Fc function of immunoglobulin, test for (2.7.9.) ................. 202
Eugenol ...................................................................................... 1571 Feline calicivirosis vaccine (inactivated) ............................... 757
Eugenolum................................................................................ 1571 Feline calicivirosis vaccine (live), freeze-dried ..................... 758
European Goldenrod........................................................5.3-3507 Feline infectious enteritis (feline panleucopenia) vaccine
European viper venom antiserum.......................................... 806 (inactivated) .............................................................................. 759
Evaluation of efficacy of veterinary vaccines and immunosera Feline infectious enteritis (feline panleucopenia) vaccine
(5.2.7.)................................................................................5.1-2829 (live) ............................................................................................ 760
Evaluation of safety of each batch of veterinary vaccines and Feline leukaemia vaccine (inactivated)...................................761
immunosera (5.2.9.) .......................................................5.1-2830 Feline panleucopenia vaccine (inactivated).......................... 759
Evaluation of safety of veterinary vaccines and immunosera Feline panleucopenia vaccine (live) ....................................... 760
(5.2.6.) ...............................................................................5.1-2827 Feline viral rhinotracheitis vaccine (inactivated) ................ 762
Evening primrose oil, refined.........................................5.1-2921 Feline viral rhinotracheitis vaccine (live), freeze-dried ...... 763
Extracta........................................................................................ 570 Felodipine .................................................................................. 1576
Extractable volume of parenteral preparations, test for Felodipinum ............................................................................. 1576
(2.9.17.)..............................................................................5.3-3363 Felypressin..........................................................................5.2-3207
Extracta fluida ........................................................................... 571 Felypressinum...................................................................5.2-3207
Extracta sicca ............................................................................. 572 Fenbendazole for veterinary use ..........................................1577
Extracta spissa ........................................................................... 572 Fenbendazolum ad usum veterinarium............................1577
Extracts ........................................................................................ 570 Fenbufen ....................................................................................1578
Extracts, dry................................................................................ 572 Fenbufenum..............................................................................1578
Extracts, dry residue of (2.8.16.)............................................. 222 Fennel, bitter.............................................................................1580
Extracts, liquid............................................................................ 571 Fennel, sweet.............................................................................1580
Extracts, loss on drying of (2.8.17.)........................................ 222 Fenofibrate ................................................................................ 1581
Extracts, soft ............................................................................... 572 Fenofibratum............................................................................ 1581
Extraneous agents in viral vaccines for human use, tests for Fenoterol hydrobromide.........................................................1583
(2.6.16.) ...................................................................................... 169 Fenoteroli hydrobromidum ..................................................1583
Extraneous agents : tests in batches of finished product of Fentanyl .....................................................................................1584
avian live virus vaccines (2.6.25.)................................5.3-3345 Fentanyl citrate.........................................................................1585
Extraneous agents : tests in seed lots of avian viral vaccines Fentanyli citras........................................................................1585
(2.6.24.) ...................................................................................... 177 Fentanylum...............................................................................1584
Eye drops ............................................................................5.3-3395 Fenticonazole nitrate ..............................................................1586
Eye lotions..........................................................................5.3-3395 Fenticonazoli nitras ...............................................................1586
Eye preparations ...............................................................5.3-3395 Fenugreek..................................................................................1588
Eye preparations, semi-solid ...........................................5.3-3396 Fermentation, products of ....................................................... 576
Ferric chloride hexahydrate ..................................................1588
F Ferri chloridum hexahydricum...........................................1588
F0 concept to steam sterilisation of aqueous preparations, Ferrosi fumaras .......................................................................1589
application of (5.1.5.) .....................................................5.1-2821 Ferrosi gluconas......................................................................1590
Factor II, human coagulation, assay of (2.7.18.) ................. 209 Ferrosi sulfas heptahydricus................................................ 1591
Factor IX coagulationis humanus ...................................... 1738 Ferrous fumarate .....................................................................1589
Factor IX, human coagulation .............................................. 1738 Ferrous gluconate....................................................................1590
Factor IX, human coagulation, assay of (2.7.11.) ................ 204 Ferrous sulphate heptahydrate............................................. 1591
Factor VII coagulationis humanus .................................... 1734 Ferrum ad praeparationes homoeopathicas ..................... 899

3666 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Feverfew .....................................................................................1592 Fluphenazini decanoas ......................................................... 1619


Fibrini glutinum......................................................................1593 Fluphenazini enantas............................................................ 1620
Fibrinogen, human .................................................................. 1740 Fluphenazini hydrochloridum ............................................ 1621
Fibrinogenum humanum ..................................................... 1740 Flurazepami monohydrochloridum................................... 1622
Fibrin sealant kit ......................................................................1593 Flurazepam monohydrochloride .......................................... 1622
Fila non resorbilia sterilia.............................................5.3-3423 Flurbiprofen .............................................................................. 1623
Fila non resorbilia sterilia in fuso ad usum Flurbiprofenum ....................................................................... 1623
veterinarium ............................................................................ 888 Fluspirilene ............................................................................... 1625
Fila resorbilia synthetica monofilamenta sterilia............ 880 Fluspirilenum .......................................................................... 1625
Fila resorbilia synthetica torta sterilia................................ 878 Flutamide................................................................................... 1626
Filipendulae ulmariae herba ............................................... 1980 Flutamidum .............................................................................. 1626
Filum bombycis tortum sterile in fuso ad usum Fluticasone propionate........................................................... 1627
veterinarium ............................................................................ 887 Fluticasoni propionas............................................................ 1627
Filum ethyleni polyterephthalici sterile in fuso ad usum Flutrimazole.............................................................................. 1629
veterinarium ............................................................................ 887 Flutrimazolum ......................................................................... 1629
Filum lini sterile in fuso ad usum veterinarium .............. 886 Foams, cutaneous ...................................................................... 608
Filum polyamidicum-6/6 sterile in fuso ad usum Foams, intrauterine ..........................................................5.3-3397
veterinarium ............................................................................ 887 Foams, medicated ...................................................................... 604
Filum polyamidicum-6 sterile in fuso ad usum Foams, rectal......................................................................5.2-3150
veterinarium ............................................................................ 886 Foams, vaginal ...................................................................5.2-3154
Finasteride.................................................................................1594 Foeniculi amari fructus.........................................................1580
Finasteridum............................................................................1594 Foeniculi amari fructus aetheroleum................................ 1108
Fish oil, rich in omega-3-acids...............................................1595 Foeniculi dulcis fructus.........................................................1580
Flecainide acetate ....................................................................1598 Folic acid.................................................................................... 1630
Flecainidi acetas .....................................................................1598 Foot-and-mouth disease (ruminants) vaccine
Flowability (2.9.16.) ................................................................... 242 (inactivated) .....................................................................5.1-2860
Flubendazole ............................................................................1599 Foreign esters in essential oils (2.8.6.) ...................................216
Flubendazolum........................................................................1599 Foreign matter (2.8.2.) .............................................................. 215
Flucloxacillin sodium .......................................................5.1-2925 Foreign oils in fatty oils by thin-layer chromatography
Flucloxacillinum natricum............................................5.1-2925 (2.4.21.) ...................................................................................... 109
Flucytosine ................................................................................ 1602 Formaldehyde, free (2.4.18.) .................................................... 109
Flucytosinum ........................................................................... 1602 Formaldehyde solution (35 per cent) .................................. 1632
Fludarabine phosphate....................................................5.1-2926 Formaldehydi solutio (35 per centum).............................. 1632
Fludarabini phosphas .....................................................5.1-2926 Formoterol fumarate dihydrate ............................................ 1632
Fludeoxyglucose (18F) injection .............................................. 822 Formoteroli fumaras dihydricus ......................................... 1632
Fludeoxyglucosi (18F) solutio iniectabilis ........................... 822 Foscarnet sodium hexahydrate............................................. 1634
Fludrocortisone acetate.......................................................... 1603 Foscarnetum natricum hexahydricum.............................. 1634
Fludrocortisoni acetas ........................................................... 1603 Fosfomycin calcium ................................................................. 1636
Flumazenil................................................................................. 1604 Fosfomycin sodium .................................................................. 1637
Flumazenil (N-[11C]methyl) injection ..................................... 825 Fosfomycin trometamol .......................................................... 1638
Flumazenil (N-[11C]methyl) solutio iniectabilis................. 825 Fosfomycinum calcicum ....................................................... 1636
Flumazenilum.......................................................................... 1604 Fosfomycinum natricum....................................................... 1637
Flumequine ............................................................................... 1605 Fosfomycinum trometamolum ............................................ 1638
Flumequinum........................................................................... 1605 Fowl cholera vaccine (inactivated) ................................5.1-2861
Flumetasone pivalate .............................................................. 1607 Fowl-pox vaccine (live) .............................................................. 766
Flumetasoni pivalas ............................................................... 1607 Framycetini sulfas .................................................................. 1639
Flunarizine dihydrochloride.................................................. 1608 Framycetin sulphate................................................................ 1639
Flunarizini dihydrochloridum ............................................ 1608 Frangula bark ........................................................................... 1641
Flunitrazepam........................................................................... 1609 Frangula bark dry extract, standardised ............................ 1642
Flunitrazepamum ................................................................... 1609 Frangulae cortex ..................................................................... 1641
Flunixini megluminum ad usum veterinarium.......5.1-2929 Frangulae corticis extractum siccum normatum ........... 1642
Flunixin meglumine for veterinary use........................5.1-2929 Fraxini folium .......................................................................... 1026
Fluocinolone acetonide .......................................................... 1610 Free formaldehyde (2.4.18.)..................................................... 109
Fluocinoloni acetonidum ..................................................... 1610 Freezing point (2.2.18.)............................................................... 34
Fluocortolone pivalate............................................................ 1611 Friability of uncoated tablets (2.9.7.)............................ 5.2-3103
Fluocortoloni pivalas ............................................................. 1611 Fructose .................................................................................... 1643
Fluorescein sodium ..........................................................5.2-3208 Fructosum ................................................................................. 1643
Fluoresceinum natricum ...............................................5.2-3208 Fucus .......................................................................................... 1869
Fluorides (2.4.5.) ........................................................................ 104 Fucus vel Ascophyllum.......................................................... 1869
Fluorimetry (2.2.21.) ................................................................... 35 Functional groups and ions, identification reactions
Fluorouracil............................................................................... 1614 (2.3.1.)........................................................................................... 95
Fluorouracilum........................................................................ 1614 Furosemide.........................................................................5.1-2930
Fluoxetine hydrochloride ................................................5.3-3503 Furosemidum ....................................................................5.1-2930
Fluoxetini hydrochloridum ...........................................5.3-3503 Furunculosis vaccine (inactivated, oil-adjuvanted, injectable)
Flupentixol dihydrochloride ...................................................1617 for salmonids ............................................................................ 767
Flupentixoli dihydrochloridum ............................................1617 Fusidic acid ............................................................................... 1645
Fluphenazine decanoate ........................................................ 1619
Fluphenazine enantate ........................................................... 1620 G
Fluphenazine hydrochloride ................................................. 1621 Galactose.................................................................................... 1649

General Notices (1) apply to all monographs and other texts 3667
Index EUROPEAN PHARMACOPOEIA 5.3

Galactosum ............................................................................... 1649 Glycerol (85 per cent).............................................................. 1672


Gallamine triethiodide ............................................................ 1649 Glycerol dibehenate..........................................................5.1-2938
Gallamini triethiodidum ....................................................... 1649 Glycerol distearate .................................................................. 1674
Gallii (67Ga) citratis solutio iniectabilis ............................... 826 Glyceroli dibehenas .........................................................5.1-2938
Gallium (67Ga) citrate injection ............................................... 826 Glyceroli distearas .................................................................. 1674
Gargles.......................................................................................... 612 Glyceroli monolinoleas ........................................................ 1675
Garlic for homoeopathic preparations .................................. 897 Glyceroli mono-oleates .......................................................... 1676
Garlic powder............................................................................ 1651 Glyceroli monostearas 40-55................................................ 1677
Gas chromatography (2.2.28.) ................................................... 42 Glyceroli trinitratis solutio ................................................... 1678
Gas detector tubes (2.1.6.) ..........................................................19 Glycerol monolinoleate........................................................... 1675
Gases, carbon dioxide in (2.5.24.)........................................... 134 Glycerol mono-oleates ............................................................ 1676
Gases, carbon monoxide in (2.5.25.)...................................... 134 Glycerol monostearate 40-55................................................. 1677
Gases, nitrogen monoxide and nitrogen dioxide in Glycerol triacetate.................................................................... 2612
(2.5.26.) ...................................................................................... 135 Glycerolum................................................................................ 1671
Gases, nitrous oxide in (2.5.35.)...............................................141 Glycerolum (85 per centum) ................................................ 1672
Gases, oxygen in (2.5.27.) ......................................................... 136 Glyceryl trinitrate solution..................................................... 1678
Gases, water in (2.5.28.)............................................................ 136 Glycine........................................................................................ 1680
Gas-gangrene antitoxin, mixed ................................................ 802 Glycinum ................................................................................... 1680
Gas-gangrene antitoxin (novyi) ............................................... 802 Glycyrrhizate ammonium ................................................5.1-2876
Gas-gangrene antitoxin (perfringens) .................................... 803 Goldenrod ...........................................................................5.2-3213
Gas-gangrene antitoxin (septicum)......................................... 804 Goldenrod, European.......................................................5.3-3507
Gastro-resistant capsules .................................................5.2-3136 Goldenseal rhizome................................................................. 1683
Gastro-resistant granules................................................. 5.2-3141 Gonadorelin acetate ................................................................ 1684
Gastro-resistant tablets ....................................................5.2-3152 Gonadorelini acetas ............................................................... 1684
Gelatin ........................................................................................ 1651 Gonadotrophin, chorionic ...................................................... 1686
Gelatina ..................................................................................... 1651 Gonadotrophin, equine serum, for veterinary use............ 1686
Gels................................................................................................ 625 Gonadotropinum chorionicum ........................................... 1686
Gels for injections ............................................................. 5.2-3146 Gonadotropinum sericum equinum ad usum
General chapters (1.3.)...................................................................6 veterinarium .......................................................................... 1686
General notices (1.).........................................................................5 Goserelin .................................................................................... 1687
General statements (1.1.)...............................................................5 Goserelinum ............................................................................. 1687
General texts on sterility (5.1.)................................................ 445 Gossypii oleum hydrogenatum............................................1370
General texts on vaccines (5.2.) .............................................. 453 Gramicidin ................................................................................. 1689
Gentamicini sulfas .................................................................. 1653 Gramicidinum.......................................................................... 1689
Gentamicin sulphate................................................................ 1653 Graminis rhizoma................................................................... 1371
Gentianae radix ....................................................................... 1654 Granisetron hydrochloride..............................................5.1-2939
Gentianae tinctura.................................................................. 1655 Granisetroni hydrochloridum.......................................5.1-2939
Gentian root .............................................................................. 1654 Granulata ........................................................................... 5.2-3140
Gentian tincture ....................................................................... 1655 Granules .............................................................................. 5.2-3140
Ginger ......................................................................................... 1656 Granules, coated................................................................ 5.2-3141
Gingival solutions ...................................................................... 612 Granules, effervescent...................................................... 5.2-3141
Ginkgo folium .......................................................................... 1657 Granules, gastro-resistant................................................ 5.2-3141
Ginkgo leaf ................................................................................ 1657 Granules, modified-release.............................................. 5.2-3141
Ginseng................................................................................5.1-2935 Greater celandine ..................................................................... 1690
Ginseng radix....................................................................5.1-2935 Griseofulvin ............................................................................... 1691
Glass containers for pharmaceutical use (3.2.1.) ................ 303 Griseofulvinum ........................................................................ 1691
Glibenclamide ........................................................................... 1659 Guaifenesin................................................................................ 1692
Glibenclamidum ...................................................................... 1659 Guaifenesinum ........................................................................ 1692
Gliclazide.................................................................................... 1660 Guanethidine monosulphate ................................................. 1694
Gliclazidum............................................................................... 1660 Guanethidini monosulfas ..................................................... 1694
Glipizide ..................................................................................... 1662 Guar ............................................................................................ 1694
Glipizidum ................................................................................ 1662 Guar galactomannan ............................................................... 1695
Glossary (dosage forms) ........................................................... 599 Guar galactomannanum ....................................................... 1695
Glucagon .................................................................................... 1663
Glucagon, human..................................................................... 1665 H
Glucagonum ............................................................................. 1663 Haemodiafiltration and for haemofiltration, solutions
Glucagonum humanum ........................................................ 1665 for .............................................................................................. 1703
Glucose, anhydrous ................................................................. 1666 Haemodialysis, concentrated solutions for ........................ 1700
Glucose, liquid .......................................................................... 1667 Haemodialysis solutions, concentrated, water for
Glucose, liquid, spray-dried.................................................... 1668 diluting..................................................................................... 1699
Glucose monohydrate ............................................................. 1669 Haemodialysis, solutions for.................................................. 1700
Glucosum anhydricum .......................................................... 1666 Haemofiltration and for haemodiafiltration, solutions
Glucosum liquidum ................................................................ 1667 for .............................................................................................. 1703
Glucosum liquidum dispersione desiccatum................... 1668 Haemophilus type b (conjugate), diphtheria, tetanus,
Glucosum monohydricum .................................................... 1669 pertussis (acellular, component) and poliomyelitis
Glutamic acid ............................................................................ 1670 (inactivated) vaccine (adsorbed) ........................................... 653
Glutathione.........................................................................5.1-2936 Haemophilus type b (conjugate), diphtheria, tetanus,
Glutathionum ....................................................................5.1-2936 pertussis and poliomyelitis (inactivated) vaccine
Glycerol ...................................................................................... 1671 (adsorbed).................................................................................. 657

3668 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Haemophilus type b conjugate vaccine................................. 662 Hexosamines in polysaccharide vaccines (2.5.20.) ............. 132
Halofantrine hydrochloride ................................................... 1705 Hexylresorcinol......................................................................... 1723
Halofantrini hydrochloridum .............................................. 1705 Hexylresorcinolum ................................................................. 1723
Haloperidol................................................................................ 1706 Hibisci sabdariffae flos .......................................................... 2376
Haloperidol decanoate............................................................ 1708 Highly purified water ..............................................................2695
Haloperidoli decanoas........................................................... 1708 Histamine (2.6.10.)..................................................................... 153
Haloperidolum......................................................................... 1706 Histamine dihydrochloride .................................................... 1724
Halothane .................................................................................. 1709 Histamine phosphate .............................................................. 1725
Halothanum.............................................................................. 1709 Histamini dihydrochloridum ............................................... 1724
Hamamelidis folium............................................................... 1711 Histamini phosphas................................................................ 1725
Hamamelis leaf ......................................................................... 1711 Histidine..............................................................................5.1-2945
Hard capsules.....................................................................5.2-3135 Histidine hydrochloride monohydrate ................................ 1727
Hard fat ...................................................................................... 1711 Histidini hydrochloridum monohydricum....................... 1727
Hard paraffin............................................................................. 2186 Histidinum .........................................................................5.1-2945
Harpagophyti radix ................................................................ 1401 Homatropine hydrobromide .................................................. 1728
Hawthorn berries ..................................................................... 1712 Homatropine methylbromide ................................................ 1729
Hawthorn leaf and flower ...................................................... 1713 Homatropini hydrobromidum ............................................. 1728
Hawthorn leaf and flower dry extract ................................. 1714 Homatropini methylbromidum ........................................... 1729
Hawthorn leaf and flower liquid extract, quantified.. 5.3-3511 Homeopathic preparations, oriental cashew for........5.3-3430
Heavy bismuth subnitrate ...................................................... 1107 Homoeopathic preparations .................................................... 893
Heavy kaolin.............................................................................. 1869 Homoeopathic preparations, arsenious trioxide for .......... 895
Heavy magnesium carbonate .........................................5.3-3547 Homoeopathic preparations, calcium iodide tetrahydrate
Heavy magnesium oxide......................................................... 1958 for ....................................................................................... 5.2-3162
Heavy metals (2.4.8.) ................................................................. 104 Homoeopathic preparations, common stinging nettle
Heavy metals in herbal drugs and fatty oils (2.4.27.)..........119 for .......................................................................................5.3-3429
Hederae folium .................................................................5.1-2954 Homoeopathic preparations, copper acetate monohydrate
Hedera helix ad praeparationes homoeopathicas... 5.2-3163 for ....................................................................................... 5.2-3162
Hedera helix for homoeopathic preparations............. 5.2-3163 Homoeopathic preparations, copper for............................... 896
Helianthi annui oleum raffinatum.....................................2524 Homoeopathic preparations, garlic for ................................. 897
Heparina massae molecularis minoris ..............................1717 Homoeopathic preparations, hedera helix for............ 5.2-3163
Heparin, assay of (2.7.5.) .......................................................... 195 Homoeopathic preparations, herbal drugs for ........... 5.2-3161
Heparin calcium ....................................................................... 1715 Homoeopathic preparations, honey bee for......................... 898
Heparin in coagulation factors, assay of (2.7.12.)............... 204 Homoeopathic preparations, hyoscyamus for ............ 5.2-3164
Heparins, low-molecular-mass ................................................1717 Homoeopathic preparations, hypericum for ........................ 898
Heparin sodium........................................................................ 1716 Homoeopathic preparations, iron for .................................... 899
Heparinum calcicum ............................................................. 1715 Homoeopathic preparations, mother tinctures for............. 894
Heparinum natricum............................................................. 1716 Homoeopathic preparations, saffron for............................... 900
Hepatitis A immunoglobulin, human ...................................1741 Honey ..................................................................................5.1-2946
Hepatitis A (inactivated) and hepatitis B (rDNA) vaccine Honey bee for homoeopathic preparations.......................... 898
(adsorbed).................................................................................. 664 Hop strobile............................................................................... 1730
Hepatitis A vaccine, assay of (2.7.14.)...........................5.1-2795 Human albumin injection, iodinated (125I)............................ 827
Hepatitis A vaccine (inactivated, adsorbed) ......................... 665 Human albumin solution ................................................ 5.3-3511
Hepatitis A vaccine (inactivated, virosome) ......................... 667 Human anti-D immunoglobulin ............................................ 1732
Hepatitis B immunoglobulin for intravenous administration, Human anti-D immunoglobulin, assay of (2.7.13.).............. 205
human .......................................................................................1741 Human anti-D immunoglobulin for intravenous
Hepatitis B immunoglobulin, human ...................................1741 administration ........................................................................ 1733
Hepatitis B (rDNA), diphtheria and tetanus vaccine Human antithrombin III, assay of (2.7.17.)........................... 209
(adsorbed).................................................................................. 641 Human antithrombin III concentrate .................................. 1733
Hepatitis B (rDNA), diphtheria, tetanus and pertussis Human coagulation factor II, assay of (2.7.18.)................... 209
(acellular, component) vaccine (adsorbed) ........................ 647 Human coagulation factor IX................................................ 1738
Hepatitis B vaccine (rDNA)...................................................... 670 Human coagulation factor IX, assay of (2.7.11.).................. 204
Hepatitis B vaccine (rDNA), assay of (2.7.15.) ..................... 207 Human coagulation factor VII .............................................. 1734
Hepatitis C virus (HCV), validation of nucleic acid Human coagulation factor VII, assay of (2.7.10.)................ 203
amplification techniques for the detection of HCV RNA in Human coagulation factor VIII......................................5.3-3513
plasma pools : Guidelines........................................................176 Human coagulation factor VIII, assay of (2.7.4.)................. 194
Heptaminol hydrochloride..................................................... 1719 Human coagulation factor VIII (rDNA)............................... 1737
Heptaminoli hydrochloridum .............................................. 1719 Human coagulation factor X, assay of (2.7.19.) ....................210
Herbal drug preparations......................................................... 572 Human coagulation factor XI................................................ 1739
Herbal drugs ............................................................................... 572 Human coagulation factor XI, assay of (2.7.22.) ................. 212
Herbal drugs and fatty oils, heavy metals in (2.4.27.).........119 Human fibrinogen.................................................................... 1740
Herbal drugs, determination of tannins (2.8.14.) ............... 221 Human hepatitis A immunoglobulin ....................................1741
Herbal drugs for homoeopathic preparations ............ 5.2-3161 Human hepatitis B immunoglobulin ....................................1741
Herbal teas................................................................................... 573 Human hepatitis B immunoglobulin for intravenous
Hexamidine diisetionate .................................................. 5.2-3217 administration .........................................................................1741
Hexamidini diisetionas .................................................. 5.2-3217 Human insulin .......................................................................... 1800
Hexetidine.................................................................................. 1721 Human measles immunoglobulin......................................... 1742
Hexetidinum............................................................................. 1721 Human normal immunoglobulin................................... 5.3-3514
Hexobarbital.............................................................................. 1722 Human normal immunoglobulin for intravenous
Hexobarbitalum ....................................................................... 1722 administration ................................................................. 5.3-3516

General Notices (1) apply to all monographs and other texts 3669
Index EUROPEAN PHARMACOPOEIA 5.3

Human plasma for fractionation.................................... 5.3-3518 Hyoscyamine sulphate .....................................................5.3-3520


Human plasma (pooled and treated for virus Hyoscyamini sulfas .........................................................5.3-3520
inactivation) ............................................................................ 1747 Hyoscyamus for homoeopathic preparations ............. 5.2-3164
Human prothrombin complex............................................... 1748 Hyoscyamus niger ad praeparationes homoeopathicas ..5.2-
Human rabies immunoglobulin............................................ 1750 3164
Human rubella immunoglobulin .......................................... 1751 Hyperici herba .........................................................................2485
Human tetanus immunoglobulin ......................................... 1751 Hypericum .................................................................................2485
Human varicella immunoglobulin........................................ 1752 Hypericum for homoeopathic preparations ......................... 898
Human varicella immunoglobulin for intravenous Hypericum perforatum
administration ........................................................................ 1753 ad praeparationes homoeopathicas................................... 898
Human von Willebrand factor, assay of (2.7.21.) .................211 Hypromellose ............................................................................ 1780
Hyaluronidase .......................................................................... 1753 Hypromellose phthalate ......................................................... 1781
Hyaluronidasum ..................................................................... 1753 Hypromellosi phthalas........................................................... 1781
Hydralazine hydrochloride .................................................... 1754 Hypromellosum ....................................................................... 1780
Hydralazini hydrochloridum ............................................... 1754
Hydrargyri dichloridum ........................................................ 1995 I
Hydrastis rhizoma .................................................................. 1683 Ibuprofen ................................................................................... 1785
Hydrochloric acid, concentrated........................................... 1755 Ibuprofenum............................................................................. 1785
Hydrochloric acid, dilute ........................................................ 1756 Iceland moss.......................................................................5.3-3525
Hydrochlorothiazide................................................................ 1756 ICH (5.8.)...................................................................................... 551
Hydrochlorothiazidum .......................................................... 1756 Ichthammol ............................................................................... 1787
Hydrocortisone......................................................................... 1757 Ichthammolum ........................................................................ 1787
Hydrocortisone acetate........................................................... 1759 Identification (2.3.) ...................................................................... 95
Hydrocortisone hydrogen succinate.....................................1761 Identification and control of residual solvents (2.4.24.).... 113
Hydrocortisoni acetas............................................................ 1759 Identification of fatty oils by thin-layer chromatography
Hydrocortisoni hydrogenosuccinas ....................................1761 (2.3.2.) .......................................................................................... 98
Hydrocortisonum .................................................................... 1757 Identification of phenothiazines by thin-layer
Hydrogenated arachis oil ....................................................... 1018 chromatography (2.3.3.) ........................................................... 99
Hydrogenated castor oil ......................................................... 1197 Identification reactions of ions and functional groups
Hydrogenated cottonseed oil ................................................1370 (2.3.1.)........................................................................................... 95
Hydrogenated soya-bean oil...................................................2475 Idoxuridine ................................................................................ 1788
Hydrogenated wool fat............................................................2708 Idoxuridinum ........................................................................... 1788
Hydrogenii peroxidum 30 per centum.............................. 1763 Iecoris aselli oleum A.............................................................1348
Hydrogenii peroxidum 3 per centum ................................ 1762 Iecoris aselli oleum B ............................................................1352
Hydrogen peroxide solution (30 per cent) ......................... 1763 Ifosfamide .................................................................................. 1789
Hydrogen peroxide solution (3 per cent)............................ 1762 Ifosfamidum ............................................................................. 1789
Hydromorphone hydrochloride ............................................ 1763 Imipenem ................................................................................... 1791
Hydromorphoni hydrochloridum ....................................... 1763 Imipenemum............................................................................ 1791
Hydrous wool fat......................................................................2709 Imipramine hydrochloride ..................................................... 1792
Hydroxocobalamin acetate..................................................... 1765 Imipramini hydrochloridum................................................ 1792
Hydroxocobalamin chloride................................................... 1766 Immunochemical methods (2.7.1.) ......................................... 187
Hydroxocobalamini acetas ................................................... 1765 Immunoglobulin, animal, anti-T lymphocyte, for human
Hydroxocobalamini chloridum ........................................... 1766 use............................................................................................. 1010
Hydroxocobalamini sulfas .................................................... 1767 Immunoglobulin for intravenous administration, human
Hydroxocobalamin sulphate .................................................. 1767 hepatitis B ................................................................................1741
Hydroxycarbamide ................................................................... 1768 Immunoglobulin for intravenous administration, human
Hydroxycarbamidum ............................................................. 1768 normal ............................................................................... 5.3-3516
Hydroxyethylcellulose......................................................5.1-2947 Immunoglobulin for intravenous administration, human
Hydroxyethylcellulosum.................................................5.1-2947 varicella.................................................................................... 1753
Hydroxyethylis salicylas........................................................ 1769 Immunoglobulin, human anti-D ........................................... 1732
Hydroxyethylmethylcellulose ................................................ 2018 Immunoglobulin, human anti-D, assay of (2.7.13.)............. 205
Hydroxyethyl salicylate........................................................... 1769 Immunoglobulin, human anti-D, for intravenous
Hydroxyl value (2.5.3.) .............................................................. 127 administration ........................................................................ 1733
Hydroxypropylbetadex............................................................ 1771 Immunoglobulin, human hepatitis A....................................1741
Hydroxypropylbetadexum .................................................... 1771 Immunoglobulin, human hepatitis B ...................................1741
Hydroxypropylcellulose .......................................................... 1773 Immunoglobulin, human measles ........................................ 1742
Hydroxypropylcellulosum .................................................... 1773 Immunoglobulin, human normal .................................. 5.3-3514
Hydroxypropylmethylcellulose.............................................. 1780 Immunoglobulin, human rabies ........................................... 1750
Hydroxypropylmethylcellulose phthalate........................... 1781 Immunoglobulin, human rubella ......................................... 1751
Hydroxyzine hydrochloride ................................................... 1774 Immunoglobulin, human tetanus......................................... 1751
Hydroxyzini hydrochloridum .............................................. 1774 Immunoglobulin, human varicella ....................................... 1752
Hymecromone........................................................................... 1775 Immunoglobulin, test for anticomplementary activity of
Hymecromonum...................................................................... 1775 (2.6.17.)....................................................................................... 170
Hyoscine.............................................................................. 5.3-3519 Immunoglobulin, test for Fc function of (2.7.9.)................. 202
Hyoscine butylbromide ........................................................... 1776 Immunoglobulinum anti-T lymphocytorum ex animale ad
Hyoscine hydrobromide.......................................................... 1777 usum humanum.................................................................... 1010
Hyoscini butylbromidum ...................................................... 1776 Immunoglobulinum humanum anti-D.............................. 1732
Hyoscini hydrobromidum..................................................... 1777 Immunoglobulinum humanum anti-D ad usum
Hyoscinum......................................................................... 5.3-3519 intravenosum ......................................................................... 1733

3670 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Immunoglobulinum humanum hepatitidis A ..................1741 Influenza vaccine (surface antigen, inactivated,


Immunoglobulinum humanum hepatitidis B ..................1741 virosome) ..........................................................................5.3-3404
Immunoglobulinum humanum hepatitidis B ad usum Influenza vaccine (whole virion, inactivated) .............5.3-3406
intravenosum ..........................................................................1741 Infrared absorption spectrophotometry (2.2.24.) ................. 37
Immunoglobulinum humanum morbillicum .................. 1742 Infusions ............................................................................. 5.2-3145
Immunoglobulinum humanum normale .................. 5.3-3514 Inhalanda...........................................................................5.1-2843
Immunoglobulinum humanum normale ad usum Inhalation gas, krypton (81MKr) ............................................... 833
intravenosum .................................................................. 5.3-3516 Inhalation, preparations for............................................5.1-2843
Immunoglobulinum humanum rabicum.......................... 1750 Inhalation, preparations for : aerodynamic assessment of fine
Immunoglobulinum humanum rubellae.......................... 1751 particles (2.9.18.) ............................................................ 5.2-3103
Immunoglobulinum humanum tetanicum ...................... 1751 Injections ............................................................................ 5.2-3145
Immunoglobulinum humanum varicellae....................... 1752 Injections, gels for............................................................. 5.2-3146
Immunoglobulinum humanum varicellae ad usum Injections or infusions, concentrates for ..................... 5.2-3145
intravenosum ......................................................................... 1753 Injections or infusions, powders for ............................. 5.2-3145
Immunosera ad usum veterinarium.................................... 575 Inositol, myo- .....................................................................5.3-3527
Immunosera and vaccines, phenol in (2.5.15.) .....................131 Inserts, ophthalmic...........................................................5.3-3396
Immunosera and vaccines, veterinary, evaluation of safety Insulin aspart ............................................................................ 1795
(5.2.6.) ...............................................................................5.1-2827 Insulin, bovine .......................................................................... 1797
Immunosera and vaccines, veterinary, evaluation of the Insulin, human.......................................................................... 1800
efficacy (5.2.7) .................................................................5.1-2829 Insulini biphasici iniectabilium.......................................... 1802
Immunosera and vaccines, veterinary, evaluation of the Insulini isophani biphasici iniectabilium ........................ 1803
safety of each batch (5.2.9.)..........................................5.1-2830 Insulini isophani iniectabilium .......................................... 1803
Immunosera ex animale ad usum humanum ................... 573 Insulin injection, biphasic ...................................................... 1802
Immunosera for human use, animal...................................... 573 Insulin injection, biphasic isophane .................................... 1803
Immunosera for veterinary use ............................................. 575 Insulin injection, isophane..................................................... 1803
Immunoserum botulinicum ................................................... 801 Insulin injection, soluble ........................................................ 1803
Immunoserum clostridii novyi alpha ad usum Insulini solubilis iniectabilium ........................................... 1803
veterinarium ...................................................................5.1-2865 Insulini zinci amorphi suspensio iniectabilis................. 1811
Immunoserum clostridii perfringentis beta ad usum Insulini zinci cristallini suspensio iniectabilis............... 1812
veterinarium ...................................................................5.1-2866 Insulini zinci suspensio iniectabilis .................................. 1811
Immunoserum clostridii perfringentis epsilon ad usum Insulin lispro ............................................................................. 1804
veterinarium ...................................................................5.1-2867 Insulin, porcine......................................................................... 1806
Immunoserum contra venena viperarum Insulin preparations, injectable ........................................... 1808
europaearum ........................................................................... 806 Insulinum aspartum .............................................................. 1795
Immunoserum diphthericum ................................................ 801 Insulinum bovinum................................................................ 1797
Immunoserum gangraenicum (Clostridium novyi) ........ 802 Insulinum humanum............................................................. 1800
Immunoserum gangraenicum Insulinum lisprum.................................................................. 1804
(Clostridium perfringens)..................................................... 803 Insulinum porcinum.............................................................. 1806
Immunoserum gangraenicum (Clostridium septicum).. 804 Insulin zinc injectable suspension ....................................... 1811
Immunoserum gangraenicum mixtum............................... 802 Insulin zinc injectable suspension (amorphous) .............. 1811
Immunoserum tetanicum ad usum humanum................. 805 Insulin zinc injectable suspension (crystalline) ................ 1812
Immunoserum tetanicum ad usum veterinarium...5.1-2868 Interferon alfa-2 concentrated solution .............................. 1812
Implants .............................................................................. 5.2-3146 Interferon gamma-1b concentrated solution ..................... 1815
Impurities in substances for pharmaceutical use, control of Interferoni alfa-2 solutio concentrata................................ 1812
(5.10.).......................................................................................... 559 Interferoni gamma-1b solutio concentrata ...................... 1815
Indapamide.........................................................................5.3-3525 Interferons, assay of (5.6.)...............................................5.3-3381
Indapamidum ...................................................................5.3-3525 int-rac-α-Tocopherolum ..................................................5.3-3631
Indicators, relationship between approximate pH and colour int-rac-α-Tocopherylis acetas ........................................5.3-3632
(2.2.4.) .......................................................................................... 27 Intramammary preparations for veterinary use.................. 606
Indii (111In) chloridi solutio .................................................... 828 Intraruminal devices ........................................................ 5.2-3141
Indii (111In) oxini solutio ......................................................... 829 Intrauterine capsules .......................................................5.3-3397
Indii (111In) pentetatis solutio iniectabilis .......................... 830 Intrauterine foams ............................................................5.3-3397
Indium (111In) chloride solution .............................................. 828 Intrauterine preparations for veterinary use ..............5.3-3397
Indium (111In) oxine solution ................................................... 829 Intrauterine solutions, suspensions..............................5.3-3397
Indium (111In) pentetate injection........................................... 830 Intrauterine sticks.............................................................5.3-3397
Indometacin .............................................................................. 1794 Intrauterine tablets...........................................................5.3-3397
Indometacinum ....................................................................... 1794 In vivo assay of poliomyelitis vaccine (inactivated)
Infectious bovine rhinotracheitis vaccine (live), (2.7.20.) .......................................................................................210
freeze-dried................................................................................ 768 Iobenguane (123I) injection....................................................... 831
Infectious bronchitis vaccine (inactivated), avian ............... 718 Iobenguane (131I) injection for diagnostic use ..................... 832
Infectious bronchitis vaccine (live), avian............................. 720 Iobenguane (131I) injection for therapeutic use................... 833
Infectious bursal disease vaccine (inactivated), avian........ 722 Iobenguani (123I) solutio iniectabilis.................................... 831
Infectious bursal disease vaccine (live), avian ..................... 723 Iobenguani (131I) solutio iniectabilis ad usum
Infectious chicken anaemia vaccine (live) ............................ 769 diagnosticum ........................................................................... 832
Infectious encephalomyelitis vaccine (live), avian .............. 725 Iobenguani (131I) solutio iniectabilis ad usum
Infectious laryngotracheitis vaccine (live), avian ................ 727 therapeuticum.......................................................................... 833
Influenza vaccine (split virion, inactivated) ................5.3-3401 Iodinated (125I) human albumin injection ............................. 827
Influenza vaccine (surface antigen, inactivated)........5.3-3402 Iodinated povidone.................................................................. 2291
Iodinati (125I) humani albumini solutio iniectabilis ........ 827

General Notices (1) apply to all monographs and other texts 3671
Index EUROPEAN PHARMACOPOEIA 5.3

Iodine.......................................................................................... 1819 Ivermectinum........................................................................... 1854


Iodine value (2.5.4.) ................................................................... 127 Ivy leaf .................................................................................5.1-2954
Iodum ......................................................................................... 1819
Iohexol........................................................................................ 1819 J
Iohexolum ................................................................................. 1819 Javanese turmeric ....................................................................2645
Ionic concentration, potentiometric determination of using Java tea ....................................................................................... 1859
ion-selective electrodes (2.2.36.)............................................. 55 Josamycin................................................................................... 1860
Ions and functional groups, identification reactions Josamycini propionas............................................................ 1861
(2.3.1.)........................................................................................... 95 Josamycin propionate.............................................................. 1861
Ion-selective electrodes, potentiometric determination of Josamycinum ........................................................................... 1860
ionic concentration (2.2.36.) ................................................... 55 Juniper........................................................................................ 1862
Iopamidol............................................................................5.2-3223 Juniper oil .................................................................................. 1863
Iopamidolum.....................................................................5.2-3223
Iopanoic acid............................................................................. 1824
K
Iotalamic acid............................................................................ 1825
Ioxaglic acid .............................................................................. 1826 Kalii acetas ...............................................................................2273
Ipecacuanhae extractum fluidum normatum ..........5.1-2951 Kalii bromidum........................................................................2273
Ipecacuanhae pulvis normatus........................................... 1829 Kalii carbonas.......................................................................... 2274
Ipecacuanhae radix................................................................ 1829 Kalii chloridum.................................................................5.2-3261
Ipecacuanhae tinctura normata ..................................5.1-2951 Kalii citras.................................................................................2275
Ipecacuanha liquid extract, standardised ....................5.1-2951 Kalii clavulanas....................................................................... 2276
Ipecacuanha, prepared............................................................ 1829 Kalii clavulanas dilutus.........................................................2278
Ipecacuanha root ..................................................................... 1829 Kalii dihydrogenophosphas .................................................2280
Ipecacuanha tincture, standardised..............................5.1-2951 Kalii hydrogenoaspartas hemihydricus............................2280
Ipratropii bromidum .............................................................. 1831 Kalii hydrogenocarbonas...................................................... 2281
Ipratropium bromide............................................................... 1831 Kalii hydrogenotartras...........................................................2282
Iron (2.4.9.).................................................................................. 107 Kalii hydroxidum ....................................................................2283
Iron for homoeopathic preparations ..................................... 899 Kalii iodidum ...........................................................................2283
Irrigation, preparations for ...................................................... 622 Kalii metabisulfis .............................................................5.3-3597
Isoconazole................................................................................ 1833 Kalii natrii tartras tetrahydricus.........................................2286
Isoconazole nitrate .................................................................. 1834 Kalii nitras ................................................................................2284
Isoconazoli nitras ................................................................... 1834 Kalii perchloras .......................................................................2285
Isoconazolum........................................................................... 1833 Kalii permanganas .................................................................2286
Isoelectric focusing (2.2.54.).......................................................81 Kalii sorbas ...............................................................................2287
Isoflurane................................................................................... 1835 Kalii sulfas ................................................................................2288
Isofluranum.............................................................................. 1835 Kanamycin acid sulphate ....................................................... 1867
Isoleucine................................................................................... 1836 Kanamycini monosulfas ....................................................... 1868
Isoleucinum.............................................................................. 1836 Kanamycini sulfas acidus..................................................... 1867
Isomalt........................................................................................ 1837 Kanamycin monosulphate...................................................... 1868
Isomaltum ................................................................................. 1837 Kaolin, heavy............................................................................. 1869
Isoniazid..................................................................................... 1839 Kaolinum ponderosum.......................................................... 1869
Isoniazidum ............................................................................. 1839 Kelp ............................................................................................. 1869
Isophane insulin injection...................................................... 1803 Ketamine hydrochloride ......................................................... 1870
Isoprenaline hydrochloride.................................................... 1839 Ketamini hydrochloridum .................................................... 1870
Isoprenaline sulphate.............................................................. 1840 Ketobemidone hydrochloride................................................ 1871
Isoprenalini hydrochloridum .............................................. 1839 Ketoconazole ............................................................................ 1872
Isoprenalini sulfas .................................................................. 1840 Ketoconazolum........................................................................ 1872
Isopropyl alcohol...................................................................... 1841 Ketoprofen................................................................................. 1874
Isopropylis myristas ........................................................5.1-2952 Ketoprofenum .......................................................................... 1874
Isopropylis palmitas........................................................5.1-2953 Ketorolac trometamol ......................................................5.3-3533
Isopropyl myristate...........................................................5.1-2952 Ketorolacum trometamolum .........................................5.3-3533
Isopropyl palmitate...........................................................5.1-2953 Ketotifen hydrogen fumarate ................................................ 1875
Isosorbide dinitrate, diluted ................................................. 1844 Ketotifeni hydrogenofumaras .............................................. 1875
Isosorbide mononitrate, diluted .......................................... 1845 Knotgrass................................................................................... 1877
Isosorbidi dinitras dilutus..................................................... 1844 Krypton (81mKr) inhalation gas................................................ 833
Isosorbidi mononitras dilutus ............................................. 1845 Kryptonum (81mKr) ad inhalationem .................................. 833
Isotretinoin ................................................................................ 1847
Isotretinoinum ......................................................................... 1847 L
Isoxsuprine hydrochloride ..................................................... 1848 Labetalol hydrochloride ......................................................... 1881
Isoxsuprini hydrochloridum ................................................ 1848 Labetaloli hydrochloridum................................................... 1881
Ispaghula husk ......................................................................... 1849 Lacca ..........................................................................................2409
Ispaghula seed .......................................................................... 1850 Lactic acid...........................................................................5.2-3227
Isradipine ............................................................................5.3-3528 Lactic acid, (S)- ..................................................................5.2-3227
Isradipinum.......................................................................5.3-3528 Lactitol monohydrate.............................................................. 1883
Itraconazole .............................................................................. 1852 Lactitolum monohydricum................................................... 1883
Itraconazolum.......................................................................... 1852 Lactobionic acid ....................................................................... 1885
Iuniperi aetheroleum............................................................. 1863 Lactose, anhydrous.................................................................. 1886
Iuniperi pseudo-fructus......................................................... 1862 Lactose monohydrate.............................................................. 1887
Ivermectin.................................................................................. 1854 Lactosum anhydricum........................................................... 1886

3672 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Lactosum monohydricum..................................................... 1887 Linoleoyl macrogolglycerides.................................................1917


Lactulose.................................................................................... 1888 Linseed ................................................................................5.1-2960
Lactulose, liquid ....................................................................... 1890 Linseed oil, virgin .................................................................... 1918
Lactulosum ............................................................................... 1888 Liothyronine sodium............................................................... 1919
Lactulosum liquidum............................................................. 1890 Liothyroninum natricum ..................................................... 1919
Lamivudine.........................................................................5.3-3537 Lipophilic solid dosage forms, dissolution test for
Lamivudinum ...................................................................5.3-3537 (2.9.42.) .............................................................................5.3-3373
Lanugo cellulosi absorbens.................................................. 2681 Liquid and semi-solid preparations, test for deliverable mass
Lanugo gossypii absorbens ..................................................1369 or volume (2.9.28.) .................................................................. 263
Lauroyl macrogolglycerides .................................................. 1892 Liquid chromatography (2.2.29.).............................................. 43
Lavandulae aetheroleum ...............................................5.3-3539 Liquid extracts............................................................................ 571
Lavandulae flos ....................................................................... 1893 Liquid glucose .......................................................................... 1667
Lavender flower........................................................................ 1893 Liquid glucose, spray-dried.................................................... 1668
Lavender oil........................................................................5.3-3539 Liquid lactulose ........................................................................ 1890
Lead in sugars (2.4.10.) ............................................................ 107 Liquid maltitol .......................................................................... 1969
Lemon oil................................................................................... 1895 Liquid paraffin .......................................................................... 2187
Leonuri cardiacae herba.......................................................2063 Liquid preparations for cutaneous application ................... 607
Leptospirosis vaccine (inactivated), bovine.......................... 730 Liquid preparations for cutaneous application,
Leptospirosis vaccine (inactivated), canine .......................... 740 veterinary .................................................................................. 630
Leucine....................................................................................... 1897 Liquid preparations for inhalation ................................5.1-2843
Leucinum .................................................................................. 1897 Liquid preparations for oral use.................................... 5.2-3142
Leuprorelin................................................................................ 1898 Liquid sorbitol (crystallising) ................................................2471
Leuprorelinum......................................................................... 1898 Liquid sorbitol (non-crystallising) ........................................2472
Levamisole for veterinary use ............................................... 1899 Liquid sorbitol, partially dehydrated ...................................2473
Levamisole hydrochloride...................................................... 1900 Liquiritiae extractum fluidum ethanolicum normatum ..5.3-
Levamisoli hydrochloridum................................................. 1900 3541
Levamisolum ad usum veterinarium ................................ 1899 Liquiritiae radix ...................................................................... 1921
Levistici radix........................................................................... 1932 Liquorice ethanolic liquid extract, standardised .......5.3-3541
Levocabastine hydrochloride ................................................ 1902 Liquorice root ........................................................................... 1921
Levocabastini hydrochloridum ........................................... 1902 Lisinopril dihydrate ................................................................. 1922
Levocarnitine .....................................................................5.1-2959 Lisinoprilum dihydricum ..................................................... 1922
Levocarnitinum................................................................5.1-2959 Lithii carbonas......................................................................... 1923
Levodopa.................................................................................... 1904 Lithii citras ............................................................................... 1924
Levodopum ............................................................................... 1904 Lithium carbonate ................................................................... 1923
Levodropropizine ..................................................................... 1905 Lithium citrate.......................................................................... 1924
Levodropropizinum................................................................ 1905 L-Methionine ([11C]methyl) injection...................................... 834
Levomenthol ............................................................................. 1907 L-Methionini ([11C]methyl) solutio iniectabilis .................. 834
Levomentholum....................................................................... 1907 Lobeline hydrochloride........................................................... 1925
Levomepromazine hydrochloride......................................... 1908 Lobelini hydrochloridum...................................................... 1925
Levomepromazine maleate .................................................... 1908 Lomustine.................................................................................. 1926
Levomepromazini hydrochloridum ................................... 1908 Lomustinum ............................................................................. 1926
Levomepromazini maleas .................................................... 1908 Loosestrife ................................................................................. 1927
Levomethadone hydrochloride ............................................. 1909 Loperamide hydrochloride..................................................... 1928
Levomethadoni hydrochloridum ........................................ 1909 Loperamide oxide monohydrate........................................... 1930
Levonorgestrel.......................................................................... 1911 Loperamidi hydrochloridum................................................ 1928
Levonorgestrelum ................................................................... 1911 Loperamidi oxidum monohydricum.................................. 1930
Levothyroxine sodium .....................................................5.3-3540 Lorazepam................................................................................. 1931
Levothyroxinum natricum ............................................5.3-3540 Lorazepamum.......................................................................... 1931
Lichen islandicus.............................................................5.3-3525 Loss on drying (2.2.32.).............................................................. 50
Lidocaine ................................................................................... 1913 Loss on drying of extracts (2.8.17.)........................................ 222
Lidocaine hydrochloride......................................................... 1914 Lovage root................................................................................ 1932
Lidocaini hydrochloridum ................................................... 1914 Lovastatin .................................................................................. 1933
Lidocainum .............................................................................. 1913 Lovastatinum ........................................................................... 1933
Light liquid paraffin ................................................................ 2186 Low-molecular-mass heparins ................................................1717
Light magnesium carbonate...........................................5.3-3548 Lozenges and pastilles.............................................................. 613
Light magnesium oxide .......................................................... 1958 Lozenges, compressed .............................................................. 613
Lime flower ............................................................................... 1914 Lubricant, silicone oil (3.1.8.).................................................. 287
Limit test of particle size by microscopy (2.9.13.) .............. 239 Lupuli flos................................................................................. 1730
Limit tests (2.4.).......................................................................... 103 Lynestrenol................................................................................ 1935
Limit tests, standard solutions for (4.1.2.)............................ 426 Lynestrenolum......................................................................... 1935
Limit tests, standard solutions for (4.1.2.)...................5.1-2818 Lysine acetate ....................................................................5.3-3542
Limonis aetheroleum............................................................. 1895 Lysine hydrochloride............................................................... 1936
Lincomycin hydrochloride ..................................................... 1915 Lysini acetas......................................................................5.3-3542
Lincomycini hydrochloridum.............................................. 1915 Lysini hydrochloridum.......................................................... 1936
Lindane ...................................................................................... 1916 Lythri herba.............................................................................. 1927
Lindanum ................................................................................. 1916
Linen thread, sterile, in distributor for veterinary use ..... 886 M
Lini oleum virginale .............................................................. 1918 Macrogol 15 hydroxystearate ................................................ 1941
Lini semen .........................................................................5.1-2960 Macrogol 20 glyceroli monostearas ................................... 1942

General Notices (1) apply to all monographs and other texts 3673
Index EUROPEAN PHARMACOPOEIA 5.3

Macrogol 20 glycerol monostearate .................................... 1942 Maleic acid................................................................................. 1966


Macrogol 6 glycerol caprylocaprate..................................... 1941 Malic acid ................................................................................... 1966
Macrogol 6 glyceroli caprylocapras................................... 1941 Mallow flower............................................................................ 1967
Macrogola.................................................................................. 1950 Maltitol ....................................................................................... 1968
Macrogol cetostearyl ether .................................................... 1943 Maltitol, liquid........................................................................... 1969
Macrogolglyceridorum caprylocaprates ........................... 1173 Maltitolum................................................................................. 1968
Macrogolglyceridorum laurates .......................................... 1892 Maltitolum liquidum............................................................... 1969
Macrogolglyceridorum linoleates........................................1917 Maltodextrin.............................................................................. 1970
Macrogolglyceridorum oleates ............................................ 2133 Maltodextrinum ....................................................................... 1970
Macrogolglyceridorum stearates..................................5.2-3274 Malvae sylvestris flos ............................................................. 1967
Macrogolglycerol cocoates..................................................... 1947 Manganese sulphate monohydrate ...................................... 1971
Macrogolglycerol hydroxystearate ................................5.2-3231 Mangani sulfas monohydricus ............................................ 1971
Macrogolglyceroli cocoates .................................................. 1947 Mannheimia vaccine (inactivated) for cattle ........................ 771
Macrogolglyceroli hydroxystearas...............................5.2-3231 Mannheimia vaccine (inactivated) for sheep........................ 772
Macrogolglyceroli ricinoleas.........................................5.3-3547 Mannitol ..............................................................................5.3-3549
Macrogolglycerol ricinoleate ..........................................5.3-3547 Mannitolum .......................................................................5.3-3549
Macrogoli 15 hydroxystearas ............................................... 1941 Maprotiline hydrochloride ..................................................... 1973
Macrogoli aether cetostearylicus ........................................ 1943 Maprotilini hydrochloridum ................................................ 1973
Macrogoli aether laurilicum ................................................ 1944 Marek’s disease vaccine (live).................................................. 774
Macrogoli aether oleicum ..................................................... 1945 Marrubii herba..................................................................5.1-3039
Macrogoli aether stearylicus................................................ 1946 Marshmallow leaf ..................................................................... 1974
Macrogoli oleas........................................................................ 1944 Marshmallow root .............................................................5.2-3232
Macrogoli stearas .................................................................... 1946 Mass spectrometry (2.2.43.)....................................................... 65
Macrogol lauryl ether ............................................................. 1944 Mass uniformity of delivered doses from multidose containers
Macrogol oleate ........................................................................ 1944 (2.9.27.) ...................................................................................... 263
Macrogol oleyl ether ............................................................... 1945 Mass uniformity of single-dose preparations (2.9.5.) ......... 233
Macrogols................................................................................... 1950 Mastic.......................................................................................... 1975
Macrogol stearate..................................................................... 1946 Masticabilia gummis medicata.....................................5.2-3136
Macrogol stearyl ether............................................................ 1946 Mastix ......................................................................................... 1975
Magaldrate................................................................................. 1951 Materials based on non-plasticised poly(vinyl chloride) for
Magaldratum ............................................................................ 1951 containers for dry dosage forms for oral administration
Magnesii acetas tetrahydricus ............................................. 1952 (3.1.11.)....................................................................................... 291
Magnesii aspartas dihydricus.............................................. 1953 Materials based on non-plasticised poly(vinyl chloride)
Magnesii chloridum 4.5-hydricum ..................................... 1955 for containers for non-injectable, aqueous solutions
Magnesii chloridum hexahydricum ................................... 1956 (3.1.10.) ...................................................................................... 289
Magnesii glycerophosphas ................................................... 1957 Materials based on plasticised poly(vinyl chloride) for
Magnesii hydroxidum ............................................................ 1957 containers for aqueous solutions for intravenous infusion
Magnesii lactas dihydricus............................................5.3-3549 (3.1.14.) ...................................................................................... 296
Magnesii oxidum leve ............................................................ 1958 Materials based on plasticised poly(vinyl chloride) for
Magnesii oxidum ponderosum............................................ 1958 containers for human blood and blood components
Magnesii peroxidum............................................................... 1959 (3.1.1.1.) ..................................................................................... 269
Magnesii pidolas ..................................................................... 1960 Materials based on plasticised poly(vinyl chloride) for
Magnesii stearas...................................................................... 1961 tubing used in sets for the transfusion of blood and blood
Magnesii subcarbonas levis...........................................5.3-3548 components (3.1.1.2.).............................................................. 272
Magnesii subcarbonas ponderosus .............................5.3-3547 Materials for containers for human blood and blood
Magnesii sulfas heptahydricus ............................................ 1962 components (3.1.1.) ................................................................. 269
Magnesii trisilicas................................................................... 1963 Materials used for the manufacture of containers (3.1.) ... 269
Magnesium (2.4.6.) .................................................................... 104 Matricariae aetheroleum................................................5.1-2967
Magnesium acetate tetrahydrate .......................................... 1952 Matricariae extractum fluidum ....................................5.1-2966
Magnesium and alkaline-earth metals (2.4.7.) ..................... 104 Matricariae flos ................................................................5.1-2965
Magnesium aspartate dihydrate ........................................... 1953 Matricaria flower ...............................................................5.1-2965
Magnesium carbonate, heavy .........................................5.3-3547 Matricaria liquid extract ..................................................5.1-2966
Magnesium carbonate, light ...........................................5.3-3548 Matricaria oil......................................................................5.1-2967
Magnesium chloride 4.5-hydrate .......................................... 1955 Maydis amylum ................................................................5.1-2965
Magnesium chloride hexahydrate ........................................ 1956 Maydis oleum raffinatum...................................................... 1964
Magnesium glycerophosphate ............................................. 1957 Meadowsweet ............................................................................ 1980
Magnesium hydroxide............................................................. 1957 Measles immunoglobulin, human ........................................ 1742
Magnesium lactate dihydrate .........................................5.3-3549 Measles, mumps and rubella vaccine (live) .......................... 678
Magnesium oxide, heavy......................................................... 1958 Measles vaccine (live) ................................................................ 679
Magnesium oxide, light........................................................... 1958 Measurement of consistency by penetrometry (2.9.9.)...... 235
Magnesium peroxide ............................................................... 1959 Mebendazole ............................................................................. 1981
Magnesium pidolate ................................................................ 1960 Mebendazolum......................................................................... 1981
Magnesium stearate................................................................. 1961 Meclozine hydrochloride........................................................ 1982
Magnesium sulphate heptahydrate...................................... 1962 Meclozini hydrochloridum ................................................... 1982
Magnesium trisilicate .............................................................. 1963 Medicated chewing gum, dissolution test for
Maize oil, refined...................................................................... 1964 (2.9.25.) ............................................................................. 5.2-3116
Maize starch .......................................................................5.1-2965 Medicated chewing gums ................................................5.2-3136
Malathion................................................................................... 1965 Medicated feeding stuffs for veterinary use, premixes for ..617
Malathionum ............................................................................ 1965 Medicated foams......................................................................... 604

3674 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Medicated plasters ..................................................................... 626 Methaqualonum ......................................................................2008


Medicated tampons.................................................................... 628 Methenamine ............................................................................2009
Medicated vaginal tampons ............................................5.2-3154 Methenaminum .......................................................................2009
Medicinal air................................................................................ 929 Methionine ................................................................................ 2010
Medicinal air, synthetic............................................................. 932 Methionine ([11C]methyl) injection, L-.................................... 834
Medium-chain triglycerides....................................................2623 Methionine, DL-......................................................................... 2010
Medroxyprogesterone acetate ........................................5.3-3551 Methioninum............................................................................ 2010
Medroxyprogesteroni acetas .........................................5.3-3551 Methods in pharmacognosy (2.8.) .......................................... 215
Mefenamic acid ......................................................................... 1984 Methods of preparation of sterile products (5.1.1.)............ 445
Mefloquine hydrochloride...................................................... 1986 Methotrexate ............................................................................. 2011
Mefloquini hydrochloridum................................................. 1986 Methotrexatum......................................................................... 2011
Megestrol acetate ..................................................................... 1987 Methylatropine bromide ......................................................... 2014
Megestroli acetas ..................................................................... 1987 Methylatropine nitrate ............................................................ 2015
Meglumine................................................................................. 1988 Methylatropini bromidum..................................................... 2014
Megluminum ............................................................................ 1988 Methylatropini nitras ............................................................. 2015
Mel........................................................................................5.1-2946 Methylcellulose......................................................................... 2016
Melaleucae aetheroleum .......................................................2534 Methylcellulosum .................................................................... 2016
Melilot..................................................................................5.3-3552 Methyldopa................................................................................ 2016
Meliloti herba ....................................................................5.3-3552 Methyldopum ........................................................................... 2016
Melissae folium........................................................................ 1989 Methylene blue .........................................................................2028
Melissa leaf ................................................................................ 1989 Methylene chloride .................................................................. 2017
Melting point - capillary method (2.2.14.)............................... 32 Methyleni chloridum.............................................................. 2017
Melting point - instantaneous method (2.2.16.) .................... 33 Methylhydroxyethylcellulose................................................. 2018
Melting point - open capillary method (2.2.15.) .................... 33 Methylhydroxyethylcellulosum............................................ 2018
Menadione ................................................................................. 1990 Methylis nicotinas............................................................5.1-2972
Menadionum ............................................................................ 1990 Methylis parahydroxybenzoas ............................................. 2013
Meningococcal group C conjugate vaccine.......................... 680 Methylis parahydroxybenzoas natricum .......................... 2441
Meningococcal polysaccharide vaccine................................. 682 Methylis salicylas .................................................................... 2014
Menthae arvensis aetheroleum partim mentholum Methyl nicotinate ..............................................................5.1-2972
depletum...........................................................................5.2-3235 Methyl parahydroxybenzoate ................................................ 2013
Menthae piperitae aetheroleum ..........................................2206 Methylpentoses in polysaccharide vaccines (2.5.21.) ......... 133
Menthae piperitae folium .....................................................2205 Methylphenobarbital ............................................................... 2019
Menthol, racemic...................................................................... 1991 Methylphenobarbitalum ........................................................ 2019
Mentholum racemicum ......................................................... 1991 Methylprednisolone.................................................................2020
Menyanthidis trifoliatae folium .......................................... 1115 Methylprednisolone acetate...................................................2022
Mepivacaine hydrochloride.................................................... 1992 Methylprednisolone hydrogen succinate ............................2024
Mepivacaini hydrochloridum .............................................. 1992 Methylprednisoloni acetas....................................................2022
Meprobamate ............................................................................ 1993 Methylprednisoloni hydrogenosuccinas...........................2024
Meprobamatum........................................................................ 1993 Methylprednisolonum............................................................2020
Mepyramine maleate ............................................................... 1994 Methylpyrrolidone, N- .............................................................2026
Mepyramini maleas................................................................ 1994 Methylrosanilinii chloridum .........................................5.1-2973
Mercaptopurine ........................................................................ 1995 Methylrosanilinium chloride ..........................................5.1-2973
Mercaptopurinum ................................................................... 1995 Methyl salicylate....................................................................... 2014
Mercuric chloride..................................................................... 1995 Methyltestosterone ..................................................................2027
Mesalazine ................................................................................. 1996 Methyltestosteronum ..............................................................2027
Mesalazinum ............................................................................ 1996 Methylthioninii chloridum ...................................................2028
Mesna...................................................................................5.1-2971 Methylthioninium chloride ....................................................2028
Mesnum ..............................................................................5.1-2971 Metixene hydrochloride..........................................................2029
Mesterolone............................................................................... 1999 Metixeni hydrochloridum .....................................................2029
Mesterolonum .......................................................................... 1999 Metoclopramide........................................................................2030
Mestranol ...................................................................................2000 Metoclopramide hydrochloride............................................. 2031
Mestranolum.............................................................................2000 Metoclopramidi hydrochloridum ........................................ 2031
Metacresol ..........................................................................5.2-3232 Metoclopramidum ...................................................................2030
Metacresolum ....................................................................5.2-3232 Metoprololi succinas ..............................................................2032
Metamizole sodium .................................................................2002 Metoprololi tartras ..................................................................2034
Metamizolum natricum.........................................................2002 Metoprolol succinate...............................................................2032
Metformin hydrochloride .......................................................2003 Metoprolol tartrate ..................................................................2034
Metformini hydrochloridum ................................................2003 Metrifonate ................................................................................2035
Methacrylic acid - ethyl acrylate copolymer (1:1) .............2005 Metrifonatum............................................................................2035
Methacrylic acid - ethyl acrylate copolymer (1:1) dispersion Metronidazole ...........................................................................2037
30 per cent ..............................................................................2005 Metronidazole benzoate .........................................................2038
Methacrylic acid - methyl methacrylate copolymer (1:1) ..2006 Metronidazoli benzoas ..........................................................2038
Methacrylic acid - methyl methacrylate copolymer (1:2) ..2007 Metronidazolum ......................................................................2037
Methadone hydrochloride...............................................5.2-3233 Mexiletine hydrochloride........................................................2039
Methadoni hydrochloridum ..........................................5.2-3233 Mexiletini hydrochloridum...................................................2039
Methanol .............................................................................5.2-3234 Mianserin hydrochloride ........................................................ 2041
Methanol and 2-propanol, test for (2.9.11.) .................5.3-3362 Mianserini hydrochloridum................................................. 2041
Methanolum.......................................................................5.2-3234 Miconazole ................................................................................2042
Methaqualone ...........................................................................2008 Miconazole nitrate ...................................................................2043

General Notices (1) apply to all monographs and other texts 3675
Index EUROPEAN PHARMACOPOEIA 5.3

Miconazoli nitras ....................................................................2043 Myristicae fragrantis aetheroleum ..................................... 2123


Miconazolum............................................................................2042 Myrrh ..........................................................................................2069
Microbiological assay of antibiotics (2.7.2.).......................... 188 Myrrha .......................................................................................2069
Microbiological examination of non-sterile products (test for Myrrhae tinctura .....................................................................2069
specified micro-organisms) (2.6.13.) .................................... 156 Myrrh tincture ..........................................................................2069
Microbiological examination of non-sterile products (total Myrtilli fructus recens............................................................ 1099
viable aerobic count) (2.6.12.)............................................... 154 Myrtilli fructus siccus............................................................. 1099
Microbiological quality of pharmaceutical preparations Myxomatosis vaccine (live) for rabbits .................................. 775
(5.1.4.)......................................................................................... 449
Microcrystalline cellulose.......................................................1228 N
Micro determination of water (2.5.32.).................................. 137 Nabumetone ..............................................................................2073
Microscopy, limit test of particle size (2.9.13.) .................... 239 Nabumetonum .........................................................................2073
Microscopy, optical (2.9.37.) ...........................................5.3-3366 N-Acetyltryptophan.....................................................................918
Midazolam .................................................................................2045 N-Acetyltryptophanum..............................................................918
Midazolamum ..........................................................................2045 N-Acetyltyrosine ......................................................................... 920
Milk-thistle fruit........................................................................2046 N-Acetyltyrosinum .................................................................... 920
Millefolii herba.........................................................................2723 Nadolol ....................................................................................... 2074
Minimising the risk of transmitting animal spongiform Nadololum................................................................................. 2074
encephalopathy agents via human and veterinary medicinal Nadroparin calcium .................................................................2075
products (5.2.8.) ....................................................................... 463 Nadroparinum calcicum .......................................................2075
Minocycline hydrochloride.....................................................2047 Naftidrofuryl hydrogen oxalate.............................................2078
Minocyclini hydrochloridum ...............................................2047 Naftidrofuryli hydrogenooxalas ..........................................2078
Minoxidil .............................................................................5.1-2974 Nalidixic acid.............................................................................2080
Minoxidilum ......................................................................5.1-2974 Naloxone hydrochloride dihydrate.......................................2080
Mint oil, partly dementholised .......................................5.2-3235 Naloxoni hydrochloridum dihydricum .............................2080
Misoprostol.........................................................................5.3-3553 Naltrexone hydrochloride................................................5.1-2979
Misoprostolum ..................................................................5.3-3553 Naltrexoni hydrochloridum...........................................5.1-2979
Mitomycin .................................................................................. 2051 Naphazoline hydrochloride....................................................2082
Mitomycinum ........................................................................... 2051 Naphazoline nitrate ..........................................................5.3-3561
Mitoxantrone hydrochloride..................................................2053 Naphazolini hydrochloridum ..............................................2082
Mitoxantroni hydrochloridum.............................................2053 Naphazolini nitras ...........................................................5.3-3561
Modified-release capsules................................................ 5.2-3136 Naproxen.............................................................................5.2-3245
Modified-release granules ............................................... 5.2-3141 Naproxenum......................................................................5.2-3245
Modified-release tablets ................................................... 5.2-3151 Narrow-leaved coneflower root ......................................5.2-3246
Molecular mass distribution in dextrans (2.2.39.) ................ 57 Nasal drops and liquid nasal sprays........................................610
Molgramostim concentrated solution .................................2054 Nasalia ..........................................................................................610
Molgramostimi solutio concentrata ...................................2054 Nasal powders..............................................................................611
Mometasone furoate.........................................................5.3-3555 Nasal preparations ......................................................................610
Mometasoni furoas ..........................................................5.3-3555 Nasal preparations, semi-solid..................................................611
Monoclonal antibodies for human use.........................5.2-3127 Nasal sticks...................................................................................611
Monographs (1.4.)...........................................................................7 Nasal washes ................................................................................611
Morantel hydrogen tartrate for veterinary use .................2059 Natrii acetas trihydricus ....................................................... 2415
Moranteli hydrogenotartras ad usum veterinarium......2059 Natrii acetatis ([1-11C]) solutio iniectabilis ......................... 839
Morphine hydrochloride..................................................5.2-3237 Natrii alendronas .................................................................... 2416
Morphine sulphate............................................................5.2-3238 Natrii alginas ........................................................................... 2417
Morphini hydrochloridum.............................................5.2-3237 Natrii amidotrizoas ................................................................ 2418
Morphini sulfas.................................................................5.2-3238 Natrii aminosalicylas dihydricus........................................ 2419
Moss, Iceland .....................................................................5.3-3525 Natrii ascorbas.........................................................................2420
Mother tinctures for homoeopathic preparations .............. 894 Natrii aurothiomalas.......................................................5.3-3613
Motherwort ...............................................................................2063 Natrii benzoas.......................................................................... 2421
Mouthwashes .............................................................................. 612 Natrii bromidum......................................................................2422
Moxonidine................................................................................2064 Natrii calcii edetas ..................................................................2422
Moxonidinum...........................................................................2064 Natrii caprylas .........................................................................2423
Mucoadhesive preparations ..................................................... 613 Natrii carbonas anhydricus...........................................5.1-3008
Mullein flower...........................................................................2065 Natrii carbonas decahydricus.......................................5.1-3008
Multidose containers, uniformity of mass of delivered doses Natrii carbonas monohydricus.....................................5.1-3009
(2.9.27.) ...................................................................................... 263 Natrii cetylo- et stearylosulfas. ............................................2426
Mumps vaccine (live) ................................................................. 684 Natrii chloridum......................................................................2428
Mupirocin...................................................................................2065 Natrii chromatis (51Cr) solutio sterilis ................................. 840
Mupirocin calcium ...................................................................2067 Natrii citras...............................................................................2429
Mupirocinum............................................................................2065 Natrii cromoglicas ..................................................................2429
Mupirocinum calcicum .........................................................2067 Natrii cyclamas........................................................................2430
Musci medicati........................................................................... 604 Natrii dihydrogenophosphas dihydricus .......................... 2431
Mycobacteria (2.6.2.) ................................................................. 149 Natrii docusas .......................................................................... 1471
Mycophenolas mofetil.....................................................5.2-3239 Natrii fluoridi (18F) solutio iniectabilis................................ 841
Mycophenolate mofetil.....................................................5.2-3239 Natrii fluoridum ......................................................................2432
Mycoplasmas (2.6.7.).................................................................. 149 Natrii fusidas............................................................................2433
myo-Inositol .......................................................................5.3-3527 Natrii glycerophosphas hydricus ........................................2434
myo-Inositolum.................................................................5.3-3527 Natrii hyaluronas....................................................................2434

3676 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Natrii hydrogenocarbonas....................................................2437 Nicotine resinate ......................................................................2096


Natrii hydroxidum ..................................................................2437 Nicotinic acid ............................................................................2097
Natrii iodidi (123I) solutio iniectabilis .................................. 842 Nicotini resinas .......................................................................2096
Natrii iodidi (131I) capsulae ad usum diagnosticum......... 843 Nicotinum .................................................................................2095
Natrii iodidi (131I) capsulae ad usum therapeuticum.......5.2- Nifedipine...................................................................................2098
3157 Nifedipinum..............................................................................2098
Natrii iodidi (131I) solutio......................................................... 844 Nifuroxazide ..............................................................................2099
Natrii iodidi (131I) solutio ad radio-signandum ................. 845 Nifuroxazidum.........................................................................2099
Natrii iodidum .........................................................................2438 Nikethamide .............................................................................. 2100
Natrii iodohippurati (123I) solutio iniectabilis ................... 845 Nimesulide................................................................................. 2101
Natrii iodohippurati (131I) solutio iniectabilis.................... 846 Nimesulidum ............................................................................ 2101
Natrii lactatis solutio..............................................................2438 Nimodipine ................................................................................ 2102
Natrii laurilsulfas ....................................................................2440 Nimodipinum ........................................................................... 2102
Natrii metabisulfis .................................................................. 2441 Nitrazepam ................................................................................ 2103
Natrii molybdas dihydricus ..................................................2442 Nitrazepamum ......................................................................... 2103
Natrii nitris ...............................................................................2443 Nitrendipine .............................................................................. 2104
Natrii nitroprussias ................................................................2443 Nitrendipinum ......................................................................... 2104
Natrii perboras hydricus .......................................................2444 Nitric acid .................................................................................. 2105
Natrii pertechnetatis (99mTc) fissione formati solutio Nitric oxide ................................................................................ 2105
iniectabilis ................................................................................ 847 Nitrofural ................................................................................... 2106
Natrii pertechnetatis (99mTc) sine fissione formati solutio Nitrofuralum............................................................................. 2106
iniectabilis ................................................................................ 848 Nitrofurantoin........................................................................... 2107
Natrii phosphatis (32P) solutio iniectabilis ......................... 849 Nitrofurantoinum.................................................................... 2107
Natrii picosulfas ......................................................................2445 Nitrogen ..................................................................................... 2108
Natrii polystyrenesulfonas....................................................2446 Nitrogen determination by sulphuric acid digestion
Natrii propionas ......................................................................2447 (2.5.9.) ........................................................................................ 129
Natrii salicylas .........................................................................2449 Nitrogen determination, primary aromatic amino
Natrii selenis pentahydricus ................................................2449 (2.5.8.) ........................................................................................ 129
Natrii (S)-lactatis solutio .......................................................2439 Nitrogenii oxidum................................................................... 2105
Natrii stearas ............................................................................2452 Nitrogenium ............................................................................. 2108
Natrii stearylis fumaras.........................................................2453 Nitrogenium oxygenio depletum ........................................ 2109
Natrii sulfas anhydricus ........................................................2454 Nitrogen, low-oxygen............................................................... 2109
Natrii sulfas decahydricus ....................................................2455 Nitrogen monoxide and nitrogen dioxide in gases
Natrii sulfis anhydricus.........................................................2455 (2.5.26.) ...................................................................................... 135
Natrii sulfis heptahydricus ...................................................2456 Nitrous oxide......................................................................5.1-2981
Natrii thiosulfas ................................................................5.1-3009 Nitrous oxide in gases (2.5.35.)................................................141
Natrii valproas .........................................................................2457 Nizatidine....................................................................................2111
Near-infrared spectrophotometry (2.2.40.)............................. 59 Nizatidinum...............................................................................2111
Neohesperidin-dihydrochalcone ...........................................2085 N-Methylpyrrolidone................................................................2026
Neohesperidin-dihydrochalconum .....................................2085 N-Methylpyrrolidonum ..........................................................2026
Neomycini sulfas .....................................................................2086 N,N-Dimethylaniline (2.4.26.) ...................................................119
Neomycin sulphate ..................................................................2086 Nomegestrol acetate................................................................ 2113
Neonatal piglet colibacillosis vaccine (inactivated) ............ 776 Nomegestroli acetas................................................................ 2113
Neonatal ruminant colibacillosis vaccine (inactivated) ..... 778 Nonoxinol 9................................................................................2114
Neostigmine bromide ..............................................................2088 Nonoxinolum 9.........................................................................2114
Neostigmine metilsulfate........................................................2089 Non-sterile products, microbiological examination of (test for
Neostigmini bromidum..........................................................2088 specified micro-organisms) (2.6.13.) .................................... 156
Neostigmini metilsulfas .........................................................2089 Non-sterile products, microbiological examination of (total
Neroli aetheroleum ..........................................................5.3-3562 viable aerobic count) (2.6.12.)............................................... 154
Neroli oil .............................................................................5.3-3562 Noradrenaline hydrochloride .................................................2114
Netilmicini sulfas ....................................................................2089 Noradrenaline tartrate ............................................................ 2115
Netilmicin sulphate..................................................................2089 Noradrenalini hydrochloridum............................................2114
Nettle leaf............................................................................5.3-3563 Noradrenalini tartras ............................................................. 2115
Neurovirulence test for poliomyelitis vaccine (oral) Norcholesteroli iodinati (131I) solutio iniectabilis ............. 836
(2.6.19.) ...................................................................................... 172 Norcholesterol injection, iodinated (131I) .............................. 836
Neurovirulence test of live viral vaccines (2.6.18.) ............. 172 Norethisterone.......................................................................... 2116
Newcastle disease vaccine (inactivated)................................ 779 Norethisterone acetate ............................................................2117
Newcastle disease vaccine (live).............................................. 781 Norethisteroni acetas ..............................................................2117
Nicergoline ................................................................................ 2091 Norethisteronum ..................................................................... 2116
Nicergolinum ........................................................................... 2091 Norfloxacin................................................................................ 2118
Nicethamidum ......................................................................... 2100 Norfloxacinum......................................................................... 2118
Nickel in polyols (2.4.15.)......................................................... 108 Norgestrel .................................................................................. 2119
Niclosamide, anhydrous .........................................................2092 Norgestrelum ............................................................................ 2119
Niclosamide monohydrate .....................................................2093 Normal immunoglobulin for intravenous administration,
Niclosamidum anhydricum..................................................2092 human ............................................................................... 5.3-3516
Niclosamidum monohydricum............................................2093 Normal immunoglobulin, human .................................. 5.3-3514
Nicotinamide .............................................................................2094 Nortriptyline hydrochloride............................................5.3-3565
Nicotinamidum........................................................................2094 Nortriptylini hydrochloridum.......................................5.3-3565
Nicotine ......................................................................................2095 Noscapine .................................................................................. 2121

General Notices (1) apply to all monographs and other texts 3677
Index EUROPEAN PHARMACOPOEIA 5.3

Noscapine hydrochloride........................................................ 2122 Orciprenalini sulfas.........................................................5.3-3576


Noscapini hydrochloridum................................................... 2122 Oregano...................................................................................... 2155
Noscapinum.............................................................................. 2121 Organ preservation, solutions for.........................................2458
Nuclear magnetic resonance spectrometry (2.2.33.).............51 Oriental cashew for homoeopathic preparations.......5.3-3430
Nucleic acid amplification techniques (2.6.21.)....................174 Origani herba........................................................................... 2155
Nucleic acids in polysaccharide vaccines (2.5.17.) .............. 132 Orodispensible tablets...................................................... 5.2-3151
Nutmeg oil ................................................................................. 2123 Oromucosal capsules ................................................................ 613
Nystatin ...................................................................................... 2124 Oromucosal drops, oromucosal sprays and sublingual
Nystatinum ............................................................................... 2124 sprays.......................................................................................... 612
Oromucosal preparations..........................................................611
O Oromucosal preparations, semi-solid..................................... 612
O-Acetyl in polysaccharide vaccines (2.5.19.) ...................... 132 Oromucosal solutions and oromucosal suspensions ......... 612
Oak bark .................................................................................... 2129 Orphenadrine citrate............................................................... 2156
Octoxinol 10 .......................................................................5.2-3251 Orphenadrine hydrochloride................................................. 2157
Octoxinolum 10 ................................................................5.2-3251 Orphenadrini citras................................................................ 2156
Octyldodecanol..................................................................5.3-3569 Orphenadrini hydrochloridum............................................ 2157
Octyldodecanolum ...........................................................5.3-3569 Orthosiphonis folium ............................................................. 1859
Octyl gallate .............................................................................. 2129 Oryzae amylum .......................................................................2369
Octylis gallas ............................................................................ 2129 Osmolality (2.2.35.)...................................................................... 54
Odour (2.3.4.)................................................................................ 99 Other provisions applying to general chapters and
Odour and taste of essential oils (2.8.8.) ...............................216 monographs (1.2.).........................................................................5
Oenotherae oleum raffinatum ......................................5.1-2921 Ouabain...................................................................................... 2158
Ofloxacin.................................................................................... 2131 Ouabainum ............................................................................... 2158
Ofloxacinum............................................................................. 2131 Oxaliplatin ................................................................................. 2159
Oils rich in omega-3- acids, composition of fatty acids Oxaliplatinum .......................................................................... 2159
(2.4.29.) ...................................................................................... 121 Oxazepam .................................................................................. 2162
Ointments .................................................................................... 625 Oxazepamum ........................................................................... 2162
Oleae folium ............................................................................. 2134 Oxeladin hydrogen citrate...................................................... 2163
Olea herbaria ............................................................................ 595 Oxeladini hydrogenocitras ................................................... 2163
Oleic acid ................................................................................... 2132 Oxfendazole for veterinary use............................................. 2164
Oleoyl macrogolglycerides..................................................... 2133 Oxfendazolum ad usum veterinarium .............................. 2164
Oleyl alcohol ............................................................................. 2134 Oxidising substances (2.5.30.)................................................. 137
Olivae oleum raffinatum ....................................................... 2135 Oxolinic acid.............................................................................. 2165
Olivae oleum virginale .......................................................... 2136 Oxprenolol hydrochloride ...................................................... 2166
Olive leaf .................................................................................... 2134 Oxprenololi hydrochloridum .............................................. 2166
Olive oil, refined ....................................................................... 2135 Oxybuprocaine hydrochloride............................................... 2167
Olive oil, virgin ......................................................................... 2136 Oxybuprocaini hydrochloridum ......................................... 2167
Olsalazine sodium.................................................................... 2137 Oxybutynin hydrochloride ..............................................5.3-3577
Olsalazinum natricum........................................................... 2137 Oxybutynini hydrochloridum .......................................5.3-3577
Omega-3-acid ethyl esters 60..........................................5.3-3569 Oxycodone hydrochloride ...............................................5.1-2987
Omega-3-acid ethyl esters 90..........................................5.3-3571 Oxycodoni hydrochloridum ..........................................5.1-2987
Omega-3 acidorum esteri ethylici 60..........................5.3-3569 Oxygen........................................................................................ 2169
Omega-3 acidorum esteri ethylici 90..........................5.3-3571 Oxygen (15O) ................................................................................ 837
Omega-3 acidorum triglycerida .......................................... 2144 Oxygen-flask method (2.5.10.)................................................. 130
Omega-3-acids, composition of fatty acids in oils rich in Oxygen in gases (2.5.27.).......................................................... 136
(2.4.29.) ...................................................................................... 121 Oxygenium................................................................................ 2169
Omega-3-acids, fish oil rich in ...............................................1595 Oxygenium (15O)........................................................................ 837
Omega-3-acid triglycerides ..................................................... 2144 Oxymetazoline hydrochloride ............................................... 2170
Omeprazole ........................................................................5.2-3251 Oxymetazolini hydrochloridum .......................................... 2170
Omeprazole sodium................................................................. 2148 Oxytetracycline dihydrate ...................................................... 2171
Omeprazolum....................................................................5.2-3251 Oxytetracycline hydrochloride .............................................. 2172
Omeprazolum natricum........................................................ 2148 Oxytetracyclini hydrochloridum......................................... 2172
Ondansetron hydrochloride dihydrate ................................ 2149 Oxytetracyclinum dihydricum............................................. 2171
Ondansetroni hydrochloridum dihydricum .................... 2149 Oxytocin ......................................................................................2174
Ononidis radix ......................................................................... 2361 Oxytocin bulk solution ........................................................... 2175
Opalescence of liquids, clarity and degree (2.2.1.) ............... 23 Oxytocini solutio ..................................................................... 2175
Ophthalmica ......................................................................5.3-3395 Oxytocinum ...............................................................................2174
Ophthalmic inserts ...........................................................5.3-3396
Opii pulvis normatus ......................................................5.3-3573 P
Opium crudum .................................................................5.3-3575 Pale coneflower root ........................................................5.2-3257
Opium, prepared................................................................5.3-3573 Palmitic acid.............................................................................. 2179
Opium, raw .........................................................................5.3-3575 Pancreas powder ...............................................................5.3-3583
Optical microscopy (2.9.37.) ...........................................5.3-3366 Pancreatis pulvis ..............................................................5.3-3583
Optical rotation (2.2.7.)............................................................... 28 Pancuronii bromidum ........................................................... 2182
Oral drops ........................................................................... 5.2-3143 Pancuronium bromide ............................................................ 2182
Oral powders...................................................................... 5.2-3147 Pansy, wild (flowering aerial parts) .....................................2700
Oral solutions, emulsions and suspensions ................ 5.2-3143 Papaverine hydrochloride ...................................................... 2183
Oral use, liquid preparations for.................................... 5.2-3142 Papaverini hydrochloridum................................................. 2183
Orciprenaline sulphate.....................................................5.3-3576 Papaveris rhoeados flos ........................................................2359

3678 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Paper chromatography (2.2.26.)............................................... 40 Peppermint oil ..........................................................................2206


Paracetamol .............................................................................. 2184 Pepsini pulvis...........................................................................2207
Paracetamolum........................................................................ 2184 Pepsin powder ..........................................................................2207
Paraffin, hard ............................................................................ 2186 Peptide mapping (2.2.55.) .......................................................... 82
Paraffin, light liquid ................................................................ 2186 Peptides, synthetic, acetic acid in (2.5.34.)............................141
Paraffin, liquid .......................................................................... 2187 Pergolide mesilate....................................................................2209
Paraffinum liquidum.............................................................. 2187 Pergolidi mesilas .....................................................................2209
Paraffinum perliquidum ....................................................... 2186 Perindopril tert-butylamine.............................................5.3-3589
Paraffinum solidum................................................................ 2186 Peritoneal dialysis, solutions for........................................... 2212
Paraffin, white soft .................................................................. 2187 Peroxide value (2.5.5.)............................................................... 128
Paraffin, yellow soft................................................................. 2188 Perphenazine ............................................................................ 2214
Parainfluenza virus vaccine (live), bovine, freeze-dried .... 732 Perphenazinum....................................................................... 2214
Parainfluenza virus vaccine (live), canine ............................ 742 Pertussis (acellular, component), diphtheria, tetanus,
Paraldehyde............................................................................... 2189 poliomyelitis (inactivated) and haemophilus type b
Paraldehydum.......................................................................... 2189 conjugate vaccine (adsorbed)................................................ 653
Parenteralia ....................................................................... 5.2-3144 Pertussis, diphtheria, tetanus and poliomyelitis (inactivated)
Parenteral preparations................................................... 5.2-3144 vaccine (adsorbed)................................................................... 656
Parenteral preparations, test for extractable volume of Pertussis, diphtheria, tetanus, poliomyelitis (inactivated) and
(2.9.17.)..............................................................................5.3-3363 haemophilus type b conjugate vaccine (adsorbed) .......... 657
Parnaparin sodium .................................................................. 2189 Pertussis vaccine........................................................................ 685
Parnaparinum natricum....................................................... 2189 Pertussis vaccine (acellular), assay of (2.7.16.).................... 208
Paroxetine hydrochloride hemihydrate............................... 2190 Pertussis vaccine (acellular, component, adsorbed) ..5.3-3407
Paroxetini hydrochloridum hemihydricum ..................... 2190 Pertussis vaccine (acellular, co-purified, adsorbed) ........... 688
Particles, fine, aerodynamic assessment of in preparations Pertussis vaccine (adsorbed) ................................................... 690
for inhalation (2.9.18.) ................................................... 5.2-3103 Pertussis vaccine, assay of (2.7.7.) .......................................... 197
Particle size by microscopy, limit test of (2.9.13.) .............. 239 Peru balsam............................................................................... 2215
Particle-size distribution estimation by analytical sieving Pessaries..............................................................................5.2-3152
(2.9.38.) .............................................................................5.3-3368 Pessaries and suppositories, disintegration of (2.9.2.) ...... 227
Particulate contamination : sub-visible particles Pessaries and suppositories, resistance to rupture
(2.9.19.) ...................................................................................... 253 (2.9.24.) ...................................................................................... 258
Particulate contamination : visible particles (2.9.20.)........ 255 Pesticide residues (2.8.13.)........................................................218
Parvovirosis vaccine (inactivated), canine ............................ 743 Pethidine hydrochloride......................................................... 2216
Parvovirosis vaccine (inactivated), porcine .......................... 787 Pethidini hydrochloridum .................................................... 2216
Parvovirosis vaccine (live), canine.......................................... 744 Pharmaceutical technical procedures (2.9.)......................... 225
Passiflorae herba..................................................................... 2192 Pharmacognosy, methods in (2.8.)......................................... 215
Passiflorae herbae extractum siccum .........................5.3-3585 Pharmacopoeial harmonisation (5.8.) ................................... 551
Passion flower .......................................................................... 2192 Phenazone................................................................................. 2217
Passion flower dry extract ..............................................5.3-3585 Phenazonum ............................................................................ 2217
Pastes............................................................................................ 625 Pheniramine maleate .............................................................. 2218
Pasteurella vaccine (inactivated) for sheep .......................... 783 Pheniramini maleas............................................................... 2218
Pastilles and lozenges............................................................... 613 Phenobarbital ........................................................................... 2219
Patches, transdermal........................................................ 5.2-3146 Phenobarbital sodium.............................................................2220
Patches, transdermal, dissolution test for (2.9.4.) .............. 231 Phenobarbitalum..................................................................... 2219
Pefloxacini mesilas dihydricus ........................................... 2193 Phenobarbitalum natricum..................................................2220
Pefloxacin mesilate dihydrate ............................................... 2193 Phenol ........................................................................................ 2221
Penbutololi sulfas.................................................................... 2195 Phenol in immunosera and vaccines (2.5.15.)......................131
Penbutolol sulphate ................................................................ 2195 Phenolphthalein.......................................................................2222
Penetrometry, measurement of consistency (2.9.9.) .......... 235 Phenolphthaleinum................................................................2222
Penicillamine......................................................................5.3-3586 Phenolsulfonphthalein ...........................................................2222
Penicillaminum ................................................................5.3-3586 Phenolsulfonphthaleinum ....................................................2222
Pentaerythrityli tetranitras dilutus..................................... 2198 Phenolum.................................................................................. 2221
Pentaerythrityl tetranitrate, diluted .................................... 2198 Phenothiazines, identification by thin-layer chromatography
Pentamidine diisetionate.................................................5.3-3588 (2.3.3.) .......................................................................................... 99
Pentamidini diisetionas .................................................5.3-3588 Phenoxyethanol........................................................................2223
Pentazocine........................................................................5.1-2991 Phenoxyethanolum ................................................................2223
Pentazocine hydrochloride .............................................5.1-2991 Phenoxymethylpenicillin .................................................5.1-2992
Pentazocine lactate ..........................................................5.1-2992 Phenoxymethylpenicillin potassium .............................5.3-3591
Pentazocini hydrochloridum ........................................5.1-2991 Phenoxymethylpenicillinum.........................................5.1-2992
Pentazocini lactas............................................................5.1-2992 Phenoxymethylpenicillinum kalicum ........................5.3-3591
Pentazocinum ...................................................................5.1-2991 Phentolamine mesilate ...........................................................2227
Pentobarbital ............................................................................ 2201 Phentolamini mesilas ............................................................2227
Pentobarbital sodium..............................................................2202 Phenylalanine ...........................................................................2228
Pentobarbitalum...................................................................... 2201 Phenylalaninum......................................................................2228
Pentobarbitalum natricum ...................................................2202 Phenylbutazone .......................................................................2229
Pentoxifylline .....................................................................5.2-3258 Phenylbutazonum...................................................................2229
Pentoxifyllinum ................................................................5.2-3258 Phenylephrine........................................................................... 2231
Pentoxyverine hydrogen citrate............................................2204 Phenylephrine hydrochloride................................................2232
Pentoxyverini hydrogenocitras ...........................................2204 Phenylephrini hydrochloridum ..........................................2232
Peppermint leaf ........................................................................2205 Phenylephrinum ..................................................................... 2231

General Notices (1) apply to all monographs and other texts 3679
Index EUROPEAN PHARMACOPOEIA 5.3

Phenylhydrargyri acetas .......................................................2232 Pivmecillinami hydrochloridum ........................................2262


Phenylhydrargyri boras.........................................................2233 Plantae ad ptisanam ................................................................ 573
Phenylhydrargyri nitras........................................................2234 Plantae medicinales ................................................................. 572
Phenylmercuric acetate ..........................................................2232 Plantae medicinales ad praeparationes
Phenylmercuric borate ...........................................................2233 homoeopathicas ............................................................. 5.2-3161
Phenylmercuric nitrate ...........................................................2234 Plantae medicinales praeparatore ....................................... 572
Phenylpropanolamine hydrochloride ..................................2234 Plantaginis lanceolatae folium ...........................................2368
Phenylpropanolamini hydrochloridum............................2234 Plantaginis ovatae semen..................................................... 1850
Phenytoin...................................................................................2235 Plantaginis ovatae seminis tegumentum ......................... 1849
Phenytoin sodium....................................................................2236 Plasma for fractionation, human ................................... 5.3-3518
Phenytoinum............................................................................2235 Plasma, human (pooled and treated for virus
Phenytoinum natricum .........................................................2236 inactivation) ............................................................................ 1747
Phloroglucinol, anhydrous .............................................5.3-3593 Plasma humanum ad separationem........................... 5.3-3518
Phloroglucinol dihydrate ................................................5.3-3594 Plasma humanum collectum deinde conditum ad viros
Phloroglucinolum anhydricum....................................5.3-3593 exstinguendos ........................................................................ 1747
Phloroglucinolum dihydricum .....................................5.3-3594 Plastic additives (3.1.13.).......................................................... 293
Pholcodine.................................................................................2237 Plastic containers and closures for pharmaceutical use
Pholcodinum ............................................................................2237 (3.2.2.) ........................................................................................ 308
Phosphates (2.4.11.) .................................................................. 108 Plastic containers for aqueous solutions for parenteral
Phosphoric acid, concentrated .............................................2237 infusion (3.2.2.1.) ..................................................................... 309
Phosphoric acid, dilute ...........................................................2238 Plastic containers for human blood and blood components,
Phosphorus in polysaccharide vaccines (2.5.18.) ............... 132 sterile (3.2.3.) ............................................................................ 309
pH, potentiometric determination of (2.2.3.) ......................... 26 Plastic syringes, single-use, sterile (3.2.8.) ............................314
Phthalylsulfathiazole ..............................................................2238 Pneumococcal polysaccharide conjugate vaccine
Phthalylsulfathiazolum .........................................................2238 (adsorbed).........................................................................5.1-2851
Physical and physicochemical methods (2.2.) ....................... 23 Pneumococcal polysaccharide vaccine ................................. 691
Physostigmine salicylate.........................................................2239 Poliomyelitis (inactivated), diphtheria, tetanus and pertussis
Physostigmine sulphate..........................................................2240 (acellular, component) vaccine (adsorbed) ........................ 648
Physostigmini salicylas .........................................................2239 Poliomyelitis (inactivated), diphtheria, tetanus and pertussis
Physostigmini sulfas ..............................................................2240 vaccine (adsorbed)................................................................... 656
Phytomenadione ...................................................................... 2241 Poliomyelitis (inactivated), diphtheria, tetanus, pertussis
Phytomenadionum ................................................................. 2241 (acellular, component) and haemophilus type b conjugate
Phytosterol ................................................................................2242 vaccine (adsorbed)................................................................... 653
Phytosterolum..........................................................................2242 Poliomyelitis (inactivated), diphtheria, tetanus, pertussis and
Picotamide monohydrate .......................................................2243 haemophilus type b conjugate vaccine (adsorbed) .......... 657
Picotamidum monohydricum..............................................2243 Poliomyelitis vaccine (inactivated) ......................................... 692
Pilocarpine hydrochloride......................................................2244 Poliomyelitis vaccine (inactivated), in vivo assay of
Pilocarpine nitrate ...................................................................2246 (2.7.20.) .......................................................................................210
Pilocarpini hydrochloridum ................................................2244 Poliomyelitis vaccine (oral) .............................................5.3-3410
Pilocarpini nitras....................................................................2246 Poliomyelitis vaccine (oral), test for neurovirulence
Pimobendan .......................................................................5.3-3594 (2.6.19.) ...................................................................................... 172
Pimobendanum ................................................................5.3-3594 Poloxamera...............................................................................2264
Pimozide ....................................................................................2247 Poloxamers ................................................................................2264
Pimozidum ...............................................................................2247 Polyacrylate dispersion 30 per cent.....................................2265
Pindolol......................................................................................2248 Polyacrylatis dispersio 30 per centum..............................2265
Pindololum ...............................................................................2248 Poly(alcohol vinylicus) ..........................................................2272
Pipemidic acid trihydrate .......................................................2249 Polyamide 6/6 suture, sterile, in distributor for veterinary
Piperacillin ................................................................................2250 use .............................................................................................. 887
Piperacillin sodium..................................................................2252 Polyamide 6 suture, sterile, in distributor for veterinary use
Piperacillinum ........................................................................2250 ..................................................................................................... 886
Piperacillinum natricum ......................................................2252 Polyethyleneglycols ................................................................. 1950
Piperazine adipate ...................................................................2253 Polyethylene terephthalate for containers for preparations
Piperazine citrate.....................................................................2254 not for parenteral use (3.1.15.) ............................................. 298
Piperazine hydrate...................................................................2255 Poly(ethylene terephthalate) suture, sterile, in distributor for
Piperazini adipas....................................................................2253 veterinary use .......................................................................... 887
Piperazini citras ......................................................................2254 Poly(ethylene - vinyl acetate) for containers and tubing for
Piperazinum hydricum .........................................................2255 total parenteral nutrition preparations (3.1.7.) ................. 285
Piracetam...................................................................................2256 Polyethylene with additives for containers for parenteral
Piracetamum ............................................................................2256 preparations and for ophthalmic preparations (3.1.5.) ... 279
Pirenzepine dihydrochloride monohydrate .......................2257 Polyethylene without additives for containers for parenteral
Pirenzepini dihydrochloridum monohydricum .............2257 preparations and for ophthalmic preparations (3.1.4.) ... 278
Piretanide ..................................................................................2258 Polygalae radix ........................................................................ 2401
Piretanidum..............................................................................2258 Polygoni avicularis herba..................................................... 1877
Piroxicam ...................................................................................2259 Polymorphism (5.9.) .................................................................. 555
Piroxicamum............................................................................2259 Polymyxin B sulphate ......................................................5.3-3595
Piscis oleum omega-3 acidis abundans ............................1595 Polymyxini B sulfas.........................................................5.3-3595
Pivampicillin.............................................................................. 2261 Polyolefines (3.1.3.) ................................................................... 274
Pivampicillinum...................................................................... 2261 Polyoxyl castor oil.............................................................5.3-3547
Pivmecillinam hydrochloride.................................................2262 Polyoxyl hydrogenated castor oil ..................................5.2-3231

3680 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Polypropylene for containers and closures for parenteral Potassium sorbate....................................................................2287


preparations and ophthalmic preparations (3.1.6.).......... 282 Potassium sulphate .................................................................2288
Polysaccharide vaccines, hexosamines in (2.5.20.)............. 132 Potato starch.............................................................................2288
Polysaccharide vaccines, methylpentoses in (2.5.21.)........ 133 Potentiometric determination of ionic concentration using
Polysaccharide vaccines, nucleic acids in (2.5.17.) ............. 132 ion-selective electrodes (2.2.36.)............................................. 55
Polysaccharide vaccines, O-acetyl in (2.5.19.)...................... 132 Potentiometric determination of pH (2.2.3.).......................... 26
Polysaccharide vaccines, phosphorus in (2.5.18.)............... 132 Potentiometric titration (2.2.20.).............................................. 35
Polysaccharide vaccines, protein in (2.5.16.) ........................131 Poultices....................................................................................... 625
Polysaccharide vaccines, ribose in (2.5.31.) ......................... 137 Pour-on preparations ................................................................ 631
Polysaccharide vaccines, sialic acid in (2.5.23.) .................. 133 Povidone .............................................................................5.2-3262
Polysaccharide vaccines, uronic acids in (2.5.22.).............. 133 Povidone, iodinated ................................................................. 2291
Polysorbate 20 ..........................................................................2267 Povidonum.........................................................................5.2-3262
Polysorbate 40 ..........................................................................2268 Povidonum iodinatum........................................................... 2291
Polysorbate 60 ..........................................................................2269 Powdered cellulose ..................................................................1232
Polysorbate 80 ..........................................................................2270 Powder flow (2.9.36.) .......................................................5.3-3363
Polysorbatum 20 .....................................................................2267 Powders and granules for oral solutions and
Polysorbatum 40 .....................................................................2268 suspensions...................................................................... 5.2-3143
Polysorbatum 60 .....................................................................2269 Powders and granules for syrups .................................. 5.2-3143
Polysorbatum 80 .....................................................................2270 Powders and tablets for rectal solutions and
Poly(vinyl acetate)....................................................................2271 suspensions...................................................................... 5.2-3149
Poly(vinyl alcohol) ...................................................................2272 Powders, ear.......................................................................5.2-3138
Poly(vinyl chloride), non-plasticised, materials based on for Powders, effervescent....................................................... 5.2-3148
containers for dry dosage forms for oral administration Powders for cutaneous application............................... 5.2-3147
(3.1.11.)....................................................................................... 291 Powders for eye drops and powders for eye lotions ..5.3-3396
Poly(vinyl chloride), non-plasticised, materials based on Powders for inhalation.....................................................5.1-2845
for containers for non-injectable aqueous solutions Powders for injections or infusions .............................. 5.2-3145
(3.1.10.) ...................................................................................... 289 Powders for oral drops..................................................... 5.2-3143
Poly(vinyl chloride), plasticised, empty sterile containers of Powders, nasal .............................................................................611
for human blood and blood components (3.2.4.) ..............311 Powders, oral ..................................................................... 5.2-3147
Poly(vinyl chloride), plasticised, materials based on for Praeadmixta ad alimenta medicata
containers for aqueous solutions for intravenous infusion ad usum veterinarium............................................................617
(3.1.14.) ...................................................................................... 296 Praeparationes ad irrigationem............................................ 622
Poly(vinyl chloride), plasticised, materials based on for Praeparationes buccales ..........................................................611
containers for human blood and blood components Praeparationes homoeopathicas .......................................... 893
(3.1.1.1.) ..................................................................................... 269 Praeparationes insulini iniectabiles .................................. 1808
Poly(vinyl chloride), plasticised, materials based on for Praeparationes intramammariae
tubing used in sets for the transfusion of blood and blood ad usum veterinarium........................................................... 606
components (3.1.1.2.).............................................................. 272 Praeparationes intraruminales .................................... 5.2-3141
Poly (vinyl chloride), plasticised, sterile containers of Praeparationes intra-uterinae ad usum veterinarium....5.3-
for human blood containing anticoagulant solution 3397
(3.2.5.) ........................................................................................ 312 Praeparationes liquidae ad usum dermicum .................... 607
Poly(vinylis acetas).................................................................2271 Praeparationes liquidae peroraliae............................. 5.2-3142
Poppy petals, red......................................................................2359 Praeparationes liquidae veterinariae ad usum dermicum
Porcine actinobacillosis vaccine (inactivated) ..................... 784 ..................................................................................................... 630
Porcine influenza vaccine (inactivated) ................................ 785 Praeparationes molles ad usum dermicum ....................... 624
Porcine insulin.......................................................................... 1806 Praeparationes pharmaceuticae in vasis cum pressu..... 622
Porcine parvovirosis vaccine (inactivated) ........................... 787 Pravastatin sodium ..................................................................2292
Porcine progressive atrophic rhinitis vaccine Pravastatinum natricum .......................................................2292
(inactivated) .............................................................................. 788 Prazepam ...................................................................................2293
Porosity of sintered-glass filters (2.1.2.)...................................17 Prazepamum ............................................................................2293
Potassium (2.4.12.) .................................................................... 108 Praziquantel ..............................................................................2294
Potassium acetate ....................................................................2273 Praziquantelum.......................................................................2294
Potassium bromide ..................................................................2273 Prazosin hydrochloride ..........................................................2295
Potassium carbonate............................................................... 2274 Prazosini hydrochloridum ...................................................2295
Potassium chloride ...........................................................5.2-3261 Prednicarbate............................................................................2297
Potassium citrate .....................................................................2275 Prednicarbatum.......................................................................2297
Potassium clavulanate ............................................................ 2276 Prednisolone .............................................................................2298
Potassium clavulanate, diluted .............................................2278 Prednisolone acetate...............................................................2299
Potassium dihydrogen phosphate ........................................2280 Prednisolone pivalate.............................................................. 2301
Potassium hydrogen aspartate hemihydrate .....................2280 Prednisolone sodium phosphate ..........................................2302
Potassium hydrogen carbonate ............................................ 2281 Prednisoloni acetas ................................................................2299
Potassium hydrogen tartrate.................................................2282 Prednisoloni natrii phosphas ..............................................2302
Potassium hydroxide ...............................................................2283 Prednisoloni pivalas............................................................... 2301
Potassium iodide......................................................................2283 Prednisolonum ........................................................................2298
Potassium metabisulphite...............................................5.3-3597 Prednisone.................................................................................2303
Potassium nitrate .....................................................................2284 Prednisonum............................................................................2303
Potassium perchlorate ............................................................2285 Prekallikrein activator (2.6.15.) .............................................. 168
Potassium permanganate.......................................................2286 Premixes for medicated feeding stuffs for veterinary use ..617
Potassium sodium tartrate tetrahydrate.............................2286 Preparations for inhalation.............................................5.1-2843

General Notices (1) apply to all monographs and other texts 3681
Index EUROPEAN PHARMACOPOEIA 5.3

Preparations for inhalation : aerodynamic assessment of fine Propyl gallate............................................................................2325


particles (2.9.18.) ............................................................ 5.2-3103 Propylis gallas..........................................................................2325
Preparations for irrigation ....................................................... 622 Propylis parahydroxybenzoas .............................................2326
Pressurised pharmaceutical preparations ............................ 622 Propylis parahydroxybenzoas natricum ..........................2448
Prilocaine...................................................................................2305 Propyl parahydroxybenzoate.................................................2326
Prilocaine hydrochloride........................................................2307 Propylthiouracil ....................................................................... 2331
Prilocaini hydrochloridum...................................................2307 Propylthiouracilum ................................................................ 2331
Prilocainum..............................................................................2305 Propyphenazone ......................................................................2332
Primaquine diphosphate ........................................................2308 Propyphenazonum .................................................................2332
Primaquini diphosphas.........................................................2308 Protamine hydrochloride .......................................................2332
Primary aromatic amino-nitrogen, determination of Protamine sulphate .................................................................2334
(2.5.8.) ........................................................................................ 129 Protamini hydrochloridum ..................................................2332
Primary standards for volumetric solutions (4.2.1.)........... 435 Protamini sulfas ......................................................................2334
Primary standards for volumetric solutions (4.2.1.) ..5.3-3378 Protein in polysaccharide vaccines (2.5.16.) .........................131
Primidone ..................................................................................2309 Protein, total (2.5.33.) ............................................................... 138
Primidonum .............................................................................2309 Prothrombin complex, human .............................................. 1748
Primulae radix......................................................................... 2310 Prothrombinum multiplex humanum ............................... 1748
Primula root .............................................................................. 2310 Protirelin ....................................................................................2335
Probenecid................................................................................. 2311 Protirelinum .............................................................................2335
Probenecidum.......................................................................... 2311 Proxyphylline ............................................................................2336
Procainamide hydrochloride ................................................. 2312 Proxyphyllinum.......................................................................2336
Procainamidi hydrochloridum............................................ 2312 Pruni africanae cortex ..........................................................2339
Procaine benzylpenicillin ....................................................... 1080 Pseudoephedrine hydrochloride ..........................................2337
Procaine hydrochloride .......................................................... 2312 Pseudoephedrini hydrochloridum .....................................2337
Procaini hydrochloridum ..................................................... 2312 Psyllii semen ............................................................................2338
Prochlorperazine maleate ...................................................... 2313 Psyllium seed ............................................................................2338
Prochlorperazini maleas....................................................... 2313 Pulveres ad usum dermicum ........................................ 5.2-3147
Producta ab ADN recombinante ........................................... 584 Pulveres perorales............................................................ 5.2-3147
Producta ab fermentatione..................................................... 576 Purified water ...........................................................................2697
Producta allergenica ................................................................ 569 Purified water, highly .............................................................2695
Producta cum possibili transmissione vectorium Pycnometric density of solids (2.9.23.) ................................. 257
enkephalopathiarum spongiformium animalium ......... 577 Pygeum africanum bark .........................................................2339
Products of fermentation ......................................................... 576 Pyrantel embonate...................................................................2339
Products of recombinant DNA technology .......................... 584 Pyranteli embonas ..................................................................2339
Products with risk of transmitting agents of animal Pyrazinamide ............................................................................2340
spongiform encephalopathies............................................... 577 Pyrazinamidum.......................................................................2340
Progesterone ............................................................................. 2314 Pyridostigmine bromide ......................................................... 2341
Progesteronum ........................................................................ 2314 Pyridostigmini bromidum .................................................... 2341
Proguanil hydrochloride ........................................................ 2315 Pyridoxine hydrochloride.......................................................2342
Proguanili hydrochloridum ................................................. 2315 Pyridoxini hydrochloridum .................................................2342
Proline ........................................................................................ 2316 Pyrimethamine .........................................................................2343
Prolinum ................................................................................... 2316 Pyrimethaminum....................................................................2343
Promazine hydrochloride....................................................... 2317 Pyrogens (2.6.8.)......................................................................... 152
Promazini hydrochloridum.................................................. 2317
Promethazine hydrochloride................................................. 2318 Q
Promethazini hydrochloridum............................................ 2318 Quantified hawthorn leaf and flower liquid extract.. 5.3-3511
Propacetamol hydrochloride ................................................. 2319 Quercus cortex ......................................................................... 2129
Propacetamoli hydrochloridum .......................................... 2319 Quinidine sulphate ..................................................................2347
Propafenone hydrochloride ............................................5.1-2996 Quinine hydrochloride............................................................2348
Propafenoni hydrochloridum .......................................5.1-2996 Quinine sulphate......................................................................2350
Propanol.....................................................................................2320
Propanolum..............................................................................2320
R
Propantheline bromide........................................................... 2321
Propanthelini bromidum ...................................................... 2321 Rabies immunoglobulin, human .......................................... 1750
Propofol......................................................................................2322 Rabies vaccine for human use prepared in cell cultures... 699
Propofolum ...............................................................................2322 Rabies vaccine (inactivated) for veterinary use................... 790
Propranolol hydrochloride.....................................................2324 Rabies vaccine (live, oral) for foxes ........................................ 792
Propranololi hydrochloridum..............................................2324 Racemic camphor..................................................................... 1172
Propylene glycol.......................................................................2327 Racemic ephedrine hydrochloride .......................................1509
Propylene glycol dicaprylocaprate.......................................2327 Racemic menthol ..................................................................... 1991
Propylene glycol dilaurate .....................................................2328 Raclopride ([11C]methoxy) injection....................................... 838
Propylene glycol monolaurate ..............................................2329 Raclopridi ([11C]methoxy) solutio iniectabilis ................... 838
Propylene glycol monopalmitostearate...............................2330 Radionuclides, table of physical characteristics (5.7.) ....... 539
Propylene glycol monostearate.............................................2330 Radiopharmaceutica................................................................ 578
Propylenglycoli dicaprylocapras ........................................2327 Radiopharmaceutical preparations ........................................ 578
Propylenglycoli dilauras .......................................................2328 Raman spectrometry (2.2.48.) ................................................... 79
Propylenglycoli monolauras................................................2329 Ramipril......................................................................................2355
Propylenglycoli monopalmitostearas................................2330 Ramiprilum ..............................................................................2355
Propylenglycolum...................................................................2327 Ranitidine hydrochloride.................................................5.3-3601

3682 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Ranitidini hydrochloridum ...........................................5.3-3601 Rosemary oil .............................................................................2378


Rapae oleum raffinatum .......................................................2359 Rosmarini aetheroleum.........................................................2378
Rapeseed oil, refined...............................................................2359 Rosmarini folium ....................................................................2377
Ratanhiae radix .......................................................................2362 Rotating viscometer method - viscosity (2.2.10.) .......5.3-3337
Ratanhiae tinctura..................................................................2362 Roxithromycin...........................................................................2379
Reagents (4.) ............................................................................... 321 Roxithromycinum ...................................................................2379
Reagents (4.1.1.)......................................................................... 321 RRR-α-Tocopherol ................................................................... 2591
Reagents (4.1.1.)................................................................ 5.1-2817 RRR-α-Tocopherolum ............................................................ 2591
Reagents (4.1.1.)................................................................5.2-3123 RRR-α-Tocopheryl acetate.....................................................2595
Reagents (4.1.1.)................................................................5.3-3377 RRR-α-Tocopheryl hydrogen succinate .......................5.1-3026
Reagents, standard solutions, buffer solutions (4.1.)......... 321 RRR-α-Tocopherylis acetas ..................................................2595
Recombinant DNA technology, products of......................... 584 RRR-α-Tocopherylis hydrogenosuccinas...................5.1-3026
Rectal capsules .................................................................. 5.2-3149 Rubber closures for containers for aqueous parenteral
Rectal foams.......................................................................5.2-3150 preparations, for powders and for freeze-dried powders
Rectalia ............................................................................... 5.2-3148 (3.2.9.) .........................................................................................316
Rectal preparations........................................................... 5.2-3148 Rubella immunoglobulin, human......................................... 1751
Rectal preparations, semi-solid ...................................... 5.2-3149 Rubella vaccine (live) ................................................................ 701
Rectal solutions, emulsions and suspensions............. 5.2-3149 Rusci rhizoma...................................................................5.3-3454
Rectal tampons..................................................................5.2-3150 Rutoside trihydrate.................................................................. 2381
Red poppy petals......................................................................2359 Rutosidum trihydricum......................................................... 2381
Refractive index (2.2.6.) .............................................................. 28
Relationship between reaction of solution, approximate pH S
and colour of certain indicators (2.2.4.) ............................... 27 Sabalis serrulatae fructus .....................................................2398
Relative density (2.2.5.)............................................................... 27 Saccharin ............................................................................5.3-3607
Repaglinide.........................................................................5.2-3267 Saccharin sodium .............................................................5.3-3608
Repaglinidum....................................................................5.2-3267 Saccharinum .....................................................................5.3-3607
Reserpine ...................................................................................2360 Saccharinum natricum ..................................................5.3-3608
Reserpinum ..............................................................................2360 Sacchari spheri........................................................................2503
Residual solvents (5.4.) ............................................................. 507 Saccharum................................................................................2499
Residual solvents, identification and control (2.4.24.) ...... 113 Safflower oil, refined ...............................................................2389
Residue on evaporation of essential oils (2.8.9.)..................216 Saffron for homoeopathic preparations................................ 900
Resistance to crushing of tablets (2.9.8.) ............................. 235 Sage leaf (salvia officinalis)....................................................2389
Resistance to rupture of suppositories and pessaries Sage leaf, three-lobed..............................................................2390
(2.9.24.) ...................................................................................... 258 Sage tincture............................................................................. 2391
Resorcinol ..................................................................................2360 Salbutamol .........................................................................5.3-3609
Resorcinolum ...........................................................................2360 Salbutamoli sulfas .......................................................... 5.3-3611
Restharrow root ....................................................................... 2361 Salbutamol sulphate ........................................................ 5.3-3611
Rhamni purshianae cortex................................................... 1194 Salbutamolum...................................................................5.3-3609
Rhatany root .............................................................................2362 Salicis cortex ............................................................................2702
Rhatany tincture ......................................................................2362 Salicylic acid.......................................................................5.1-3007
Rhei radix..................................................................................2363 Salmeteroli xinafoas .......................................................5.2-3271
Rhenii sulfidi colloidalis et technetii (99mTc) solutio Salmeterol xinafoate.........................................................5.2-3271
iniectabilis ................................................................................ 851 Salmonis domestici oleum ...................................................2396
Rhubarb .....................................................................................2363 Salmon oil, farmed...................................................................2396
Ribavirin..............................................................................5.1-3002 Salviae officinalis folium ......................................................2389
Ribavirinum ......................................................................5.1-3002 Salviae sclareae aetheroleum .............................................. 1311
Riboflavin...................................................................................2365 Salviae tinctura ....................................................................... 2391
Riboflavini natrii phosphas .................................................2366 Salviae trilobae folium ..........................................................2390
Riboflavin sodium phosphate................................................2366 Sambuci flos............................................................................. 1496
Riboflavinum............................................................................2365 Saponification value (2.5.6.).................................................... 129
Ribose in polysaccharide vaccines (2.5.31.) ......................... 137 Saw palmetto fruit ...................................................................2398
Ribwort plantain ......................................................................2368 Scopolamine....................................................................... 5.3-3519
Rice starch.................................................................................2369 Scopolamine butylbromide .................................................... 1776
Ricini oleum hydrogenatum ................................................ 1197 Scopolamine hydrobromide................................................... 1777
Ricini oleum virginale........................................................... 1197 Scopolamini butylbromidum ............................................... 1776
Rifabutin ....................................................................................2369 Scopolamini hydrobromidum.............................................. 1777
Rifabutinum..............................................................................2369 Scopolaminum.................................................................. 5.3-3519
Rifampicin..................................................................................2371 Selegiline hydrochloride ........................................................2400
Rifampicinum ..........................................................................2371 Selegilini hydrochloridum....................................................2400
Rifamycin sodium.....................................................................2372 Selenii disulfidum................................................................... 2401
Rifamycinum natricum .........................................................2372 Selenium disulphide................................................................ 2401
Rilmenidine dihydrogen phosphate .....................................2373 Semecarpus anacardium
Rilmenidini dihydrogenophosphas....................................2373 ad praeparationes homoeopathicas..........................5.3-3430
Risperidone ........................................................................5.3-3602 Semi-micro determination of water (2.5.12.) ....................... 130
Risperidonum ...................................................................5.3-3602 Semi-solid and liquid preparations, test for deliverable mass
Roman chamomile flower ......................................................1245 or volume (2.9.28.) .................................................................. 263
Rosae pseudo-fructus ............................................................. 1472 Semi-solid ear preparations ............................................5.2-3138
Roselle ........................................................................................ 2376 Semi-solid eye preparations ............................................5.3-3396
Rosemary leaf ...........................................................................2377 Semi-solid intrauterine preparations ............................5.3-3397

General Notices (1) apply to all monographs and other texts 3683
Index EUROPEAN PHARMACOPOEIA 5.3

Semi-solid nasal preparations...................................................611 Sodium carboxymethylcellulose, cross-linked ................... 1371


Semi-solid oromucosal preparations...................................... 612 Sodium carboxymethylcellulose, low-substituted............. 1190
Semi-solid preparations for cutaneous application ............ 624 Sodium cetostearyl sulphate .................................................2426
Semi-solid rectal preparations........................................ 5.2-3149 Sodium chloride.......................................................................2428
Semi-solid vaginal preparations.....................................5.2-3153 Sodium chromate (51Cr) sterile solution ............................... 840
Senega root ............................................................................... 2401 Sodium citrate ..........................................................................2429
Sennae folii extractum siccum normatum.......................2403 Sodium cromoglicate ..............................................................2429
Sennae folium..........................................................................2402 Sodium cyclamate....................................................................2430
Sennae fructus acutifoliae....................................................2404 Sodium dihydrogen phosphate dihydrate .......................... 2431
Sennae fructus angustifoliae ...............................................2405 Sodium fluoride .......................................................................2432
Senna leaf ..................................................................................2402 Sodium fluoride (18F) injection ............................................... 841
Senna leaf dry extract, standardised ...................................2403 Sodium fusidate .......................................................................2433
Senna pods, Alexandrian........................................................2404 Sodium glycerophosphate, hydrated ...................................2434
Senna pods, Tinnevelly...........................................................2405 Sodium hyaluronate ................................................................2434
Separation techniques, chromatographic (2.2.46.) .............. 69 Sodium hydrogen carbonate .................................................2437
Serine..........................................................................................2406 Sodium hydroxide....................................................................2437
Serinum.....................................................................................2406 Sodium iodide...........................................................................2438
Serpylli herba........................................................................... 2701 Sodium iodide (123I) injection .................................................. 842
Sertaconazole nitrate..............................................................2407 Sodium iodide (131I) capsules for diagnostic use................. 843
Sertaconazoli nitras ...............................................................2407 Sodium iodide (131I) capsules for therapeutic use .....5.2-3157
Sesame oil, refined ..................................................................2408 Sodium iodide (131I) solution ................................................... 844
Sesami oleum raffinatum .....................................................2408 Sodium iodide (131I) solution for radiolabelling .................. 845
Sets for the transfusion of blood and blood components Sodium iodohippurate (123I) injection ................................... 845
(3.2.6.) .........................................................................................313 Sodium iodohippurate (131I) injection ................................... 846
Shampoos .................................................................................... 608 Sodium lactate solution..........................................................2438
Shellac .......................................................................................2409 Sodium laurilsulfate ................................................................2440
Sialic acid in polysaccharide vaccines (2.5.23.)................... 133 Sodium metabisulphite........................................................... 2441
Sieves (2.1.4.) .................................................................................18 Sodium methyl parahydroxybenzoate................................. 2441
Sieve test (2.9.12.)...................................................................... 239 Sodium molybdate dihydrate ................................................2442
Sieving, analytical, particle-size distribution estimation by Sodium nitrite...........................................................................2443
(2.9.38.) .............................................................................5.3-3368 Sodium nitroprusside .............................................................2443
Silica ad usum dentalem....................................................... 2411 Sodium perborate, hydrated..................................................2444
Silica, colloidal anhydrous ..................................................... 2410 Sodium pertechnetate (99mTc) injection (fission) ................ 847
Silica, colloidal hydrated ........................................................ 2411 Sodium pertechnetate (99mTc) injection (non-fission) ........ 848
Silica colloidalis anhydrica.................................................. 2410 Sodium phosphate (32P) injection .......................................... 849
Silica colloidalis hydrica....................................................... 2411 Sodium picosulfate .................................................................2445
Silica, dental type..................................................................... 2411 Sodium polystyrene sulphonate ...........................................2446
Silicone elastomer for closures and tubing (3.1.9.)............ 288 Sodium propionate ..................................................................2447
Silicone oil used as a lubricant (3.1.8.) ................................. 287 Sodium propyl parahydroxybenzoate..................................2448
Silk suture, sterile, braided, in distributor for veterinary use Sodium salicylate .....................................................................2449
..................................................................................................... 887 Sodium selenite pentahydrate ..............................................2449
Silver, colloidal, for external use ...................................5.3-3613 Sodium (S)-lactate solution ...................................................2439
Silver nitrate ............................................................................. 2412 Sodium starch glycolate (type A) ..................................5.2-3272
Silybi mariani fructus............................................................2046 Sodium starch glycolate (type B) ..................................5.2-3273
Simeticone................................................................................. 2412 Sodium starch glycolate (type C) ......................................... 2451
Simeticonum ............................................................................ 2412 Sodium stearate .......................................................................2452
Simvastatin................................................................................ 2413 Sodium stearyl fumarate ........................................................2453
Simvastatinum......................................................................... 2413 Sodium sulphate, anhydrous.................................................2454
Single-dose preparations, uniformity of content (2.9.6.)... 234 Sodium sulphate decahydrate...............................................2455
Single-dose preparations, uniformity of mass (2.9.5.)........ 233 Sodium sulphite, anhydrous..................................................2455
Sintered-glass filters (2.1.2.) .......................................................17 Sodium sulphite heptahydrate..............................................2456
Size-exclusion chromatography (2.2.30.)................................ 45 Sodium thiosulphate........................................................5.1-3009
(S)-Lactic acid.....................................................................5.2-3227 Sodium valproate .....................................................................2457
Sodium acetate ([1-11C]) injection........................................... 839 Soft capsules ......................................................................5.2-3135
Sodium acetate trihydrate ..................................................... 2415 Softening time determination of lipophilic suppositories
Sodium alendronate ................................................................ 2416 (2.9.22.) ...................................................................................... 256
Sodium alginate ....................................................................... 2417 Soft extracts ................................................................................ 572
Sodium amidotrizoate............................................................. 2418 Soiae oleum hydrogenatum .................................................2475
Sodium aminosalicylate dihydrate ....................................... 2419 Soiae oleum raffinatum ........................................................ 2476
Sodium ascorbate ....................................................................2420 Solani amylum ........................................................................2288
Sodium aurothiomalate...................................................5.3-3613 Solidaginis herba .............................................................5.2-3213
Sodium benzoate ..................................................................... 2421 Solidaginis virgaureae herba........................................5.3-3507
Sodium bromide.......................................................................2422 Solid dosage forms, dissolution test for (2.9.3.).........5.3-3353
Sodium calcium edetate .........................................................2422 Solids, density of (2.2.42.).......................................................... 64
Sodium caprylate .....................................................................2423 Solids, pycnometric density of (2.9.23.) ................................ 257
Sodium carbonate, anhydrous .......................................5.1-3008 Solubility in alcohol of essential oils (2.8.10.) ......................216
Sodium carbonate decahydrate .....................................5.1-3008 Soluble tablets................................................................... 5.2-3151
Sodium carbonate monohydrate ...................................5.1-3009 Solutiones ad conservationem partium corporis...........2458
Sodium carboxymethylcellulose ........................................... 1189

3684 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Solutiones ad haemocolaturam Spironolactone .........................................................................2482


haemodiacolaturamque ...................................................... 1703 Spironolactonum ....................................................................2482
Solutiones ad haemodialysim ............................................. 1700 Spot-on preparations................................................................. 631
Solutiones ad peritonealem dialysim................................ 2212 Sprays ........................................................................................... 631
Solutiones anticoagulantes et sanguinem humanum Squalane ....................................................................................2483
conservantes .......................................................................... 1007 Squalanum................................................................................2483
Solutions for haemodialysis................................................... 1700 Standard solutions for limit tests (4.1.2.) ............................. 426
Solutions for haemodialysis, concentrated, water for Standard solutions for limit tests (4.1.2.) .................... 5.1-2818
diluting..................................................................................... 1699 Stanni colloidalis et technetii (99mTc)
Solutions for haemofiltration and for haemodiafiltra- solutio iniectabilis .................................................................. 853
tion............................................................................................ 1703 Stanni pyrophosphatis et technetii (99mTc) solutio
Solutions for organ preservation..........................................2458 iniectabilis ................................................................................ 865
Solutions for peritoneal dialysis ........................................... 2212 Stannosi chloridum dihydricum.........................................2486
Solutions, suspensions, intrauterine ............................5.3-3397 Stannous chloride dihydrate .................................................2486
Solvents, residual (5.4.) ............................................................ 507 Stanozolol..................................................................................2486
Solvents, residual, identification and control (2.4.24.)...... 113 Stanozololum ...........................................................................2486
Somatostatin .............................................................................2459 Star anise...................................................................................2487
Somatostatinum ......................................................................2459 Star anise oil .............................................................................2488
Somatropin......................................................................... 5.3-3614 Starch glycolate (type A), sodium .................................5.2-3272
Somatropin bulk solution ............................................... 5.3-3616 Starch glycolate (type B), sodium .................................5.2-3273
Somatropin for injection .................................................5.3-3619 Starch glycolate (type C), sodium ........................................ 2451
Somatropini solutio ad praeparationem ................... 5.3-3616 Starch, maize .....................................................................5.1-2965
Somatropinum.................................................................. 5.3-3614 Starch, potato ...........................................................................2288
Somatropinum ad iniectabilium..................................5.3-3619 Starch, pregelatinised .............................................................2490
Sorbic acid.................................................................................2467 Starch, rice ................................................................................2369
Sorbitani lauras.......................................................................2467 Starch, wheat ............................................................................2698
Sorbitani oleas.........................................................................2468 Statistical analysis of results of biological assays and tests
Sorbitani palmitas ..................................................................2468 (5.3.)............................................................................................ 475
Sorbitani sesquioleas .............................................................2468 Stavudine............................................................................5.1-3012
Sorbitani stearas .....................................................................2469 Stavudinum .......................................................................5.1-3012
Sorbitani trioleas ....................................................................2469 Steam sterilisation of aqueous preparations, application of
Sorbitan laurate .......................................................................2467 the F0 concept (5.1.5.)....................................................5.1-2821
Sorbitan oleate .........................................................................2468 Stearic acid................................................................................2490
Sorbitan palmitate ...................................................................2468 Stearoyl macrogolglycerides ..........................................5.2-3274
Sorbitan sesquioleate..............................................................2468 Stearyl alcohol...................................................................5.3-3621
Sorbitan stearate......................................................................2469 Sterile braided silk suture in distributor for veterinary
Sorbitan trioleate.....................................................................2469 use............................................................................................... 887
Sorbitol.......................................................................................2470 Sterile catgut............................................................................... 873
Sorbitol, liquid (crystallising)................................................2471 Sterile catgut in distributor for veterinary use ................... 885
Sorbitol, liquid (non-crystallising)........................................2472 Sterile containers of plasticised poly (vinyl chloride)
Sorbitol, liquid, partially dehydrated...................................2473 for human blood containing anticoagulant solution
Sorbitolum ................................................................................2470 (3.2.5.) ........................................................................................ 312
Sorbitolum liquidum cristallisabile....................................2471 Sterile linen thread in distributor for veterinary use......... 886
Sorbitolum liquidum non cristallisabile...........................2472 Sterile non-absorbable strands in distributor for veterinary
Sorbitolum liquidum partim deshydricum ......................2473 use............................................................................................... 888
Sotalol hydrochloride ............................................................. 2474 Sterile non-absorbable sutures ......................................5.3-3423
Sotaloli hydrochloridum ....................................................... 2474 Sterile plastic containers for human blood and blood
Soya-bean oil, hydrogenated..................................................2475 components (3.2.3.) ................................................................. 309
Soya-bean oil, refined.............................................................. 2476 Sterile polyamide 6/6 suture in distributor for veterinary
Specific surface area by air permeability (2.9.14.).............. 239 use............................................................................................... 887
Specific surface area by gas adsorption (2.9.26.) ...... 5.1-2811 Sterile polyamide 6 suture in distributor for veterinary
Spectinomycin hydrochloride................................................ 2476 use............................................................................................... 886
Spectinomycini hydrochloridum........................................ 2476 Sterile poly(ethylene terephthalate) suture in distributor for
Spectrometry, atomic absorption (2.2.23.)............................. 36 veterinary use ........................................................................... 887
Spectrometry, atomic emission (2.2.22.)................................. 35 Sterile products, methods of preparation (5.1.1.)............... 445
Spectrometry, mass (2.2.43.) ..................................................... 65 Sterile single-use plastic syringes (3.2.8.)..............................314
Spectrometry, nuclear magnetic resonance (2.2.33.) ...........51 Sterile synthetic absorbable braided sutures ...................... 878
Spectrometry, Raman (2.2.48.) ................................................. 79 Sterile synthetic absorbable monofilament sutures........... 880
Spectrometry, X-ray fluorescence (2.2.37.)............................. 56 Sterilisation procedures, biological indicators (5.1.2.) ...... 447
Spectrophotometry, infrared absorption (2.2.24.)................ 37 Sterility (2.6.1.) ........................................................................... 145
Spectrophotometry, near-infrared (2.2.40.)............................ 59 Sterols in fatty oils (2.4.23.)............................................5.1-2787
Spectrophotometry, ultraviolet and visible absorption Sticks ............................................................................................ 626
(2.2.25.) .............................................................................5.2-3089 Sticks, intrauterine ...........................................................5.3-3397
SPF chicken flocks for the production and quality control of Sticks, nasal..................................................................................611
vaccines (5.2.2.)...............................................................5.1-2825 St. John’s wort..........................................................................2485
Spiramycin.......................................................................... 5.1-3010 Stomata and stomatal index (2.8.3.) ...................................... 215
Spiramycinum .................................................................. 5.1-3010 Stramonii folium .....................................................................2492
Spirapril hydrochloride monohydrate.................................2480 Stramonii pulvis normatus...................................................2494
Spiraprili hydrochloridum monohydricum .....................2480 Stramonium leaf.......................................................................2492

General Notices (1) apply to all monographs and other texts 3685
Index EUROPEAN PHARMACOPOEIA 5.3

Stramonium, prepared ............................................................2494 Sumatriptani succinas...........................................................2522


Strands, sterile non-absorbable, in distributor for veterinary Sumatriptan succinate............................................................2522
use .............................................................................................. 888 Sunflower oil, refined .............................................................2524
Streptokinase bulk solution ...........................................5.3-3622 Supercritical fluid chromatography (2.2.45.) ........................ 68
Streptokinasi solutio ad praeparationem ..................5.3-3622 Suppositories ..................................................................... 5.2-3149
Streptomycini sulfas...............................................................2496 Suppositories and pessaries, disintegration of (2.9.2.)...... 227
Streptomycin sulphate ............................................................2496 Suppositories and pessaries, resistance to rupture
Strontii (89Sr) chloridi solutio iniectabilis.......................... 850 (2.9.24.) ...................................................................................... 258
Strontium (89Sr) chloride injection ........................................ 850 Suppositories, lipophilic, softening time determination
Styli............................................................................................... 626 (2.9.22.) ...................................................................................... 256
Subdivision of tablets.......................................................5.2-3150 Suspensions, solutions, intrauterine ............................5.3-3397
Sublingual tablets and buccal tablets ................................... 613 Sutures, sterile non-absorbable .....................................5.3-3423
Substances for pharmaceutical use ....................................... 586 Sutures, sterile synthetic absorbable braided .................... 878
Substances for pharmaceutical use, control of impurities Sutures, sterile synthetic absorbable monofilament ........ 880
(5.10.).......................................................................................... 559 Suxamethonii chloridum ......................................................2525
Substances of animal origin for the production of veterinary Suxamethonium chloride.......................................................2525
vaccines (5.2.5.)........................................................................ 460 Suxibuzone................................................................................2525
Sub-visible particles, particulate contamination (2.9.19.).. 253 Suxibuzonum ...........................................................................2525
Succinylsulfathiazole ..............................................................2498 Sweet fennel..............................................................................1580
Succinylsulfathiazolum.........................................................2498 Sweet orange oil.......................................................................2526
Sucrose.......................................................................................2499 Swelling index (2.8.4.)............................................................... 215
Sufentanil .................................................................................. 2501 Swine erysipelas vaccine (inactivated) .................................. 793
Sufentanil citrate .....................................................................2502 Swine-fever vaccine (live), classical, freeze-dried ................ 793
Sufentanili citras.....................................................................2502 Symbols and abbreviations (1.5.).................................................9
Sufentanilum............................................................................ 2501 Synthetic absorbable braided sutures, sterile ..................... 878
Sugars, lead in (2.4.10.) ............................................................ 107 Synthetic absorbable monofilament sutures, sterile.......... 880
Sugar spheres ...........................................................................2503 Syringes, plastic, sterile single-use (3.2.8.)............................314
Sulfacetamide sodium.............................................................2504 Syrups.................................................................................. 5.2-3143
Sulfacetamidum natricum....................................................2504
Sulfadiazine...............................................................................2505 T
Sulfadiazinum .........................................................................2505 Table of physical characteristics of radionuclides mentioned
Sulfadimidine............................................................................2506 in the European Pharmacopoeia (5.7.) ............................... 539
Sulfadimidinum.......................................................................2506 Tablets .................................................................................5.2-3150
Sulfadoxine................................................................................2507 Tablets and capsules, disintegration of (2.9.1.) ..........5.3-3351
Sulfadoxinum...........................................................................2507 Tablets, buccal ............................................................................ 613
Sulfafurazole.............................................................................2508 Tablets, coated................................................................... 5.2-3151
Sulfafurazolum ........................................................................2508 Tablets, dispersible ........................................................... 5.2-3151
Sulfaguanidine..........................................................................2508 Tablets, effervescent ......................................................... 5.2-3151
Sulfaguanidinum ....................................................................2508 Tablets for intrauterine solutions and suspensions ..5.3-3397
Sulfamerazine...........................................................................2509 Tablets for use in the mouth ..........................................5.2-3152
Sulfamerazinum......................................................................2509 Tablets for vaginal solutions and suspensions ...........5.2-3153
Sulfamethizole.......................................................................... 2510 Tablets, gastro-resistant...................................................5.2-3152
Sulfamethizolum ..................................................................... 2510 Tablets, intrauterine .........................................................5.3-3397
Sulfamethoxazole .............................................................5.3-3623 Tablets, modified-release ................................................. 5.2-3151
Sulfamethoxazolum.........................................................5.3-3623 Tablets, orodispersible ..................................................... 5.2-3151
Sulfamethoxypyridazine for veterinary use ....................... 2512 Tablets, resistance to crushing (2.9.8.) ................................. 235
Sulfamethoxypyridazinum ad usum veterinarium ....... 2512 Tablets, soluble.................................................................. 5.2-3151
Sulfanilamide ............................................................................ 2513 Tablets, sublingual..................................................................... 613
Sulfanilamidum....................................................................... 2513 Tablets, uncoated ..............................................................5.2-3150
Sulfasalazine ............................................................................. 2514 Tablets, uncoated, friability of (2.9.7.) .......................... 5.2-3103
Sulfasalazinum........................................................................ 2514 Tablets, vaginal..................................................................5.2-3153
Sulfathiazole ............................................................................. 2516 Talc....................................................................................... 5.1-3017
Sulfathiazolum ........................................................................ 2516 Talcum ................................................................................ 5.1-3017
Sulfinpyrazone ......................................................................... 2517 Tamoxifen citrate .............................................................. 5.1-3018
Sulfinpyrazonum .................................................................... 2517 Tamoxifeni citras.............................................................. 5.1-3018
Sulfisomidine ............................................................................ 2518 Tamponae medicatae ............................................................... 628
Sulfisomidinum....................................................................... 2518 Tampons, ear......................................................................5.2-3138
Sulfur ad usum externum.....................................................2520 Tampons, medicated ................................................................. 628
Sulfuris colloidalis et technetii (99mTc) solutio Tampons, rectal .................................................................5.2-3150
iniectabilis ................................................................................ 852 Tampons, vaginal, medicated .........................................5.2-3154
Sulindac ..................................................................................... 2518 Tanaceti parthenii herba ......................................................1592
Sulindacum .............................................................................. 2518 Tannic acid ................................................................................2534
Sulphated ash (2.4.14.) ....................................................5.3-3341 Tannins in herbal drugs, determination of (2.8.14.) .......... 221
Sulphates (2.4.13.) ..................................................................... 108 Tanninum .................................................................................2534
Sulphur dioxide (2.5.29.).......................................................... 136 Tartaric acid ..............................................................................2534
Sulphur for external use ........................................................2520 Teat dips....................................................................................... 631
Sulphuric acid...........................................................................2520 Tea tree oil .................................................................................2534
Sulpiride..................................................................................... 2521 Teat sprays................................................................................... 631
Sulpiridum................................................................................ 2521 Technetii (99mTc) et etifenini solutio iniectabilis............... 853

3686 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Technetii (99mTc) exametazimi solutio iniectabilis ........... 854 Tetanus, diphtheria, pertussis (acellular, component),
Technetii (99mTc) gluconatis solutio iniectabilis................ 856 poliomyelitis (inactivated) and haemophilus type b
Technetii (99mTc) humani albumini solutio iniectabilis .. 856 conjugate vaccine (adsorbed)................................................ 653
Technetii (99mTc) macrosalbi suspensio iniectabilis......... 858 Tetanus, diphtheria, pertussis and poliomyelitis (inactivated)
Technetii (99mTc) medronati solutio iniectabilis................ 859 vaccine (adsorbed)................................................................... 656
Technetii (99mTc) mertiatidi solutio iniectabilis................. 860 Tetanus, diphtheria, pertussis, poliomyelitis (inactivated) and
Technetii (99mTc) microsphaerarum suspensio haemophilus type b conjugate vaccine (adsorbed) .......... 657
iniectabilis ................................................................................ 861 Tetanus immunoglobulin, human ........................................ 1751
Technetii (99mTc) pentetatis solutio iniectabilis................. 862 Tetanus vaccine (adsorbed) ..................................................... 702
Technetii (99mTc) sestamibi solutio iniectabilis.................. 863 Tetanus vaccine (adsorbed), assay of (2.7.8.) ..............5.1-2791
Technetii (99mTc) succimeri solutio iniectabilis................. 865 Tetanus vaccine for veterinary use ........................................ 795
Technetium (99mTc) colloidal rhenium sulphide injection Tetracaine hydrochloride .......................................................2546
..................................................................................................... 851 Tetracaini hydrochloridum ..................................................2546
Technetium (99mTc) colloidal sulphur injection ................... 852 Tetracosactide...........................................................................2547
Technetium (99mTc) colloidal tin injection ............................ 853 Tetracosactidum ......................................................................2547
Technetium (99mTc) etifenin injection .................................... 853 Tetracycline ...............................................................................2549
Technetium (99mTc) exametazime injection .......................... 854 Tetracycline hydrochloride .................................................... 2551
Technetium (99mTc) gluconate injection ................................ 856 Tetracyclini hydrochloridum ............................................... 2551
Technetium (99mTc) human albumin injection ..................... 856 Tetracyclinum ..........................................................................2549
Technetium (99mTc) macrosalb injection................................ 858 Tetrazepam ................................................................................2552
Technetium (99mTc) medronate injection............................... 859 Tetrazepamum .........................................................................2552
Technetium (99mTc) mertiatide injection ............................... 860 Tetryzoline hydrochloride...............................................5.1-3020
Technetium (99mTc) microspheres injection.......................... 861 Tetryzolini hydrochloridum..........................................5.1-3020
Technetium (99mTc) pentetate injection................................. 862 Thallosi (201Tl) chloridi solutio iniectabilis......................... 867
Technetium (99mTc) sestamibi injection ................................. 863 Thallous (201Tl) chloride injection........................................... 867
Technetium (99mTc) succimer injection.................................. 865 Theobromine.............................................................................2554
Technetium (99mTc) tin pyrophosphate injection................. 865 Theobrominum ........................................................................2554
Temazepam................................................................................2535 Theophylline .............................................................................2554
Temazepamum ........................................................................2535 Theophylline-ethylenediamine ..............................................2557
Tenosynovitis avian viral vaccine (live) ................................. 729 Theophylline-ethylenediamine hydrate ...............................2557
Tenoxicam..................................................................................2537 Theophylline monohydrate....................................................2555
Tenoxicamum ..........................................................................2537 Theophyllinum.........................................................................2554
Terbinafine hydrochloride...............................................5.3-3627 Theophyllinum et ethylenediaminum ...............................2557
Terbinafini hydrochloridum .........................................5.3-3627 Theophyllinum et ethylenediaminum hydricum............2557
Terbutaline sulphate ...............................................................2538 Theophyllinum monohydricum ..........................................2555
Terbutalini sulfas ....................................................................2538 Thermal analysis (2.2.34.). ......................................................... 52
Terconazole ...............................................................................2539 Thermogravimetry (2.2.34.)....................................................... 52
Terconazolum ..........................................................................2539 Thiamazole ................................................................................2558
Terebinthini aetheroleum ab pinum pinastrum .............2645 Thiamazolum ...........................................................................2558
Terfenadine................................................................................2540 Thiamine hydrochloride .........................................................2559
Terfenadinum...........................................................................2540 Thiamine nitrate....................................................................... 2561
Terminology used in monographs on vaccines (5.2.1.) ..... 453 Thiamini hydrochloridum ....................................................2559
tert-Butylamini perindoprilum.....................................5.3-3589 Thiamini nitras........................................................................ 2561
Test for anticomplementary activity of immunoglobulin Thiamphenicol ..........................................................................2562
(2.6.17.)....................................................................................... 170 Thiamphenicolum...................................................................2562
Test for anti-D antibodies in human immunoglobulin for Thin-layer chromatography (2.2.27.).............................5.2-3090
intravenous administration (2.6.26.) ..........................5.3-3348 Thiomersal..........................................................................5.1-3021
Test for deliverable mass or volume of liquid and semi-solid Thiomersalum...................................................................5.1-3021
preparations (2.9.28.).............................................................. 263 Thiopental sodium and sodium carbonate.........................2564
Test for extractable volume of parenteral preparations Thiopentalum natricum et natrii carbonas .....................2564
(2.9.17.)..............................................................................5.3-3363 Thioridazine ..............................................................................2565
Test for Fc function of immunoglobulin (2.7.9.) ................. 202 Thioridazine hydrochloride ...................................................2566
Test for methanol and 2-propanol (2.9.11.) .................5.3-3362 Thioridazini hydrochloridum..............................................2566
Test for neurovirulence of live virus vaccines (2.6.18.) ..... 172 Thioridazinum.........................................................................2565
Test for neurovirulence of poliomyelitis vaccine (oral) Three-lobed sage leaf...............................................................2390
(2.6.19.) ...................................................................................... 172 Threonine...................................................................................2566
Testosterone..............................................................................2542 Threoninum..............................................................................2566
Testosterone enantate.............................................................2544 Thyme .........................................................................................2567
Testosterone propionate.........................................................2545 Thyme oil ..................................................................................2569
Testosteroni enantas ..............................................................2544 Thyme, wild ............................................................................... 2701
Testosteroni propionas ..........................................................2545 Thymi aetheroleum ................................................................2569
Testosteronum..........................................................................2542 Thymi herba .............................................................................2567
Tests for extraneous agents in viral vaccines for human use Thymol........................................................................................2570
(2.6.16.) ...................................................................................... 169 Thymolum .................................................................................2570
Tetanus antitoxin for human use ........................................... 805 Tiabendazole .............................................................................2570
Tetanus antitoxin for veterinary use.............................5.1-2868 Tiabendazolum ........................................................................2570
Tetanus, diphtheria and hepatitis B (rDNA) vaccine Tiamulin for veterinary use ...................................................2571
(adsorbed).................................................................................. 641 Tiamulin hydrogen fumarate for veterinary use ...............2573
Tiamulini hydrogenofumaras ad usum veterinarium ..2573

General Notices (1) apply to all monographs and other texts 3687
Index EUROPEAN PHARMACOPOEIA 5.3

Tiamulinum ad usum veterinarium ..................................2571 Tranexamic acid .......................................................................2609


Tianeptine sodium ...................................................................2575 Transdermal patches ........................................................ 5.2-3146
Tianeptinum natricum ..........................................................2575 Transdermal patches, dissolution test for (2.9.4.) .............. 231
Tiapride hydrochloride ...........................................................2577 Trapidil ....................................................................................... 2610
Tiapridi hydrochloridum ......................................................2577 Trapidilum ................................................................................ 2610
Tiaprofenic acid ........................................................................2578 Tretinoin .................................................................................... 2611
Ticarcillin sodium..............................................................5.3-3628 Tretinoinum.............................................................................. 2611
Ticarcillinum natricum ..................................................5.3-3628 Triacetin ..................................................................................... 2612
Tick-borne encephalitis vaccine (inactivated) ............. 5.3-3414 Triacetinum .............................................................................. 2612
Ticlopidine hydrochloride ...................................................... 2581 Triamcinolone........................................................................... 2613
Ticlopidini hydrochloridum................................................. 2581 Triamcinolone acetonide........................................................ 2614
Tiliae flos................................................................................... 1914 Triamcinolone hexacetonide ................................................. 2616
Tilidine hydrochloride hemihydrate ....................................2582 Triamcinoloni acetonidum................................................... 2614
Tilidini hydrochloridum hemihydricum...........................2582 Triamcinoloni hexacetonidum............................................ 2616
Timololi maleas .......................................................................2584 Triamcinolonum ..................................................................... 2613
Timolol maleate ........................................................................2584 Triamterene ............................................................................... 2617
Tincturae ..................................................................................... 571 Triamterenum .......................................................................... 2617
Tincturae maternae Tribenoside................................................................................ 2617
ad praeparationes homoeopathicas................................... 894 Tribenosidum ........................................................................... 2617
Tinctures ...................................................................................... 571 Tributyl acetylcitrate ............................................................... 2619
Tinidazole ..................................................................................2585 Tributylis acetylcitras............................................................. 2619
Tinidazolum .............................................................................2585 Tricalcii phosphas................................................................... 1167
Tinnevelly senna pods.............................................................2405 Trichloroacetic acid .................................................................2620
Tinzaparin sodium ...................................................................2586 Triethanolamine .......................................................................2632
Tinzaparinum natricum .......................................................2586 Triethyl citrate ..........................................................................2620
Tioconazole ...............................................................................2586 Triethylis citras ........................................................................2620
Tioconazolum ..........................................................................2586 Trifluoperazine hydrochloride .............................................. 2621
Titanii dioxidum......................................................................2587 Trifluoperazini hydrochloridum......................................... 2621
Titanium dioxide ......................................................................2587 Triflusal ......................................................................................2622
Titration, amperometric (2.2.19.).............................................. 34 Triflusalum ...............................................................................2622
Titration, potentiometric (2.2.20.)............................................ 35 Triglycerida saturata media.................................................2623
Titrations, complexometric (2.5.11.) ...................................... 130 Triglycerides, medium-chain..................................................2623
Tobramycin .........................................................................5.3-3629 Triglycerides, omega-3-acid.................................................... 2144
Tobramycinum..................................................................5.3-3629 Trigonellae foenugraeci semen...........................................1588
α-Tocopherol acetate concentrate (powder form) ............2592 Trihexyphenidyl hydrochloride.............................................2625
Tocopherol, all-rac-α- .......................................................5.3-3631 Trihexyphenidyli hydrochloridum .....................................2625
α-Tocopheroli acetatis pulvis ...............................................2592 Trimetazidine dihydrochloride..............................................2626
Tocopherol, RRR-α- ................................................................. 2591 Trimetazidini dihydrochloridum........................................2626
Tocopheryl acetate, all-rac-α- .........................................5.3-3632 Trimethadione ..........................................................................2627
Tocopheryl acetate, RRR-α-...................................................2595 Trimethadionum .....................................................................2627
Tocopheryl hydrogen succinate, DL-α- ................................2597 Trimethoprim............................................................................2628
Tocopheryl hydrogen succinate, RRR-α- .....................5.1-3026 Trimethoprimum.....................................................................2628
Tolbutamide ..............................................................................2600 Trimipramine maleate.............................................................2630
Tolbutamidum..........................................................................2600 Trimipramini maleas .............................................................2630
Tolfenamic acid......................................................................... 2601 Tri-n-butylis phosphas............................................................ 2631
Tolnaftate ..................................................................................2602 Tri-n-butyl phosphate .............................................................. 2631
Tolnaftatum ..............................................................................2602 Tritiated (3H) water injection................................................... 867
Tolu balsam ...............................................................................2603 Tritici aestivi oleum raffinatum ..........................................2699
Torasemide, anhydrous....................................................5.2-3279 Tritici aestivi oleum virginale..............................................2699
Torasemidum anhydricum ............................................5.2-3279 Tritici amylum .........................................................................2698
Tormentil ...................................................................................2604 Trolamine...................................................................................2632
Tormentillae rhizoma ............................................................2604 Trolaminum..............................................................................2632
Tormentillae tinctura .............................................................2605 Trometamol ...............................................................................2633
Tormentil tincture....................................................................2605 Trometamolum ........................................................................2633
Tosylchloramide sodium.........................................................2605 Tropicamide...............................................................................2634
Tosylchloramidum natricum ...............................................2605 Tropicamidum .........................................................................2634
Total ash (2.4.16.)....................................................................... 108 Trospii chloridum ............................................................5.2-3281
Total organic carbon in water for pharmaceutical use Trospium chloride.............................................................5.2-3281
(2.2.44.) ........................................................................................ 68 Troxerutin...........................................................................5.3-3634
Total protein (2.5.33.) ............................................................... 138 Troxerutinum ....................................................................5.3-3634
Toxicity, abnormal (2.6.9.)........................................................ 153 Trypsin .......................................................................................2635
Toxin, botulinum type A for injection...................................1117 Trypsinum.................................................................................2635
Toxinum botulinicum typum A ad iniectabile .................1117 Tryptophan................................................................................2636
Tragacanth ................................................................................2606 Tryptophanum .........................................................................2636
Tragacantha..............................................................................2606 TSE, animal, minimising the risk of transmitting via human
Tramadol hydrochloride .........................................................2607 and veterinary medicinal products (5.2.8.) ........................ 463
Tramadoli hydrochloridum ..................................................2607 TSE, animal, products with risk of transmitting agents
Tramazoline hydrochloride monohydrate ...................5.3-3633 of.................................................................................................. 577
Tramazolini hydrochloridum monohydricum .........5.3-3633 Tuberculin for human use, old..............................................2638

3688 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Tuberculini aviarii derivatum proteinosum Vaccines, adsorbed, aluminium in (2.5.13.)...........................131


purificatum.............................................................................2640 Vaccines, adsorbed, calcium in (2.5.14.).................................131
Tuberculini bovini derivatum proteinosum Vaccines and immunosera, phenol in (2.5.15.).....................131
purificatum............................................................................. 2641 Vaccines and immunosera, veterinary, evaluation of efficacy
Tuberculini derivatum proteinosum purificatum ad usum (5.2.7.)................................................................................5.1-2829
humanum ...............................................................................2642 Vaccines and immunosera, veterinary, evaluation of safety
Tuberculin purified protein derivative, avian ....................2640 (5.2.6.) ...............................................................................5.1-2827
Tuberculin purified protein derivative, bovine.................. 2641 Vaccines and immunosera, veterinary, evaluation of the
Tuberculin purified protein derivative for human use ....2642 safety of each batch (5.2.9.)..........................................5.1-2830
Tuberculinum pristinum ad usum humanum ................2638 Vaccines for human use...................................................5.2-3129
Tubes for comparative tests (2.1.5.) ..........................................19 Vaccines for human use, cell substrates for the production of
Tubing and closures, silicone elastomer for (3.1.9.)........... 288 (5.2.3.) ........................................................................................ 455
Tubing and containers for total parenteral nutrition Vaccines for human use, viral, extraneous agents in
preparations, poly(ethylene - vinyl acetate) for (3.1.7.) ... 285 (2.6.16.) ...................................................................................... 169
Tubing used in sets for the transfusion of blood and blood Vaccines for veterinary use.............................................5.3-3387
components, materials based on plasticised poly(vinyl Vaccines, polysaccharide, hexosamines in (2.5.20.)............ 132
chloride) for (3.1.1.2.) ............................................................. 272 Vaccines, polysaccharide, methylpentoses in (2.5.21.)....... 133
Tubocurarine chloride ............................................................2644 Vaccines, polysaccharide, nucleic acids in (2.5.17.) ............ 132
Tubocurarini chloridum........................................................2644 Vaccines, polysaccharide, O-acetyl in (2.5.19.)..................... 132
Turmeric, javanese...................................................................2645 Vaccines, polysaccharide, phosphorus in (2.5.18.) ............. 132
Turpentine oil, Pinus pinaster type .....................................2645 Vaccines, polysaccharide, protein in (2.5.16.) .......................131
Tylosin for veterinary use ......................................................2647 Vaccines, polysaccharide, ribose in (2.5.31.) ........................ 137
Tylosini phosphatis solutio ad usum veterinarium .......2648 Vaccines, polysaccharide, sialic acid in (2.5.23.) ................. 133
Tylosini tartras ad usum veterinarium .............................2650 Vaccines, polysaccharide, uronic acids in (2.5.22.)............. 133
Tylosin phosphate bulk solution for veterinary use ........2648 Vaccines, SPF chicken flocks for the production and quality
Tylosin tartrate for veterinary use .......................................2650 control of (5.2.2.) ...........................................................5.1-2825
Tylosinum ad usum veterinarium......................................2647 Vaccines, terminology (5.2.1.) ................................................. 453
Typhoid polysaccharide vaccine ............................................. 705 Vaccines, veterinary, cell cultures for the production of
Typhoid vaccine.......................................................................... 707 (5.2.4.) ........................................................................................ 458
Typhoid vaccine, freeze-dried.................................................. 707 Vaccines, veterinary, substances of animal origin for the
Typhoid vaccine (live, oral, strain Ty 21a)............................ 708 production of (5.2.5.) .............................................................. 460
Tyrosine...................................................................................... 2651 Vaccines, viral live, test for neurovirulence (2.6.18.).......... 172
Tyrosinum................................................................................. 2651 Vaccinum actinobacillosis inactivatum ad suem ............. 784
Tyrothricin..........................................................................5.1-3028 Vaccinum adenovirosidis caninae vivum........................... 738
Tyrothricinum...................................................................5.1-3028 Vaccinum adenovirosis caninae inactivatum ................... 738
Vaccinum anaemiae infectivae pulli vivum....................... 769
U Vaccinum anthracis vivum ad usum veterinarium.......... 715
Ubidecarenone..........................................................................2657 Vaccinum aphtharum epizooticarum inactivatum ad
Ubidecarenonum.....................................................................2657 ruminantes ......................................................................5.1-2860
Udder-washes .............................................................................. 631 Vaccinum bronchitidis infectivae aviariae inactivatum.. 718
Ultraviolet absorption spectrophotometry (2.2.25.) ..5.2-3089 Vaccinum bronchitidis infectivae aviariae vivum............ 720
Ultraviolet ray lamps for analytical purposes (2.1.3.)............17 Vaccinum brucellosis (Brucella melitensis stirpe Rev. 1)
Uncoated tablets................................................................5.2-3150 vivum cryodesiccatum ad usum veterinarium ......5.1-2859
Undecylenic acid ......................................................................2658 Vaccinum bursitidis infectivae aviariae inactivatum...... 722
Uniformity of content of single-dose preparations Vaccinum bursitidis infectivae aviariae vivum................. 723
(2.9.6.) ........................................................................................ 234 Vaccinum calicivirosis felinae inactivatum ....................... 757
Uniformity of dosage units (2.9.40.) .............................5.3-3370 Vaccinum calicivirosis felinae vivum cryodesiccatum ... 758
Uniformity of mass of delivered doses from multidose Vaccinum cholerae ................................................................... 637
containers (2.9.27.).................................................................. 263 Vaccinum cholerae aviariae inactivatum..................5.1-2861
Uniformity of mass of single-dose preparations (2.9.5.) .... 233 Vaccinum cholerae cryodesiccatum..................................... 638
Units of the International System (SI) used in the Vaccinum clostridii botulini ad usum veterinarium ....... 745
Pharmacopoeia and equivalence with other units (1.6.) ...10 Vaccinum clostridii chauvoei ad usum veterinarium ..... 745
Unsaponifiable matter (2.5.7.) ................................................. 129 Vaccinum clostridii novyi B ad usum veterinarium ....... 746
Urea.............................................................................................2658 Vaccinum clostridii perfringentis
Ureum.........................................................................................2658 ad usum veterinarium........................................................... 747
Urofollitropin ............................................................................2659 Vaccinum clostridii septici ad usum veterinarium.......... 749
Urofollitropinum .....................................................................2659 Vaccinum colibacillosis fetus a partu recentis inactivatum
Urokinase................................................................................... 2661 ad ruminantes ......................................................................... 778
Urokinasum .............................................................................. 2661 Vaccinum colibacillosis fetus a partu recentis inactivatum
Uronic acids in polysaccharide vaccines (2.5.22.)............... 133 ad suem ..................................................................................... 776
Ursodeoxycholic acid .............................................................2662 Vaccinum diarrhoeae viralis bovinae inactivatum .......... 734
Urtica dioica ad praeparationes homoeopathicas ..5.3-3429 Vaccinum diphtheriae adsorbatum ...................................... 660
Urticae folium ...................................................................5.3-3563 Vaccinum diphtheriae adulti et adulescentis
Uvae ursi folium ...................................................................... 1054 adsorbatum............................................................................... 661
Vaccinum diphtheriae et tetani adsorbatum ..................... 639
Vaccinum diphtheriae et tetani adulti et adulescentis
V
adsorbatum............................................................................... 639
Vaccina ad usum humanum .........................................5.2-3129 Vaccinum diphtheriae, tetani et hepatitidis B (ADNr)
Vaccina ad usum veterinarium ....................................5.3-3387 adsorbatum............................................................................... 641

General Notices (1) apply to all monographs and other texts 3689
Index EUROPEAN PHARMACOPOEIA 5.3

Vaccinum diphtheriae, tetani et pertussis adsorbatum .. 643 Vaccinum morbi Aujeszkyi ad suem vivum cryodesiccatum
Vaccinum diphtheriae, tetani et pertussis sine cellulis ex ad usum parenterale ...............................................................717
elementis praeparatum adsorbatum.................................. 642 Vaccinum morbi Carrei vivum cryodesiccatum ad canem
Vaccinum diphtheriae, tetani, pertussis et poliomyelitidis ..................................................................................................... 740
inactivatum adsorbatum....................................................... 656 Vaccinum morbi Carrei vivum cryodesiccatum ad
Vaccinum diphtheriae, tetani, pertussis, poliomyelitidis mustelidas................................................................................. 751
inactivatum et haemophili stirpe b coniugatum Vaccinum morbillorum, parotitidis et rubellae vivum.... 678
adsorbatum............................................................................... 657 Vaccinum morbillorum vivum............................................... 679
Vaccinum diphtheriae, tetani, pertussis sine cellulis ex Vaccinum morbi Marek vivum .............................................. 774
elementis praeparatum et haemophili stirpe b coniugatum Vaccinum morbi partus diminutionis MCMLXXVI
adsorbatum............................................................................... 645 inactivatum ad pullum .......................................................... 753
Vaccinum diphtheriae, tetani, pertussis sine cellulis Vaccinum myxomatosidis vivum ad cuniculum ............... 775
ex elementis praeparatum et hepatitidis B (ADNr) Vaccinum panleucopeniae felinae infectivae
adsorbatum............................................................................... 647 inactivatum .............................................................................. 759
Vaccinum diphtheriae, tetani, pertussis sine cellulis ex Vaccinum panleucopeniae felinae infectivae vivum....... 760
elementis praeparatum et poliomyelitidis inactivatum Vaccinum parainfluenzae viri bovini vivum
adsorbatum............................................................................... 648 cryodesiccatum ....................................................................... 732
Vaccinum diphtheriae, tetani, pertussis sine cellulis Vaccinum parainfluenzae viri canini vivum..................... 742
ex elementis praeparatum, hepatitidis B (ADNr), Vaccinum paramyxoviris 3 aviarii inactivatum ............... 728
poliomyelitidis inactivatum et haemophili stirpe b Vaccinum parotitidis vivum ................................................... 684
coniugatum adsorbatum....................................................... 650 Vaccinum parvovirosis caninae inactivatum .................... 743
Vaccinum diphtheriae, tetani, pertussis sine cellulis ex Vaccinum parvovirosis caninae vivum ............................... 744
elementis praeparatum poliomyelitidis inactivatum et Vaccinum parvovirosis inactivatum ad suem ................... 787
haemophili stirpe b coniugatum adsorbatum................. 653 Vaccinum pasteurellae inactivatum ad ovem.................... 783
Vaccinum encephalitidis ixodibus advectae Vaccinum pertussis................................................................... 685
inactivatum ..................................................................... 5.3-3414 Vaccinum pertussis adsorbatum ........................................... 690
Vaccinum encephalomyelitidis infectivae aviariae Vaccinum pertussis sine cellulis copurificatum
vivum.......................................................................................... 725 adsorbatum............................................................................... 688
Vaccinum erysipelatis suillae inactivatum ........................ 793 Vaccinum pertussis sine cellulis ex elementis praeparatum
Vaccinum febris flavae vivum.......................................5.1-2852 adsorbatum......................................................................5.3-3407
Vaccinum febris typhoidi ........................................................ 707 Vaccinum pestis anatis vivum ......................................5.3-3419
Vaccinum febris typhoidi cryodesiccatum ......................... 707 Vaccinum pestis classicae suillae vivum
Vaccinum febris typhoidis polysaccharidicum ................. 705 cryodesiccatum ....................................................................... 793
Vaccinum febris typhoidis vivum perorale (stirpe Vaccinum pneumococcale polysaccharidicum................. 691
Ty 21a) ....................................................................................... 708 Vaccinum pneumococcale polysaccharidicum coniugatum
Vaccinum furunculosidis ad salmonidas inactivatum cum adsorbatum......................................................................5.1-2851
adiuvatione oleosa ad iniectionem.................................... 767 Vaccinum poliomyelitidis inactivatum ............................... 692
Vaccinum haemophili stirpe b coniugatum....................... 662 Vaccinum poliomyelitidis perorale ............................. 5.3-3410
Vaccinum hepatitidis A inactivatum adsorbatum ............ 665 Vaccinum pseudopestis aviariae inactivatum................... 779
Vaccinum hepatitidis A inactivatum et hepatitidis B (ADNr) Vaccinum pseudopestis aviariae vivum.............................. 781
adsorbatum............................................................................... 664 Vaccinum rabiei ex cellulis ad usum humanum .............. 699
Vaccinum hepatitidis A inactivatum virosomale.............. 667 Vaccinum rabiei inactivatum ad usum veterinarium ..... 790
Vaccinum hepatitidis B (ADNr)............................................. 670 Vaccinum rabiei perorale vivum ad vulpem ...................... 792
Vaccinum hepatitidis viralis anatis stirpe I vivum .......... 751 Vaccinum rhinitidis atrophicantis ingravescentis suillae
Vaccinum herpesviris equini inactivatum ......................... 754 inactivatum .............................................................................. 788
Vaccinum inactivatum diarrhoeae vituli coronaviro Vaccinum rhinotracheitidis infectivae bovinae vivum
illatae ......................................................................................... 736 cryodesiccatum ....................................................................... 768
Vaccinum inactivatum diarrhoeae vituli rotaviro Vaccinum rhinotracheitidis viralis felinae inactivatum.. 762
illatae ......................................................................................... 737 Vaccinum rhinotracheitidis viralis felinae vivum
Vaccinum influenzae equi inactivatum.............................. 755 cryodesiccatum ....................................................................... 763
Vaccinum influenzae inactivatum ad suem ...................... 785 Vaccinum rubellae vivum ....................................................... 701
Vaccinum influenzae inactivatum ex corticis antigeniis Vaccinum tenosynovitidis viralis aviariae vivum ............ 729
praeparatum....................................................................5.3-3402 Vaccinum tetani adsorbatum ................................................. 702
Vaccinum influenzae inactivatum ex corticis antigeniis Vaccinum tetani ad usum veterinarium ............................. 795
praeparatum virosomale..............................................5.3-3404 Vaccinum tuberculosis (BCG) cryodesiccatum ................. 636
Vaccinum influenzae inactivatum ex viris integris Vaccinum varicellae vivum .................................................... 709
praeparatum....................................................................5.3-3406 Vaccinum variolae gallinaceae vivum ............................... 766
Vaccinum influenzae inactivatum ex virorum fragmentis Vaccinum vibriosidis ad salmonidas inactivatum ........... 797
praeparatum....................................................................5.3-3401 Vaccinum vibriosidis aquae frigidae inactivatum ad
Vaccinum laryngotracheitidis infectivae aviariae salmonidas................................................................................ 796
vivum.......................................................................................... 727 Vaccinum viri syncytialis meatus spiritus bovini vivum
Vaccinum leptospirosis bovinae inactivatum.................... 730 cryodesiccatum ....................................................................... 733
Vaccinum leptospirosis caninae inactivatum ................... 740 Vaginal capsules ................................................................5.2-3153
Vaccinum leucosis felinae inactivatum................................761 Vaginal foams.....................................................................5.2-3154
Vaccinum mannheimiae inactivatum ad bovidas ............ 771 Vaginalia ............................................................................5.2-3152
Vaccinum mannheimiae inactivatum ad ovem ................ 772 Vaginal preparations ........................................................5.2-3152
Vaccinum meningococcale classis C coniugatum ........... 680 Vaginal preparations, semi-solid ....................................5.2-3153
Vaccinum meningococcale polysaccharidicum................ 682 Vaginal solutions and suspensions, tablets for...........5.2-3153
Vaccinum morbi Aujeszkyi ad suem inactivatum ............ 715 Vaginal solutions, emulsions and suspensions...........5.2-3153

3690 See the information section on general monographs (cover pages)


EUROPEAN PHARMACOPOEIA 5.3 Index

Vaginal tablets ...................................................................5.2-3153 Water, determination by distillation (2.2.13.) ........................ 32


Vaginal tampons, medicated...........................................5.2-3154 Water for diluting concentrated haemodialysis
Valerianae radix ......................................................................2667 solutions .................................................................................. 1699
Valerian root..............................................................................2667 Water for injections .................................................................2692
Validation of nucleic acid amplification techniques for the Water for pharmaceutical use, total organic carbon in
detection of hepatitis C virus (HCV) RNA in plasma pools : (2.2.44.) ........................................................................................ 68
Guidelines...................................................................................176 Water, highly purified .............................................................2695
Valine ..........................................................................................2668 Water in essential oils (2.8.5.) ..................................................216
Valinum .....................................................................................2668 Water in gases (2.5.28.) ............................................................ 136
Valproic acid..............................................................................2669 Water: micro determination (2.5.32.) .................................... 137
Vancomycin hydrochloride ....................................................2670 Water, purified..........................................................................2697
Vancomycini hydrochloridum.............................................2670 Water: semi-micro determination (2.5.12.)........................... 130
Vanillin .......................................................................................2672 Wheat-germ oil, refined ..........................................................2699
Vanillinum ................................................................................2672 Wheat-germ oil, virgin.............................................................2699
Varicella immunoglobulin for intravenous administration, Wheat starch .............................................................................2698
human ...................................................................................... 1753 White beeswax .......................................................................... 1057
Varicella immunoglobulin, human....................................... 1752 White horehound ..............................................................5.1-3039
Varicella vaccine (live)............................................................... 709 White soft paraffin................................................................... 2187
Vaselinum album..................................................................... 2187 Wild pansy (flowering aerial parts)......................................2700
Vaselinum flavum ................................................................... 2188 Wild thyme ................................................................................ 2701
Vegetable drugs, determination of essential oils in vegetable Willow bark ...............................................................................2702
drugs (2.8.12.) ...........................................................................217 Wool alcohols............................................................................2703
Vegetable fatty oils..................................................................... 595 Wool fat ...............................................................................5.2-3285
Verapamil hydrochloride ........................................................2673 Wool fat, hydrogenated...........................................................2708
Verapamili hydrochloridum .................................................2673 Wool fat, hydrous.....................................................................2709
Verbasci flos..............................................................................2065 Wormwood ................................................................................ 2710
Veterinary liquid preparations for cutaneous application.. 630
Vibriosis (cold-water) vaccine (inactivated) for salmonids.. 796 X
Vibriosis vaccine (inactivated) for salmonids....................... 797 Xanthan gum ............................................................................ 2715
VICH (5.8.)................................................................................... 551 Xanthani gummi ..................................................................... 2715
Vinblastine sulphate................................................................2675 Xenon (133Xe) injection.............................................................. 869
Vinblastini sulfas.....................................................................2675 Xenoni (133Xe) solutio iniectabilis ......................................... 869
Vincristine sulphate.................................................................2675 X-ray fluorescence spectrometry (2.2.37.)............................... 56
Vincristini sulfas .....................................................................2675 Xylazine hydrochloride for veterinary use ......................... 2716
Vindesine sulphate ..................................................................2677 Xylazini hydrochloridum ad usum veterinarium .......... 2716
Vindesini sulfas .......................................................................2677 Xylitol...................................................................................5.3-3647
Vinorelbine tartrate ..........................................................5.1-3033 Xylitolum ............................................................................5.3-3647
Vinorelbini tartras............................................................5.1-3033 Xylometazoline hydrochloride .............................................. 2719
Violae herba cum flore ..........................................................2700 Xylometazolini hydrochloridum ......................................... 2719
Viper venom antiserum, European ........................................ 806 Xylose..........................................................................................2720
Viscometer method, capillary (2.2.9.)...................................... 29 Xylosum .....................................................................................2720
Viscometer method, falling ball (2.2.49.)................................ 80
Viscose wadding, absorbent .................................................. 2681
Y
Viscosity (2.2.8.) ........................................................................... 29
Viscosity - rotating viscometer method (2.2.10.)........5.3-3337 Yarrow ........................................................................................2723
Visible absorption spectrophotometry (2.2.25.).........5.2-3089 Yellow beeswax ......................................................................... 1058
Visible particles, particulate contamination (2.9.20.) ........ 255 Yellow fever vaccine (live) ...............................................5.1-2852
Vitamin A ............................................................................5.3-3639 Yellow soft paraffin.................................................................. 2188
Vitamin A concentrate (oily form), synthetic..............5.3-3640
Vitamin A concentrate (powder form), synthetic.......5.3-3641 Z
Vitamin A concentrate (solubilisate/emulsion), Zidovudine..........................................................................5.1-3043
synthetic ...........................................................................5.3-3642 Zidovudinum .....................................................................5.1-3043
Vitaminum A .....................................................................5.3-3639 Zinc acetate dihydrate.............................................................2728
Vitaminum A densatum oleosum ................................5.3-3640 Zinc acexamate .........................................................................2729
Vitaminum A in aqua dispergibile ..............................5.3-3642 Zinc chloride .............................................................................2730
Vitaminum A pulvis.........................................................5.3-3641 Zinci acetas dihydricus .........................................................2728
Volumetric analysis (4.2.) ......................................................... 435 Zinci acexamas........................................................................2729
Volumetric solutions (4.2.2.).................................................... 435 Zinci chloridum.......................................................................2730
Volumetric solutions (4.2.2.)...........................................5.3-3378 Zinci oxidum ............................................................................ 2731
Volumetric solutions, primary standards for (4.2.1.) ......... 435 Zinci stearas .............................................................................2732
Volumetric solutions, primary standards for (4.2.1.) ..5.3-3378 Zinci sulfas heptahydricus....................................................2732
Von Willebrand factor, human, assay of (2.7.21.).................211 Zinci sulfas hexahydricus .....................................................2733
Zinci undecylenas...................................................................2733
W Zinc oxide................................................................................... 2731
Warfarin sodium....................................................................... 2691 Zinc stearate..............................................................................2732
Warfarin sodium clathrate ..................................................... 2691 Zinc sulphate heptahydrate ...................................................2732
Warfarinum natricum............................................................ 2691 Zinc sulphate hexahydrate.....................................................2733
Warfarinum natricum clathratum...................................... 2691 Zinc undecylenate ....................................................................2733
Water (15O) injection.................................................................. 868 Zingiberis rhizoma ................................................................. 1656

General Notices (1) apply to all monographs and other texts 3691
Index EUROPEAN PHARMACOPOEIA 5.3

Zolpidemi tartras.....................................................................2734 Zopiclonum...............................................................................2735


Zolpidem tartrate .....................................................................2734 Zuclopenthixol decanoate ......................................................2736
Zopiclone ...................................................................................2735 Zuclopenthixoli decanoas.....................................................2736

3692 See the information section on general monographs (cover pages)

Вам также может понравиться